O60507	TPST1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein-tyrosine sulfotransferase 1 (EC 2.8.2.20) (Tyrosylprotein sulfotransferase 1) (TPST-1)	TPST1	12020;	9606.ENSP00000302413;
Q9NP99	TREM1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Triggering receptor expressed on myeloid cells 1 (TREM-1) (Triggering receptor expressed on monocytes 1) (CD antigen CD354)	TREM1	17760;	9606.ENSP00000244709;
P61088	UBE2N_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ubiquitin-conjugating enzyme E2 N (EC 2.3.2.23) (Bendless-like ubiquitin-conjugating enzyme) (E2 ubiquitin-conjugating enzyme N) (Ubc13) (UbcH13) (Ubiquitin carrier protein N) (Ubiquitin-protein ligase N)	UBE2N BLU	12492;	9606.ENSP00000316176;
Q8NDB2	BANK1_HUMAN	reviewed	Evidence at protein level	5 out of 5	B-cell scaffold protein with ankyrin repeats	BANK1	18233;	9606.ENSP00000320509;
Q13075	BIRC1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Baculoviral IAP repeat-containing protein 1 (Neuronal apoptosis inhibitory protein)	NAIP BIRC1	7634;	9606.ENSP00000428657;
O00590	ACKR2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Atypical chemokine receptor 2 (C-C chemokine receptor D6) (Chemokine receptor CCR-10) (Chemokine receptor CCR-9) (Chemokine-binding protein 2) (Chemokine-binding protein D6)	ACKR2 CCBP2 CCR10 CMKBR9 D6	1565;	9606.ENSP00000416996;
P31749	AKT1_HUMAN	reviewed	Evidence at protein level	5 out of 5	RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)	AKT1 PKB RAC	391;	9606.ENSP00000451828;
P02760	AMBP_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein AMBP (Protein HC) [Cleaved into: Alpha-1-microglobulin (EC 1.6.2.-) (Alpha-1 microglycoprotein) (Complex-forming glycoprotein heterogeneous in charge); Inter-alpha-trypsin inhibitor light chain (ITI-LC) (Bikunin) (EDC1) (HI-30) (Uronic-acid-rich protein); Trypstatin]	AMBP HCP ITIL	453;	9606.ENSP00000265132;
Q9BQI0	AIF1L_HUMAN	reviewed	Evidence at protein level	5 out of 5	Allograft inflammatory factor 1-like (Ionized calcium-binding adapter molecule 2)	AIF1L C9orf58 IBA2 UNQ672/PRO1306	28904;	
P06881	CALCA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Calcitonin gene-related peptide 1 (Alpha-type CGRP) (Calcitonin gene-related peptide I) (CGRP-I)	CALCA CALC1	1437;	
P17516	AK1C4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Aldo-keto reductase family 1 member C4 (EC 1.1.1.-) (EC 1.1.1.209) (EC 1.1.1.210) (EC 1.1.1.51) (EC 1.1.1.53) (EC 1.1.1.62) (3-alpha-hydroxysteroid dehydrogenase type I) (3-alpha-HSD1) (EC 1.1.1.357) (3alpha-hydroxysteroid 3-dehydrogenase) (Chlordecone reductase) (CDR) (EC 1.1.1.225) (Dihydrodiol dehydrogenase 4) (DD-4) (DD4) (HAKRA)	AKR1C4 CHDR	387;	9606.ENSP00000369814;
P20292	AL5AP_HUMAN	reviewed	Evidence at protein level	5 out of 5	Arachidonate 5-lipoxygenase-activating protein (FLAP) (MK-886-binding protein)	ALOX5AP FLAP	436;	9606.ENSP00000479870;
P40145	ADCY8_HUMAN	reviewed	Evidence at protein level	5 out of 5	Adenylate cyclase type 8 (EC 4.6.1.1) (ATP pyrophosphate-lyase 8) (Adenylate cyclase type VIII) (Adenylyl cyclase 8) (AC8) (Ca(2+)/calmodulin-activated adenylyl cyclase)	ADCY8	239;	9606.ENSP00000286355;
Q7Z4H4	ADM2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein ADM2 (Intermedin) [Cleaved into: Adrenomedullin-2 (AM2) (Intermedin-long) (IMDL); Intermedin-short (IMDS)]	ADM2 AM2	28898;	9606.ENSP00000379087;
P08588	ADRB1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Beta-1 adrenergic receptor (Beta-1 adrenoreceptor) (Beta-1 adrenoceptor)	ADRB1 ADRB1R B1AR	285;	9606.ENSP00000358301;
P05090	APOD_HUMAN	reviewed	Evidence at protein level	5 out of 5	Apolipoprotein D (Apo-D) (ApoD)	APOD	612;	9606.ENSP00000345179;
P22362	CCL1_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C motif chemokine 1 (Small-inducible cytokine A1) (T lymphocyte-secreted protein I-309)	CCL1 SCYA1	10609;	9606.ENSP00000225842;
Q9ULZ3	ASC_HUMAN	reviewed	Evidence at protein level	5 out of 5	Apoptosis-associated speck-like protein containing a CARD (hASC) (Caspase recruitment domain-containing protein 5) (PYD and CARD domain-containing protein) (Target of methylation-induced silencing 1)	PYCARD ASC CARD5 TMS1	16608;	9606.ENSP00000247470;
P49682	CXCR3_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-X-C chemokine receptor type 3 (CXC-R3) (CXCR-3) (CKR-L2) (G protein-coupled receptor 9) (Interferon-inducible protein 10 receptor) (IP-10 receptor) (CD antigen CD183)	CXCR3 GPR9	4540;	9606.ENSP00000362795;
Q01844	EWS_HUMAN	reviewed	Evidence at protein level	5 out of 5	RNA-binding protein EWS (EWS oncogene) (Ewing sarcoma breakpoint region 1 protein)	EWSR1 EWS	3508;	9606.ENSP00000400142;
Q96RT1	ERBIN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Erbin (Densin-180-like protein) (Erbb2-interacting protein) (Protein LAP2)	ERBIN ERBB2IP KIAA1225 LAP2	15842;	9606.ENSP00000426632;
Q09472	EP300_HUMAN	reviewed	Evidence at protein level	5 out of 5	Histone acetyltransferase p300 (p300 HAT) (EC 2.3.1.48) (E1A-associated protein p300) (Histone butyryltransferase p300) (EC 2.3.1.-) (Histone crotonyltransferase p300) (EC 2.3.1.-) (Protein 2-hydroxyisobutyryltransferase p300) (EC 2.3.1.-) (Protein lactyltransferas p300) (EC 2.3.1.-) (Protein propionyltransferase p300) (EC 2.3.1.-)	EP300 P300	3373;	9606.ENSP00000263253;
P16422	EPCAM_HUMAN	reviewed	Evidence at protein level	5 out of 5	Epithelial cell adhesion molecule (Ep-CAM) (Adenocarcinoma-associated antigen) (Cell surface glycoprotein Trop-1) (Epithelial cell surface antigen) (Epithelial glycoprotein) (EGP) (Epithelial glycoprotein 314) (EGP314) (hEGP314) (KS 1/4 antigen) (KSA) (Major gastrointestinal tumor-associated protein GA733-2) (Tumor-associated calcium signal transducer 1) (CD antigen CD326)	EPCAM GA733-2 M1S2 M4S1 MIC18 TACSTD1 TROP1	11529;	9606.ENSP00000263735;
Q01362	FCERB_HUMAN	reviewed	Evidence at protein level	5 out of 5	High affinity immunoglobulin epsilon receptor subunit beta (FcERI) (Fc epsilon receptor I beta-chain) (IgE Fc receptor subunit beta) (Membrane-spanning 4-domains subfamily A member 2)	MS4A2 APY FCER1B IGER	7316;	9606.ENSP00000278888;
P53355	DAPK1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1)	DAPK1 DAPK	2674;	9606.ENSP00000386135;
Q8NE71	ABCF1_HUMAN	reviewed	Evidence at protein level	5 out of 5	ATP-binding cassette sub-family F member 1 (ATP-binding cassette 50) (TNF-alpha-stimulated ABC protein)	ABCF1 ABC50	70;	9606.ENSP00000313603;
Q9NUN7	ACER3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Alkaline ceramidase 3 (AlkCDase 3) (Alkaline CDase 3) (EC 3.5.1.-) (EC 3.5.1.23) (Alkaline dihydroceramidase SB89) (Alkaline phytoceramidase) (aPHC)	ACER3 APHC PHCA	16066;	9606.ENSP00000434480;
Q10588	BST1_HUMAN	reviewed	Evidence at protein level	5 out of 5	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 (EC 3.2.2.6) (ADP-ribosyl cyclase 2) (Bone marrow stromal antigen 1) (BST-1) (Cyclic ADP-ribose hydrolase 2) (cADPr hydrolase 2) (CD antigen CD157)	BST1	1118;	9606.ENSP00000265016;
P46663	BKRB1_HUMAN	reviewed	Evidence at protein level	5 out of 5	B1 bradykinin receptor (B1R) (BK-1 receptor)	BDKRB1 BRADYB1	1029;	9606.ENSP00000216629;
O43709	BUD23_HUMAN	reviewed	Evidence at protein level	5 out of 5	Probable 18S rRNA (guanine-N(7))-methyltransferase (EC 2.1.1.-) (Bud site selection protein 23 homolog) (Metastasis-related methyltransferase 1) (Williams-Beuren syndrome chromosomal region 22 protein) (rRNA methyltransferase and ribosome maturation factor)	BUD23 MERM1 WBSCR22 HUSSY-03 PP3381	16405;	9606.ENSP00000401191;
P30411	BKRB2_HUMAN	reviewed	Evidence at protein level	5 out of 5	B2 bradykinin receptor (B2R) (BK-2 receptor)	BDKRB2 BKR2	1030;	9606.ENSP00000450482;
Q9BYV9	BACH2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transcription regulator protein BACH2 (BTB and CNC homolog 2)	BACH2	14078;	9606.ENSP00000257749;
P27348	1433T_HUMAN	reviewed	Evidence at protein level	5 out of 5	14-3-3 protein theta (14-3-3 protein T-cell) (14-3-3 protein tau) (Protein HS1)	YWHAQ	12854;	9606.ENSP00000371267;
P50406	5HT6R_HUMAN	reviewed	Evidence at protein level	5 out of 5	5-hydroxytryptamine receptor 6 (5-HT-6) (5-HT6) (Serotonin receptor 6)	HTR6	5301;	9606.ENSP00000289753;
P15291	B4GT1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase) (EC 2.4.1.38) (Lactose synthase A protein) (EC 2.4.1.22) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (Neolactotriaosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.275) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1]	B4GALT1 GGTB2	924;	9606.ENSP00000369055;
P00813	ADA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase)	ADA ADA1	186;	9606.ENSP00000361965;
P07550	ADRB2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Beta-2 adrenergic receptor (Beta-2 adrenoreceptor) (Beta-2 adrenoceptor)	ADRB2 ADRB2R B2AR	286;	9606.ENSP00000305372;
Q03989	ARI5A_HUMAN	reviewed	Evidence at protein level	5 out of 5	AT-rich interactive domain-containing protein 5A (ARID domain-containing protein 5A) (Modulator recognition factor 1) (MRF-1)	ARID5A MRF1	17361;	9606.ENSP00000350078;
Q9NR48	ASH1L_HUMAN	reviewed	Evidence at protein level	5 out of 5	Histone-lysine N-methyltransferase ASH1L (EC 2.1.1.359) (EC 2.1.1.367) (ASH1-like protein) (huASH1) (Absent small and homeotic disks protein 1 homolog) (Lysine N-methyltransferase 2H)	ASH1L KIAA1420 KMT2H	19088;	9606.ENSP00000376204;
O00585	CCL21_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C motif chemokine 21 (6Ckine) (Beta-chemokine exodus-2) (Secondary lymphoid-tissue chemokine) (SLC) (Small-inducible cytokine A21)	CCL21 SCYA21 UNQ784/PRO1600	10620;	9606.ENSP00000259607;
O00626	CCL22_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C motif chemokine 22 (CC chemokine STCP-1) (MDC(1-69)) (Macrophage-derived chemokine) (Small-inducible cytokine A22) (Stimulated T-cell chemotactic protein 1) [Cleaved into: MDC(3-69); MDC(5-69); MDC(7-69)]	CCL22 MDC SCYA22 A-152E5.1	10621;	9606.ENSP00000219235;
P55773	CCL23_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C motif chemokine 23 (CK-beta-8) (CKB-8) (Macrophage inflammatory protein 3) (MIP-3) (Myeloid progenitor inhibitory factor 1) (MPIF-1) (Small-inducible cytokine A23) [Cleaved into: CCL23(19-99); CCL23(22-99); CCL23(27-99); CCL23(30-99)]	CCL23 MIP3 MPIF1 SCYA23	10622;	
O00175	CCL24_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C motif chemokine 24 (CK-beta-6) (Eosinophil chemotactic protein 2) (Eotaxin-2) (Myeloid progenitor inhibitory factor 2) (MPIF-2) (Small-inducible cytokine A24)	CCL24 MPIF2 SCYA24	10623;	9606.ENSP00000400533;
O15444	CCL25_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C motif chemokine 25 (Chemokine TECK) (Small-inducible cytokine A25) (Thymus-expressed chemokine)	CCL25 SCYA25 TECK	10624;	9606.ENSP00000375086;
Q9Y4X3	CCL27_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C motif chemokine 27 (CC chemokine ILC) (Cutaneous T-cell-attracting chemokine) (CTACK) (ESkine) (IL-11 R-alpha-locus chemokine) (Skinkine) (Small-inducible cytokine A27)	CCL27 ILC SCYA27	10626;	9606.ENSP00000259631;
P25063	CD24_HUMAN	reviewed	Evidence at protein level	5 out of 5	Signal transducer CD24 (Small cell lung carcinoma cluster 4 antigen) (CD antigen CD24)	CD24 CD24A	1645;	9606.ENSP00000483985;
O75366	AVIL_HUMAN	reviewed	Evidence at protein level	5 out of 5	Advillin (p92)	AVIL	14188;	9606.ENSP00000257861;
O00421	CCRL2_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C chemokine receptor-like 2 (Chemokine receptor CCR11) (Chemokine receptor X) (Putative MCP-1 chemokine receptor)	CCRL2 CCR11 CCR6 CKRX CRAM HCR	1612;	9606.ENSP00000349967;
P78357	CNTP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Contactin-associated protein 1 (Caspr) (Caspr1) (Neurexin IV) (Neurexin-4) (p190)	CNTNAP1 CASPR NRXN4	8011;	9606.ENSP00000264638;
P78540	ARGI2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Arginase-2, mitochondrial (EC 3.5.3.1) (Arginase II) (Kidney-type arginase) (Non-hepatic arginase) (Type II arginase)	ARG2	664;	9606.ENSP00000261783;
P02652	APOA2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Apolipoprotein A-II (Apo-AII) (ApoA-II) (Apolipoprotein A2) [Cleaved into: Proapolipoprotein A-II (ProapoA-II); Truncated apolipoprotein A-II (Apolipoprotein A-II(1-76))]	APOA2	601;	9606.ENSP00000356969;
P02649	APOE_HUMAN	reviewed	Evidence at protein level	5 out of 5	Apolipoprotein E (Apo-E)	APOE	613;	9606.ENSP00000252486;
Q9BWU1	CDK19_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cyclin-dependent kinase 19 (EC 2.7.11.22) (CDC2-related protein kinase 6) (Cell division cycle 2-like protein kinase 6) (Cell division protein kinase 19) (Cyclin-dependent kinase 11) (Death-preventing kinase)	CDK19 CDC2L6 CDK11 KIAA1028	19338;	9606.ENSP00000357907;
O15467	CCL16_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C motif chemokine 16 (Chemokine CC-4) (HCC-4) (Chemokine LEC) (IL-10-inducible chemokine) (LCC-1) (Liver-expressed chemokine) (Lymphocyte and monocyte chemoattractant) (LMC) (Monotactin-1) (MTN-1) (NCC-4) (Small-inducible cytokine A16)	CCL16 ILINCK NCC4 SCYA16	10614;	9606.ENSP00000478024;
A6NC98	CC88B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Coiled-coil domain-containing protein 88B (Brain leucine zipper domain-containing protein) (Gipie) (Hook-related protein 3) (HkRP3)	CCDC88B BRLZ	26757;	9606.ENSP00000349238;
P61073	CXCR4_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-X-C chemokine receptor type 4 (CXC-R4) (CXCR-4) (FB22) (Fusin) (HM89) (LCR1) (Leukocyte-derived seven transmembrane domain receptor) (LESTR) (Lipopolysaccharide-associated protein 3) (LAP-3) (LPS-associated protein 3) (NPYRL) (Stromal cell-derived factor 1 receptor) (SDF-1 receptor) (CD antigen CD184)	CXCR4	2561;	9606.ENSP00000386884;
P10092	CALCB_HUMAN	reviewed	Evidence at protein level	5 out of 5	Calcitonin gene-related peptide 2 (Beta-type CGRP) (Beta-CGRP) (Calcitonin gene-related peptide II) (CGRP-II)	CALCB CALC2	1438;	9606.ENSP00000433490;
Q07021	C1QBP_HUMAN	reviewed	Evidence at protein level	5 out of 5	Complement component 1 Q subcomponent-binding protein, mitochondrial (ASF/SF2-associated protein p32) (Glycoprotein gC1qBP) (C1qBP) (Hyaluronan-binding protein 1) (Mitochondrial matrix protein p32) (gC1q-R protein) (p33) (SF2AP32)	C1QBP GC1QBP HABP1 SF2P32	1243;	9606.ENSP00000225698;
P22674	CCNO_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cyclin-O	CCNO	18576;	9606.ENSP00000282572;
P26842	CD27_HUMAN	reviewed	Evidence at protein level	5 out of 5	CD27 antigen (CD27L receptor) (T-cell activation antigen CD27) (T14) (Tumor necrosis factor receptor superfamily member 7) (CD antigen CD27)	CD27 TNFRSF7	11922;	9606.ENSP00000266557;
P10747	CD28_HUMAN	reviewed	Evidence at protein level	5 out of 5	T-cell-specific surface glycoprotein CD28 (TP44) (CD antigen CD28)	CD28	1653;	9606.ENSP00000324890;
P29965	CD40L_HUMAN	reviewed	Evidence at protein level	5 out of 5	CD40 ligand (CD40-L) (T-cell antigen Gp39) (TNF-related activation protein) (TRAP) (Tumor necrosis factor ligand superfamily member 5) (CD antigen CD154) [Cleaved into: CD40 ligand, membrane form; CD40 ligand, soluble form (sCD40L)]	CD40LG CD40L TNFSF5 TRAP	11935;	9606.ENSP00000359663;
P0C0L5	CO4B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Complement C4-B (Basic complement C4) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 3) [Cleaved into: Complement C4 beta chain; Complement C4-B alpha chain; C4a anaphylatoxin; C4b-B; C4d-B; Complement C4 gamma chain]	C4B CO4 CPAMD3; C4B_2	1324;42398;	9606.ENSP00000415941;
Q68CJ9	CR3L3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cyclic AMP-responsive element-binding protein 3-like protein 3 (cAMP-responsive element-binding protein 3-like protein 3) (Transcription factor CREB-H) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 3]	CREB3L3 CREBH HYST1481	18855;	9606.ENSP00000078445;
Q9UBJ2	ABCD2_HUMAN	reviewed	Evidence at protein level	5 out of 5	ATP-binding cassette sub-family D member 2 (EC 3.1.2.-) (EC 7.6.2.-) (Adrenoleukodystrophy-like 1) (Adrenoleukodystrophy-related protein) (hALDR)	ABCD2 ALD1 ALDL1 ALDR ALDRP	66;	9606.ENSP00000310688;
P12821	ACE_HUMAN	reviewed	Evidence at protein level	5 out of 5	Angiotensin-converting enzyme (ACE) (EC 3.2.1.-) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (CD antigen CD143) [Cleaved into: Angiotensin-converting enzyme, soluble form]	ACE DCP DCP1	2707;	9606.ENSP00000290866;
O60885	BRD4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Bromodomain-containing protein 4 (Protein HUNK1)	BRD4 HUNK1	13575;	9606.ENSP00000263377;
Q06187	BTK_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase)	BTK AGMX1 ATK BPK	1133;	9606.ENSP00000483570;
P05067	A4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Amyloid-beta precursor protein (APP) (ABPP) (APPI) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) (Cerebral vascular amyloid peptide) (CVAP) (PreA4) (Protease nexin-II) (PN-II) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (Beta-secretase C-terminal fragment) (Beta-CTF); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Amyloid intracellular domain 59) (AICD-59) (AID(59)) (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Amyloid intracellular domain 57) (AICD-57) (AID(57)) (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Amyloid intracellular domain 50) (AICD-50) (AID(50)) (Gamma-CTF(50)); C31]	APP A4 AD1	620;	9606.ENSP00000284981;
Q9UIR0	BTNL2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Butyrophilin-like protein 2 (BTL-II)	BTNL2	1142;	9606.ENSP00000390613;
P30542	AA1R_HUMAN	reviewed	Evidence at protein level	5 out of 5	Adenosine receptor A1	ADORA1	262;	9606.ENSP00000356205;
P29274	AA2AR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Adenosine receptor A2a	ADORA2A ADORA2	263;	9606.ENSP00000480012;
P29275	AA2BR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Adenosine receptor A2b	ADORA2B	264;	9606.ENSP00000304501;
P0DMS8	AA3R_HUMAN	reviewed	Evidence at protein level	5 out of 5	Adenosine receptor A3	ADORA3	268;	
O95415	BRI3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Brain protein I3 (pRGR2)	BRI3	1109;	9606.ENSP00000297290;
P01011	AACT_HUMAN	reviewed	Evidence at protein level	5 out of 5	Alpha-1-antichymotrypsin (ACT) (Cell growth-inhibiting gene 24/25 protein) (Serpin A3) [Cleaved into: Alpha-1-antichymotrypsin His-Pro-less]	SERPINA3 AACT GIG24 GIG25	16;	9606.ENSP00000450540;
Q9UHX3	AGRE2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Adhesion G protein-coupled receptor E2 (EGF-like module receptor 2) (EGF-like module-containing mucin-like hormone receptor-like 2) (CD antigen CD312)	ADGRE2 EMR2	3337;	9606.ENSP00000319883;
P11274	BCR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Breakpoint cluster region protein (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-26)	BCR BCR1 D22S11	1014;	9606.ENSP00000303507;
P30988	CALCR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Calcitonin receptor (CT-R)	CALCR	1440;	9606.ENSP00000352561;
P42330	AK1C3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Aldo-keto reductase family 1 member C3 (EC 1.1.1.-) (EC 1.1.1.210) (EC 1.1.1.53) (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 5) (17-beta-HSD 5) (3-alpha-HSD type II, brain) (3-alpha-hydroxysteroid dehydrogenase type 2) (3-alpha-HSD type 2) (EC 1.1.1.357) (Chlordecone reductase homolog HAKRb) (Dihydrodiol dehydrogenase 3) (DD-3) (DD3) (Dihydrodiol dehydrogenase type I) (HA1753) (Prostaglandin F synthase) (PGFS) (EC 1.1.1.188) (Testosterone 17-beta-dehydrogenase 5) (EC 1.1.1.239) (EC 1.1.1.64)	AKR1C3 DDH1 HSD17B5 KIAA0119 PGFS	386;	9606.ENSP00000369927;
P49662	CASP4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Caspase-4 (CASP-4) (EC 3.4.22.57) (ICE and Ced-3 homolog 2) (ICH-2) (ICE(rel)-II) (Mih1) (Protease TX) [Cleaved into: Caspase-4 subunit p10; Caspase-4 subunit p20]	CASP4 ICH2	1505;	9606.ENSP00000388566;
Q8IUX7	AEBP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Adipocyte enhancer-binding protein 1 (AE-binding protein 1) (Aortic carboxypeptidase-like protein)	AEBP1 ACLP	303;	9606.ENSP00000223357;
O43306	ADCY6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Adenylate cyclase type 6 (EC 4.6.1.1) (ATP pyrophosphate-lyase 6) (Adenylate cyclase type VI) (Adenylyl cyclase 6) (Ca(2+)-inhibitable adenylyl cyclase)	ADCY6 KIAA0422	237;	9606.ENSP00000311405;
P33076	C2TA_HUMAN	reviewed	Evidence at protein level	5 out of 5	MHC class II transactivator (CIITA) (EC 2.3.1.-) (EC 2.7.11.1)	CIITA MHC2TA	7067;	9606.ENSP00000485010;
Q15848	ADIPO_HUMAN	reviewed	Evidence at protein level	5 out of 5	Adiponectin (30 kDa adipocyte complement-related protein) (Adipocyte complement-related 30 kDa protein) (ACRP30) (Adipocyte, C1q and collagen domain-containing protein) (Adipose most abundant gene transcript 1 protein) (apM-1) (Gelatin-binding protein)	ADIPOQ ACDC ACRP30 APM1 GBP28	13633;	9606.ENSP00000389814;
O95971	BY55_HUMAN	reviewed	Evidence at protein level	5 out of 5	CD160 antigen (Natural killer cell receptor BY55) (CD antigen CD160) [Cleaved into: CD160 antigen, soluble form]	CD160 BY55	17013;	9606.ENSP00000235933;
Q99616	CCL13_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C motif chemokine 13 (CK-beta-10) (Monocyte chemoattractant protein 4) (Monocyte chemotactic protein 4) (MCP-4) (NCC-1) (Small-inducible cytokine A13) [Cleaved into: C-C motif chemokine 13, long chain; C-C motif chemokine 13, medium chain; C-C motif chemokine 13, short chain]	CCL13 MCP4 NCC1 SCYA13	10611;	9606.ENSP00000225844;
Q92879	CELF1_HUMAN	reviewed	Evidence at protein level	5 out of 5	CUGBP Elav-like family member 1 (CELF-1) (50 kDa nuclear polyadenylated RNA-binding protein) (Bruno-like protein 2) (CUG triplet repeat RNA-binding protein 1) (CUG-BP1) (CUG-BP- and ETR-3-like factor 1) (Deadenylation factor CUG-BP) (Embryo deadenylation element-binding protein homolog) (EDEN-BP homolog) (RNA-binding protein BRUNOL-2)	CELF1 BRUNOL2 CUGBP CUGBP1 NAB50	2549;	9606.ENSP00000435926;
P17405	ASM_HUMAN	reviewed	Evidence at protein level	5 out of 5	Sphingomyelin phosphodiesterase (EC 3.1.4.12) (EC 3.1.4.3) (Acid sphingomyelinase) (aSMase)	SMPD1 ASM	11120;	9606.ENSP00000340409;
Q9UNA0	ATS5_HUMAN	reviewed	Evidence at protein level	5 out of 5	A disintegrin and metalloproteinase with thrombospondin motifs 5 (ADAM-TS 5) (ADAM-TS5) (ADAMTS-5) (EC 3.4.24.-) (A disintegrin and metalloproteinase with thrombospondin motifs 11) (ADAM-TS 11) (ADAMTS-11) (ADMP-2) (Aggrecanase-2)	ADAMTS5 ADAMTS11 ADMP2	221;	9606.ENSP00000284987;
Q676U5	A16L1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Autophagy-related protein 16-1 (APG16-like 1)	ATG16L1 APG16L UNQ9393/PRO34307	21498;	9606.ENSP00000375872;
Q2M3G0	ABCB5_HUMAN	reviewed	Evidence at protein level	5 out of 5	ATP-binding cassette sub-family B member 5 (ABCB5 P-gp) (P-glycoprotein ABCB5) (EC 7.6.2.2)	ABCB5	46;	9606.ENSP00000384881;
Q86SQ4	AGRG6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Adhesion G-protein coupled receptor G6 (Developmentally regulated G-protein-coupled receptor) (G-protein coupled receptor 126) (Vascular inducible G protein-coupled receptor) [Cleaved into: ADGRG6 N-terminal fragment (ADGRG6-NTF); ADGRG6 C-terminal fragment (ADGRG6-CTF)]	ADGRG6 DREG GPR126 VIGR	13841;	9606.ENSP00000356581;
Q9UHK6	AMACR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Alpha-methylacyl-CoA racemase (EC 5.1.99.4) (2-methylacyl-CoA racemase)	AMACR	451;	9606.ENSP00000371517;
P30556	AGTR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Type-1 angiotensin II receptor (AT1AR) (AT1BR) (Angiotensin II type-1 receptor) (AT1)	AGTR1 AGTR1A AGTR1B AT2R1 AT2R1B	336;	9606.ENSP00000419422;
Q12904	AIMP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 (Multisynthase complex auxiliary component p43) [Cleaved into: Endothelial monocyte-activating polypeptide 2 (EMAP-2) (Endothelial monocyte-activating polypeptide II) (EMAP-II) (Small inducible cytokine subfamily E member 1)]	AIMP1 EMAP2 SCYE1	10648;	9606.ENSP00000378191;
O14862	AIM2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interferon-inducible protein AIM2 (Absent in melanoma 2)	AIM2	357;	9606.ENSP00000357112;
O15143	ARC1B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Actin-related protein 2/3 complex subunit 1B (Arp2/3 complex 41 kDa subunit) (p41-ARC)	ARPC1B ARC41	704;	9606.ENSP00000389631;
O00622	CCN1_HUMAN	reviewed	Evidence at protein level	5 out of 5	CCN family member 1 (Cellular communication network factor 1) (Cysteine-rich angiogenic inducer 61) (Insulin-like growth factor-binding protein 10) (IBP-10) (IGF-binding protein 10) (IGFBP-10) (Protein CYR61) (Protein GIG1)	CCN1 CYR61 GIG1 IGFBP10	2654;	9606.ENSP00000398736;
Q8IXS2	DRC2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Dynein regulatory complex subunit 2 (Coiled-coil domain-containing protein 65) (Testis development protein NYD-SP28)	CCDC65 DRC2	29937;	9606.ENSP00000312706;
P07203	GPX1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Glutathione peroxidase 1 (GPx-1) (GSHPx-1) (EC 1.11.1.9) (Cellular glutathione peroxidase)	GPX1	4553;	9606.ENSP00000407375;
P28799	GRN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Progranulin (PGRN) (Acrogranin) (Epithelin precursor) (Glycoprotein of 88 Kda) (GP88) (Glycoprotein 88) (Granulin precursor) (PC cell-derived growth factor) (PCDGF) (Proepithelin) (PEPI) [Cleaved into: Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Epithelin-2) (Granulin B); Granulin-4 (Epithelin-1) (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E)]	GRN	4601;	9606.ENSP00000053867;
P09341	GROA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Growth-regulated alpha protein (C-X-C motif chemokine 1) (GRO-alpha(1-73)) (Melanoma growth stimulatory activity) (MGSA) (Neutrophil-activating protein 3) (NAP-3) [Cleaved into: GRO-alpha(4-73); GRO-alpha(5-73); GRO-alpha(6-73)]	CXCL1 GRO GRO1 GROA MGSA SCYB1	4602;	9606.ENSP00000379110;
P57764	GSDMD_HUMAN	reviewed	Evidence at protein level	5 out of 5	Gasdermin-D (Gasdermin domain-containing protein 1) [Cleaved into: Gasdermin-D, N-terminal (GSDMD-NT) (hGSDMD-NTD); Gasdermin-D, C-terminal (GSDMD-CT) (hGSDMD-CTD)]	GSDMD DFNA5L GSDMDC1 FKSG10	25697;	9606.ENSP00000433209;
O95267	GRP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	RAS guanyl-releasing protein 1 (Calcium and DAG-regulated guanine nucleotide exchange factor II) (CalDAG-GEFII) (Ras guanyl-releasing protein)	RASGRP1 RASGRP	9878;	9606.ENSP00000310244;
O60443	GSDME_HUMAN	reviewed	Evidence at protein level	5 out of 5	Gasdermin-E (Inversely correlated with estrogen receptor expression 1) (ICERE-1) (Non-syndromic hearing impairment protein 5) [Cleaved into: Gasdermin-E, N-terminal (GSDME-NT); Gasdermin-E, C-terminal (GSDME-CT)]	GSDME DFNA5 ICERE1	2810;	9606.ENSP00000339587;
Q99678	GPR20_HUMAN	reviewed	Evidence at protein level	5 out of 5	G-protein coupled receptor 20	GPR20	4475;	9606.ENSP00000366970;
O00155	GPR25_HUMAN	reviewed	Evidence at protein level	5 out of 5	Probable G-protein coupled receptor 25	GPR25	4480;	9606.ENSP00000301917;
P31994	FCG2B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Low affinity immunoglobulin gamma Fc region receptor II-b (IgG Fc receptor II-b) (CDw32) (Fc-gamma RII-b) (Fc-gamma-RIIb) (FcRII-b) (CD antigen CD32)	FCGR2B CD32 FCG2 IGFR2	3618;	9606.ENSP00000351497;
O00270	GPR31_HUMAN	reviewed	Evidence at protein level	5 out of 5	12-(S)-hydroxy-5,8,10,14-eicosatetraenoic acid receptor (12-(S)-HETE receptor) (12-HETER) (G-protein coupled receptor 31) (GPR31/12-HETER)	GPR31	4486;	9606.ENSP00000355799;
Q13227	GPS2_HUMAN	reviewed	Evidence at protein level	5 out of 5	G protein pathway suppressor 2 (GPS-2)	GPS2	4550;	9606.ENSP00000370104;
P19652	A1AG2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Alpha-1-acid glycoprotein 2 (AGP 2) (Orosomucoid-2) (OMD 2)	ORM2 AGP2	8499;	9606.ENSP00000394936;
Q9UNA3	A4GCT_HUMAN	reviewed	Evidence at protein level	5 out of 5	Alpha-1,4-N-acetylglucosaminyltransferase (Alpha4GnT) (EC 2.4.1.-)	A4GNT	17968;	9606.ENSP00000236709;
A8K2U0	A2ML1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Alpha-2-macroglobulin-like protein 1 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 9)	A2ML1 CPAMD9	23336;	9606.ENSP00000299698;
P48960	AGRE5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Adhesion G protein-coupled receptor E5 (Leukocyte antigen CD97) (CD antigen CD97) [Cleaved into: Adhesion G protein-coupled receptor E5 subunit alpha; Adhesion G protein-coupled receptor E5 subunit beta]	ADGRE5 CD97	1711;	9606.ENSP00000242786;
Q04771	ACVR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Activin receptor type-1 (EC 2.7.11.30) (Activin receptor type I) (ACTR-I) (Activin receptor-like kinase 2) (ALK-2) (Serine/threonine-protein kinase receptor R1) (SKR1) (TGF-B superfamily receptor type I) (TSR-I)	ACVR1 ACVRLK2	171;	9606.ENSP00000263640;
P50052	AGTR2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Type-2 angiotensin II receptor (Angiotensin II type-2 receptor) (AT2)	AGTR2	338;	9606.ENSP00000360973;
Q8N4X5	AF1L2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Actin filament-associated protein 1-like 2 (AFAP1-like protein 2)	AFAP1L2 KIAA1914 XB130	25901;	9606.ENSP00000303042;
P51684	CCR6_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C chemokine receptor type 6 (C-C CKR-6) (CC-CKR-6) (CCR-6) (Chemokine receptor-like 3) (CKR-L3) (DRY6) (G-protein coupled receptor 29) (GPR-CY4) (GPRCY4) (LARC receptor) (CD antigen CD196)	CCR6 CKRL3 CMKBR6 GPR29 STRL22	1607;	9606.ENSP00000343952;
P32248	CCR7_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C chemokine receptor type 7 (C-C CKR-7) (CC-CKR-7) (CCR-7) (BLR2) (CDw197) (Epstein-Barr virus-induced G-protein coupled receptor 1) (EBI1) (EBV-induced G-protein coupled receptor 1) (MIP-3 beta receptor) (CD antigen CD197)	CCR7 CMKBR7 EBI1 EVI1	1608;	9606.ENSP00000246657;
Q9BXJ3	C1QT4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Complement C1q tumor necrosis factor-related protein 4 (C1q/TNF-related protein 4)	C1QTNF4 CTRP4	14346;	9606.ENSP00000302274;
Q9BZP6	CHIA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Acidic mammalian chitinase (AMCase) (EC 3.2.1.14) (Lung-specific protein TSA1902)	CHIA	17432;	9606.ENSP00000358755;
P32929	CGL_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cystathionine gamma-lyase (CGL) (CSE) (EC 4.4.1.1) (Cysteine desulfhydrase) (Cysteine-protein sulfhydrase) (Gamma-cystathionase) (Homocysteine desulfhydrase) (EC 4.4.1.2)	CTH	2501;	9606.ENSP00000359976;
P01024	CO3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Complement C3 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1) [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc); Complement C3 alpha chain; C3a anaphylatoxin; Acylation stimulating protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2]	C3 CPAMD1	1318;	9606.ENSP00000245907;
P20036	DPA1_HUMAN	reviewed	Evidence at protein level	5 out of 5	HLA class II histocompatibility antigen, DP alpha 1 chain (DP(W3)) (DP(W4)) (HLA-SB alpha chain) (MHC class II DP3-alpha) (MHC class II DPA1)	HLA-DPA1 HLA-DP1A HLASB	4938;	9606.ENSP00000393566;
P04440	DPB1_HUMAN	reviewed	Evidence at protein level	5 out of 5	HLA class II histocompatibility antigen, DP beta 1 chain (HLA class II histocompatibility antigen, DP(W4) beta chain) (MHC class II antigen DPB1)	HLA-DPB1 HLA-DP1B	4940;	9606.ENSP00000408146;
Q96DT5	DYH11_HUMAN	reviewed	Evidence at protein level	5 out of 5	Dynein axonemal heavy chain 11 (Axonemal beta dynein heavy chain 11) (Ciliary dynein heavy chain 11)	DNAH11	2942;	9606.ENSP00000475939;
Q07817	B2CL1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Bcl-2-like protein 1 (Bcl2-L-1) (Apoptosis regulator Bcl-X)	BCL2L1 BCL2L BCLX	992;	9606.ENSP00000302564;
Q13489	BIRC3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Baculoviral IAP repeat-containing protein 3 (EC 2.3.2.27) (Apoptosis inhibitor 2) (API2) (Cellular inhibitor of apoptosis 2) (C-IAP2) (IAP homolog C) (Inhibitor of apoptosis protein 1) (hIAP-1) (hIAP1) (RING finger protein 49) (RING-type E3 ubiquitin transferase BIRC3) (TNFR2-TRAF-signaling complex protein 1)	BIRC3 API2 MIHC RNF49	591;	9606.ENSP00000263464;
Q92560	BAP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ubiquitin carboxyl-terminal hydrolase BAP1 (EC 3.4.19.12) (BRCA1-associated protein 1) (Cerebral protein 6)	BAP1 KIAA0272 hucep-6	950;	9606.ENSP00000417132;
Q16548	B2LA1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Bcl-2-related protein A1 (Bcl-2-like protein 5) (Bcl2-L-5) (Hemopoietic-specific early response protein) (Protein BFL-1) (Protein GRS)	BCL2A1 BCL2L5 BFL1 GRS HBPA1	991;	9606.ENSP00000267953;
Q16570	ACKR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Atypical chemokine receptor 1 (Duffy antigen/chemokine receptor) (Fy glycoprotein) (GpFy) (Glycoprotein D) (Plasmodium vivax receptor) (CD antigen CD234)	ACKR1 DARC FY GPD	4035;	9606.ENSP00000357103;
Q8NFM4	ADCY4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Adenylate cyclase type 4 (EC 4.6.1.1) (ATP pyrophosphate-lyase 4) (Adenylate cyclase type IV) (Adenylyl cyclase 4)	ADCY4	235;	9606.ENSP00000312126;
Q92583	CCL17_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C motif chemokine 17 (CC chemokine TARC) (Small-inducible cytokine A17) (Thymus and activation-regulated chemokine)	CCL17 SCYA17 TARC	10615;	9606.ENSP00000219244;
P55774	CCL18_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C motif chemokine 18 (Alternative macrophage activation-associated CC chemokine 1) (AMAC-1) (CC chemokine PARC) (Dendritic cell chemokine 1) (DC-CK1) (Macrophage inflammatory protein 4) (MIP-4) (Pulmonary and activation-regulated chemokine) (Small-inducible cytokine A18) [Cleaved into: CCL18(1-68); CCL18(3-69); CCL18(4-69)]	CCL18 AMAC1 DCCK1 MIP4 PARC SCYA18	10616;	9606.ENSP00000479955;
Q9H467	CUED2_HUMAN	reviewed	Evidence at protein level	5 out of 5	CUE domain-containing protein 2	CUEDC2 C10orf66 HOYS6	28352;	9606.ENSP00000358953;
P49238	CX3C1_HUMAN	reviewed	Evidence at protein level	5 out of 5	CX3C chemokine receptor 1 (C-X3-C CKR-1) (CX3CR1) (Beta chemokine receptor-like 1) (CMK-BRL-1) (CMK-BRL1) (Fractalkine receptor) (G-protein coupled receptor 13) (V28)	CX3CR1 CMKBRL1 GPR13	2558;	9606.ENSP00000351059;
P48546	GIPR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Gastric inhibitory polypeptide receptor (GIP-R) (Glucose-dependent insulinotropic polypeptide receptor)	GIPR	4271;	9606.ENSP00000467494;
P09681	GIP_HUMAN	reviewed	Evidence at protein level	5 out of 5	Gastric inhibitory polypeptide (GIP) (Glucose-dependent insulinotropic polypeptide) (Incretin hormone)	GIP	4270;	9606.ENSP00000350005;
Q9Y2X7	GIT1_HUMAN	reviewed	Evidence at protein level	5 out of 5	ARF GTPase-activating protein GIT1 (ARF GAP GIT1) (Cool-associated and tyrosine-phosphorylated protein 1) (CAT-1) (CAT1) (G protein-coupled receptor kinase-interactor 1) (GRK-interacting protein 1) (p95-APP1)	GIT1	4272;	9606.ENSP00000378338;
P78545	ELF3_HUMAN	reviewed	Evidence at protein level	5 out of 5	ETS-related transcription factor Elf-3 (E74-like factor 3) (Epithelial-restricted with serine box) (Epithelium-restricted Ets protein ESX) (Epithelium-specific Ets transcription factor 1) (ESE-1)	ELF3 ERT ESX JEN	3318;	9606.ENSP00000352673;
Q9BSW2	EFC4B_HUMAN	reviewed	Evidence at protein level	5 out of 5	EF-hand calcium-binding domain-containing protein 4B (Calcium release-activated calcium channel regulator 2A) (CRAC channel regulator 2A) (Calcium release-activated channel regulator 2A) (Ras-related protein Rab-46)	CRACR2A EFCAB4B RAB46	28657;	9606.ENSP00000409382;
Q5T7M4	ADIPL_HUMAN	reviewed	Evidence at protein level	5 out of 5	Adipolin (Adipose-derived insulin-sensitizing factor) (C1q and TNF related protein 12) (Complement C1q tumor necrosis factor-related protein 12) [Cleaved into: Adipolin fC1QTNF12 (Adipolin fCTRP12) (Adipolin full-length form); Adipolin gC1QTNF12 (Adipolin cleaved form) (Adipolin gCTRP12)]	C1QTNF12 C1QDC2 CTRP12 FAM132A	32308;	9606.ENSP00000329137;
P51679	CCR4_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C chemokine receptor type 4 (C-C CKR-4) (CC-CKR-4) (CCR-4) (CCR4) (K5-5) (CD antigen CD194)	CCR4 CMKBR4	1605;	9606.ENSP00000332659;
O43866	CD5L_HUMAN	reviewed	Evidence at protein level	5 out of 5	CD5 antigen-like (Apoptosis inhibitor expressed by macrophages) (hAIM) (CT-2) (IgM-associated peptide) (SP-alpha)	CD5L API6 UNQ203/PRO229	1690;	9606.ENSP00000357156;
P02647	APOA1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Apolipoprotein A-I (Apo-AI) (ApoA-I) (Apolipoprotein A1) [Cleaved into: Proapolipoprotein A-I (ProapoA-I); Truncated apolipoprotein A-I (Apolipoprotein A-I(1-242))]	APOA1	600;	9606.ENSP00000236850;
Q16663	CCL15_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C motif chemokine 15 (Chemokine CC-2) (HCC-2) (Leukotactin-1) (LKN-1) (MIP-1 delta) (Macrophage inflammatory protein 5) (MIP-5) (Mrp-2b) (NCC-3) (Small-inducible cytokine A15) [Cleaved into: CCL15(22-92); CCL15(25-92); CCL15(29-92)]	CCL15 MIP5 NCC3 SCYA15	10613;	9606.ENSP00000484078;
O15484	CAN5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Calpain-5 (EC 3.4.22.-) (Calpain htra-3) (New calpain 3) (nCL-3)	CAPN5 NCL3	1482;	9606.ENSP00000278559;
O95388	CCN4_HUMAN	reviewed	Evidence at protein level	5 out of 5	CCN family member 4 (WNT1-inducible-signaling pathway protein 1) (WISP-1) (Wnt-1-induced secreted protein)	CCN4 WISP1	12769;	9606.ENSP00000250160;
Q9UI46	DNAI1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Dynein axonemal intermediate chain 1 (Axonemal dynein intermediate chain 1)	DNAI1	2954;	9606.ENSP00000480538;
P20930	FILA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Filaggrin	FLG	3748;	9606.ENSP00000357789;
P21728	DRD1_HUMAN	reviewed	Evidence at protein level	5 out of 5	D(1A) dopamine receptor (Dopamine D1 receptor)	DRD1	3020;	9606.ENSP00000377353;
P51828	ADCY7_HUMAN	reviewed	Evidence at protein level	5 out of 5	Adenylate cyclase type 7 (EC 4.6.1.1) (ATP pyrophosphate-lyase 7) (Adenylate cyclase type VII) (Adenylyl cyclase 7)	ADCY7 KIAA0037	238;	9606.ENSP00000378187;
O95622	ADCY5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Adenylate cyclase type 5 (EC 4.6.1.1) (ATP pyrophosphate-lyase 5) (Adenylate cyclase type V) (Adenylyl cyclase 5) (AC5)	ADCY5	236;	9606.ENSP00000419361;
P78325	ADAM8_HUMAN	reviewed	Evidence at protein level	5 out of 5	Disintegrin and metalloproteinase domain-containing protein 8 (ADAM 8) (EC 3.4.24.-) (Cell surface antigen MS2) (CD antigen CD156a)	ADAM8 MS2	215;	9606.ENSP00000453302;
P13945	ADRB3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Beta-3 adrenergic receptor (Beta-3 adrenoreceptor) (Beta-3 adrenoceptor)	ADRB3 ADRB3R B3AR	288;	9606.ENSP00000343782;
O75179	ANR17_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16)	ANKRD17 GTAR KIAA0697	23575;	9606.ENSP00000351416;
P21730	C5AR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	C5a anaphylatoxin chemotactic receptor 1 (C5a anaphylatoxin chemotactic receptor) (C5a-R) (C5aR) (CD antigen CD88)	C5AR1 C5AR C5R1	1338;	9606.ENSP00000347197;
P51681	CCR5_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C chemokine receptor type 5 (C-C CKR-5) (CC-CKR-5) (CCR-5) (CCR5) (CHEMR13) (HIV-1 fusion coreceptor) (CD antigen CD195)	CCR5 CMKBR5	1606;	9606.ENSP00000292303;
Q15517	CDSN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Corneodesmosin (S protein)	CDSN	1802;	
P28845	DHI1_HUMAN	reviewed	Evidence at protein level	5 out of 5	11-beta-hydroxysteroid dehydrogenase 1 (11-DH) (11-beta-HSD1) (EC 1.1.1.146) (7-oxosteroid reductase) (EC 1.1.1.201) (Corticosteroid 11-beta-dehydrogenase isozyme 1) (Short chain dehydrogenase/reductase family 26C member 1)	HSD11B1 HSD11 HSD11L SDR26C1	5208;	9606.ENSP00000355995;
O43143	DHX15_HUMAN	reviewed	Evidence at protein level	5 out of 5	ATP-dependent RNA helicase DHX15 (EC 3.6.4.13) (ATP-dependent RNA helicase #46) (DEAH box protein 15) (Splicing factor Prp43) (hPrp43)	DHX15 DBP1 DDX15	2738;	9606.ENSP00000336741;
Q99467	CD180_HUMAN	reviewed	Evidence at protein level	5 out of 5	CD180 antigen (Lymphocyte antigen 64) (Radioprotective 105 kDa protein) (CD antigen CD180)	CD180 LY64 RP105	6726;	9606.ENSP00000256447;
Q9GZS0	DNAI2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Dynein axonemal intermediate chain 2 (Axonemal dynein intermediate chain 2)	DNAI2	18744;	9606.ENSP00000400252;
Q6ZUJ8	BCAP_HUMAN	reviewed	Evidence at protein level	5 out of 5	Phosphoinositide 3-kinase adapter protein 1 (B-cell adapter for phosphoinositide 3-kinase) (B-cell phosphoinositide 3-kinase adapter protein 1)	PIK3AP1 BCAP	30034;	9606.ENSP00000339826;
O43286	B4GT5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Beta-1,4-galactosyltransferase 5 (Beta-1,4-GalTase 5) (Beta4Gal-T5) (b4Gal-T5) (EC 2.4.1.-) (Beta-1,4-GalT II) (Glucosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.274) (Lactosylceramide synthase) (LacCer synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 5)	B4GALT5	928;	9606.ENSP00000360776;
P12643	BMP2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Bone morphogenetic protein 2 (BMP-2) (Bone morphogenetic protein 2A) (BMP-2A)	BMP2 BMP2A	1069;	9606.ENSP00000368104;
O00238	BMR1B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Bone morphogenetic protein receptor type-1B (BMP type-1B receptor) (BMPR-1B) (EC 2.7.11.30) (CD antigen CDw293)	BMPR1B	1077;	9606.ENSP00000401907;
Q9H257	CARD9_HUMAN	reviewed	Evidence at protein level	5 out of 5	Caspase recruitment domain-containing protein 9 (hCARD9)	CARD9	16391;	9606.ENSP00000360797;
Q16581	C3AR_HUMAN	reviewed	Evidence at protein level	5 out of 5	C3a anaphylatoxin chemotactic receptor (C3AR) (C3a-R)	C3AR1 AZ3B C3R1 HNFAG09	1319;	9606.ENSP00000302079;
P33151	CADH5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cadherin-5 (7B4 antigen) (Vascular endothelial cadherin) (VE-cadherin) (CD antigen CD144)	CDH5	1764;	9606.ENSP00000344115;
Q8N884	CGAS_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cyclic GMP-AMP synthase (cGAMP synthase) (cGAS) (h-cGAS) (EC 2.7.7.86) (2'3'-cGAMP synthase) (Mab-21 domain-containing protein 1)	CGAS C6orf150 MB21D1	21367;	9606.ENSP00000359339;
O15263	DFB4A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Beta-defensin 4A (Beta-defensin 2) (BD-2) (hBD-2) (Defensin, beta 2) (Skin-antimicrobial peptide 1) (SAP1)	DEFB4A DEFB102 DEFB2 DEFB4; DEFB4B	2767;30193;	9606.ENSP00000303532;
P60033	CD81_HUMAN	reviewed	Evidence at protein level	5 out of 5	CD81 antigen (26 kDa cell surface protein TAPA-1) (Target of the antiproliferative antibody 1) (Tetraspanin-28) (Tspan-28) (CD antigen CD81)	CD81 TAPA1 TSPAN28	1701;	9606.ENSP00000263645;
P19876	CXCL3_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-X-C motif chemokine 3 (GRO-gamma(1-73)) (Growth-regulated protein gamma) (GRO-gamma) (Macrophage inflammatory protein 2-beta) (MIP2-beta) [Cleaved into: GRO-gamma(5-73)]	CXCL3 GRO3 GROG SCYB3	4604;	9606.ENSP00000296026;
P80162	CXCL6_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-X-C motif chemokine 6 (Chemokine alpha 3) (CKA-3) (Granulocyte chemotactic protein 2) (GCP-2) (Small-inducible cytokine B6) [Cleaved into: Small-inducible cytokine B6, N-processed variant 1; Small-inducible cytokine B6, N-processed variant 2; Small-inducible cytokine B6, N-processed variant 3]	CXCL6 GCP2 SCYB6	10643;	9606.ENSP00000226317;
Q96HY6	DDRGK_HUMAN	reviewed	Evidence at protein level	5 out of 5	DDRGK domain-containing protein 1 (Dashurin) (UFM1-binding and PCI domain-containing protein 1)	DDRGK1 C20orf116 UFBP1	16110;	9606.ENSP00000346483;
P01909	DQA1_HUMAN	reviewed	Evidence at protein level	5 out of 5	HLA class II histocompatibility antigen, DQ alpha 1 chain (DC-1 alpha chain) (DC-alpha) (HLA-DCA) (MHC class II DQA1)	HLA-DQA1	4942;	
Q9H6Z9	EGLN3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Prolyl hydroxylase EGLN3 (EC 1.14.11.-) (Egl nine homolog 3) (EC 1.14.11.29) (HPH-1) (Hypoxia-inducible factor prolyl hydroxylase 3) (HIF-PH3) (HIF-prolyl hydroxylase 3) (HPH-3) (Prolyl hydroxylase domain-containing protein 3) (PHD3)	EGLN3	14661;	9606.ENSP00000250457;
P32121	ARRB2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Beta-arrestin-2 (Arrestin beta-2) (Non-visual arrestin-3)	ARRB2 ARB2 ARR2	712;	9606.ENSP00000403701;
O43520	AT8B1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Phospholipid-transporting ATPase IC (EC 7.6.2.1) (ATPase class I type 8B member 1) (Familial intrahepatic cholestasis type 1) (P4-ATPase flippase complex alpha subunit ATP8B1)	ATP8B1 ATPIC FIC1 PFIC	3706;	9606.ENSP00000445359;
P58397	ATS12_HUMAN	reviewed	Evidence at protein level	5 out of 5	A disintegrin and metalloproteinase with thrombospondin motifs 12 (ADAM-TS 12) (ADAM-TS12) (ADAMTS-12) (EC 3.4.24.-)	ADAMTS12 UNQ1918/PRO4389	14605;	9606.ENSP00000422554;
P01023	A2MG_HUMAN	reviewed	Evidence at protein level	5 out of 5	Alpha-2-macroglobulin (Alpha-2-M) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 5)	A2M CPAMD5 FWP007	7;	9606.ENSP00000323929;
O43918	AIRE_HUMAN	reviewed	Evidence at protein level	5 out of 5	Autoimmune regulator (Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein) (APECED protein)	AIRE APECED	360;	9606.ENSP00000291582;
Q96QP1	ALPK1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Alpha-protein kinase 1 (EC 2.7.11.1) (Chromosome 4 kinase) (Lymphocyte alpha-protein kinase)	ALPK1 KIAA1527 LAK	20917;	9606.ENSP00000398048;
P35318	ADML_HUMAN	reviewed	Evidence at protein level	5 out of 5	Pro-adrenomedullin [Cleaved into: Adrenomedullin (AM); Proadrenomedullin N-20 terminal peptide (ProAM N-terminal 20 peptide) (PAMP) (ProAM-N20)]	ADM AM	259;	9606.ENSP00000436607;
P05089	ARGI1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Arginase-1 (EC 3.5.3.1) (Liver-type arginase) (Type I arginase)	ARG1	663;	9606.ENSP00000349446;
P01019	ANGT_HUMAN	reviewed	Evidence at protein level	5 out of 5	Angiotensinogen (Serpin A8) [Cleaved into: Angiotensin-1 (Angiotensin 1-10) (Angiotensin I) (Ang I); Angiotensin-2 (Angiotensin 1-8) (Angiotensin II) (Ang II); Angiotensin-3 (Angiotensin 2-8) (Angiotensin III) (Ang III) (Des-Asp[1]-angiotensin II); Angiotensin-4 (Angiotensin 3-8) (Angiotensin IV) (Ang IV); Angiotensin 1-9; Angiotensin 1-7; Angiotensin 1-5; Angiotensin 1-4]	AGT SERPINA8	333;	9606.ENSP00000355627;
Q16853	AOC3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Membrane primary amine oxidase (EC 1.4.3.21) (Copper amine oxidase) (HPAO) (Semicarbazide-sensitive amine oxidase) (SSAO) (Vascular adhesion protein 1) (VAP-1)	AOC3 VAP1	550;	9606.ENSP00000312326;
O00203	AP3B1_HUMAN	reviewed	Evidence at protein level	5 out of 5	AP-3 complex subunit beta-1 (Adaptor protein complex AP-3 subunit beta-1) (Adaptor-related protein complex 3 subunit beta-1) (Beta-3A-adaptin) (Clathrin assembly protein complex 3 beta-1 large chain)	AP3B1 ADTB3A	566;	9606.ENSP00000255194;
Q16515	ASIC2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Acid-sensing ion channel 2 (ASIC2) (Amiloride-sensitive brain sodium channel) (Amiloride-sensitive cation channel 1, neuronal) (Amiloride-sensitive cation channel neuronal 1) (Brain sodium channel 1) (BNC1) (BNaC1) (Mammalian degenerin homolog) (MDEG)	ASIC2 ACCN ACCN1 BNAC1 MDEG	99;	
P34972	CNR2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)	CNR2 CB2A CB2B	2160;	9606.ENSP00000363596;
P23786	CPT2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Carnitine O-palmitoyltransferase 2, mitochondrial (EC 2.3.1.21) (Carnitine palmitoyltransferase II) (CPT II)	CPT2 CPT1	2330;	9606.ENSP00000360541;
Q14624	ITIH4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) (Inter-alpha-trypsin inhibitor family heavy chain-related protein) (IHRP) (Plasma kallikrein sensitive glycoprotein 120) (Gp120) (PK-120) [Cleaved into: 70 kDa inter-alpha-trypsin inhibitor heavy chain H4; 35 kDa inter-alpha-trypsin inhibitor heavy chain H4]	ITIH4 IHRP ITIHL1 PK120 PRO1851	6169;	9606.ENSP00000266041;
Q9H000	MKRN2_HUMAN	reviewed	Evidence at protein level	5 out of 5	E3 ubiquitin-protein ligase makorin-2 (EC 2.3.2.27) (RING finger protein 62) (RING-type E3 ubiquitin transferase makorin-2)	MKRN2 RNF62 HSPC070	7113;	9606.ENSP00000170447;
P45985	MP2K4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Dual specificity mitogen-activated protein kinase kinase 4 (MAP kinase kinase 4) (MAPKK 4) (EC 2.7.12.2) (JNK-activating kinase 1) (MAPK/ERK kinase 4) (MEK 4) (SAPK/ERK kinase 1) (SEK1) (Stress-activated protein kinase kinase 1) (SAPK kinase 1) (SAPKK-1) (SAPKK1) (c-Jun N-terminal kinase kinase 1) (JNKK)	MAP2K4 JNKK1 MEK4 MKK4 PRKMK4 SEK1 SERK1 SKK1	6844;	9606.ENSP00000410402;
P08253	MMP2_HUMAN	reviewed	Evidence at protein level	5 out of 5	72 kDa type IV collagenase (EC 3.4.24.24) (72 kDa gelatinase) (Gelatinase A) (Matrix metalloproteinase-2) (MMP-2) (TBE-1) [Cleaved into: PEX]	MMP2 CLG4A	7166;	9606.ENSP00000219070;
P35232	PHB1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Prohibitin 1	PHB1 PHB	8912;	9606.ENSP00000479488;
P06400	RB_HUMAN	reviewed	Evidence at protein level	5 out of 5	Retinoblastoma-associated protein (p105-Rb) (p110-RB1) (pRb) (Rb) (pp110)	RB1	9884;	9606.ENSP00000267163;
Q9HBD1	RC3H2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Roquin-2 (EC 2.3.2.27) (Membrane-associated nucleic acid-binding protein) (RING finger and CCCH-type zinc finger domain-containing protein 2) (RING finger protein 164) (RING-type E3 ubiquitin transferase Roquin-2)	RC3H2 MNAB RNF164	21461;	9606.ENSP00000362774;
Q5TC82	RC3H1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Roquin-1 (Roquin) (EC 2.3.2.27) (RING finger and C3H zinc finger protein 1) (RING finger and CCCH-type zinc finger domain-containing protein 1) (RING finger protein 198)	RC3H1 KIAA2025 RNF198	29434;	9606.ENSP00000356669;
Q15109	RAGE_HUMAN	reviewed	Evidence at protein level	5 out of 5	Advanced glycosylation end product-specific receptor (Receptor for advanced glycosylation end products)	AGER RAGE	320;	9606.ENSP00000364210;
O60894	RAMP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Receptor activity-modifying protein 1 (Calcitonin-receptor-like receptor activity-modifying protein 1) (CRLR activity-modifying protein 1)	RAMP1	9843;	9606.ENSP00000254661;
P49792	RBP2_HUMAN	reviewed	Evidence at protein level	5 out of 5	E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (Ran-binding protein 2) (RanBP2) (p270)	RANBP2 NUP358	9848;	9606.ENSP00000283195;
O60895	RAMP2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Receptor activity-modifying protein 2 (Calcitonin-receptor-like receptor activity-modifying protein 2) (CRLR activity-modifying protein 2)	RAMP2	9844;	9606.ENSP00000253796;
O60896	RAMP3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Receptor activity-modifying protein 3 (Calcitonin-receptor-like receptor activity-modifying protein 3) (CRLR activity-modifying protein 3)	RAMP3	9845;	9606.ENSP00000242249;
P49116	NR2C2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nuclear receptor subfamily 2 group C member 2 (Orphan nuclear receptor TAK1) (Orphan nuclear receptor TR4) (Testicular receptor 4)	NR2C2 TAK1 TR4	7972;	9606.ENSP00000483059;
P10451	OSTP_HUMAN	reviewed	Evidence at protein level	5 out of 5	Osteopontin (Bone sialoprotein 1) (Nephropontin) (Secreted phosphoprotein 1) (SPP-1) (Urinary stone protein) (Uropontin)	SPP1 BNSP OPN PSEC0156	11255;	9606.ENSP00000378517;
Q99650	OSMR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Oncostatin-M-specific receptor subunit beta (Interleukin-31 receptor subunit beta) (IL-31 receptor subunit beta) (IL-31R subunit beta) (IL-31R-beta) (IL-31RB)	OSMR OSMRB	8507;	9606.ENSP00000274276;
Q01804	OTUD4_HUMAN	reviewed	Evidence at protein level	5 out of 5	OTU domain-containing protein 4 (EC 3.4.19.12) (HIV-1-induced protein HIN-1)	OTUD4 HIN-1 KIAA1046	24949;	9606.ENSP00000409279;
P98160	PGBM_HUMAN	reviewed	Evidence at protein level	5 out of 5	Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide]	HSPG2	5273;	9606.ENSP00000363827;
P10276	RARA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Retinoic acid receptor alpha (RAR-alpha) (Nuclear receptor subfamily 1 group B member 1)	RARA NR1B1	9864;	9606.ENSP00000254066;
Q99969	RARR2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Retinoic acid receptor responder protein 2 (Chemerin) (RAR-responsive protein TIG2) (Tazarotene-induced gene 2 protein)	RARRES2 TIG2	9868;	9606.ENSP00000418009;
Q2TAL8	QRIC1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transcriptional regulator QRICH1 (Glutamine-rich protein 1)	QRICH1	24713;	9606.ENSP00000378830;
Q9UJ41	RABX5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Rab5 GDP/GTP exchange factor (RAP1) (Rabaptin-5-associated exchange factor for Rab5) (Rabex-5)	RABGEF1 RABEX5	17676;	9606.ENSP00000370208;
P63000	RAC1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ras-related C3 botulinum toxin substrate 1 (EC 3.6.5.2) (Cell migration-inducing gene 5 protein) (Ras-like protein TC25) (p21-Rac1)	RAC1 TC25 MIG5	9801;	9606.ENSP00000348461;
P04090	REL2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Prorelaxin H2 [Cleaved into: Relaxin B chain; Relaxin A chain]	RLN2	10027;	9606.ENSP00000371040;
Q8WXF3	REL3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Relaxin-3 (Insulin-like peptide INSL7) (Insulin-like peptide 7) (Prorelaxin H3) [Cleaved into: Relaxin-3 B chain; Relaxin-3 A chain]	RLN3 INSL7 RXN3 ZINS4 UNQ6188/PRO20213	17135;	9606.ENSP00000397415;
Q01201	RELB_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transcription factor RelB (I-Rel)	RELB	9956;	9606.ENSP00000221452;
Q9UHI8	ATS1_HUMAN	reviewed	Evidence at protein level	5 out of 5	A disintegrin and metalloproteinase with thrombospondin motifs 1 (ADAM-TS 1) (ADAM-TS1) (ADAMTS-1) (EC 3.4.24.-) (METH-1)	ADAMTS1 KIAA1346 METH1	217;	9606.ENSP00000284984;
P21918	DRD5_HUMAN	reviewed	Evidence at protein level	5 out of 5	D(1B) dopamine receptor (D(5) dopamine receptor) (D1beta dopamine receptor) (Dopamine D5 receptor)	DRD5 DRD1B DRD1L2	3026;	9606.ENSP00000306129;
P63096	GNAI1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Guanine nucleotide-binding protein G(i) subunit alpha-1 (Adenylate cyclase-inhibiting G alpha protein)	GNAI1	4384;	9606.ENSP00000343027;
O14775	GNB5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Guanine nucleotide-binding protein subunit beta-5 (Gbeta5) (Transducin beta chain 5)	GNB5	4401;	9606.ENSP00000261837;
P25092	GUC2C_HUMAN	reviewed	Evidence at protein level	5 out of 5	Guanylyl cyclase C (GC-C) (EC 4.6.1.2) (Heat-stable enterotoxin receptor) (STA receptor) (hSTAR) (Intestinal guanylate cyclase)	GUCY2C GUC2C STAR	4688;	9606.ENSP00000261170;
P20702	ITAX_HUMAN	reviewed	Evidence at protein level	5 out of 5	Integrin alpha-X (CD11 antigen-like family member C) (Leu M5) (Leukocyte adhesion glycoprotein p150,95 alpha chain) (Leukocyte adhesion receptor p150,95) (CD antigen CD11c)	ITGAX CD11C	6152;	9606.ENSP00000454623;
P23458	JAK1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tyrosine-protein kinase JAK1 (EC 2.7.10.2) (Janus kinase 1) (JAK-1)	JAK1 JAK1A JAK1B	6190;	9606.ENSP00000343204;
O60674	JAK2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tyrosine-protein kinase JAK2 (EC 2.7.10.2) (Janus kinase 2) (JAK-2)	JAK2	6192;	9606.ENSP00000371067;
P05556	ITB1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Integrin beta-1 (Fibronectin receptor subunit beta) (Glycoprotein IIa) (GPIIA) (VLA-4 subunit beta) (CD antigen CD29)	ITGB1 FNRB MDF2 MSK12	6153;	9606.ENSP00000379350;
P10914	IRF1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interferon regulatory factor 1 (IRF-1)	IRF1	6116;	9606.ENSP00000245414;
P01308	INS_HUMAN	reviewed	Evidence at protein level	5 out of 5	Insulin [Cleaved into: Insulin B chain; Insulin A chain]	INS	6081;	9606.ENSP00000380432;
P52333	JAK3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tyrosine-protein kinase JAK3 (EC 2.7.10.2) (Janus kinase 3) (JAK-3) (Leukocyte janus kinase) (L-JAK)	JAK3	6193;	9606.ENSP00000391676;
P30511	HLAF_HUMAN	reviewed	Evidence at protein level	5 out of 5	HLA class I histocompatibility antigen, alpha chain F (CDA12) (HLA F antigen) (Leukocyte antigen F) (MHC class I antigen F)	HLA-F HLA-5.4 HLAF	4963;	9606.ENSP00000259951;
Q9Y2R2	PTN22_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tyrosine-protein phosphatase non-receptor type 22 (EC 3.1.3.48) (Hematopoietic cell protein-tyrosine phosphatase 70Z-PEP) (Lymphoid phosphatase) (LyP) (PEST-domain phosphatase) (PEP)	PTPN22 PTPN8	9652;	9606.ENSP00000352833;
P17706	PTN2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tyrosine-protein phosphatase non-receptor type 2 (EC 3.1.3.48) (T-cell protein-tyrosine phosphatase) (TCPTP)	PTPN2 PTPT	9650;	9606.ENSP00000311857;
P28070	PSB4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Proteasome subunit beta type-4 (26 kDa prosomal protein) (HsBPROS26) (PROS-26) (Macropain beta chain) (Multicatalytic endopeptidase complex beta chain) (Proteasome beta chain) (Proteasome chain 3) (HsN3)	PSMB4 PROS26	9541;	9606.ENSP00000290541;
P21246	PTN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Pleiotrophin (PTN) (Heparin-binding brain mitogen) (HBBM) (Heparin-binding growth factor 8) (HBGF-8) (Heparin-binding growth-associated molecule) (HB-GAM) (Heparin-binding neurite outgrowth-promoting factor) (HBNF) (Heparin-binding neurite outgrowth-promoting factor 1) (HBNF-1) (Osteoblast-specific factor 1) (OSF-1)	PTN HBNF1 NEGF1	9630;	9606.ENSP00000341170;
Q8IXQ6	PARP9_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein mono-ADP-ribosyltransferase PARP9 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 9) (ARTD9) (B aggressive lymphoma protein) (Poly [ADP-ribose] polymerase 9) (PARP-9)	PARP9 BAL BAL1	24118;	9606.ENSP00000353512;
Q01726	MSHR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Melanocyte-stimulating hormone receptor (MSH-R) (Melanocortin receptor 1) (MC1-R)	MC1R MSHR	6929;	9606.ENSP00000451605;
Q92542	NICA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nicastrin	NCSTN KIAA0253 UNQ1874/PRO4317	17091;	9606.ENSP00000294785;
Q96RI1	NR1H4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Bile acid receptor (Farnesoid X-activated receptor) (Farnesol receptor HRR-1) (Nuclear receptor subfamily 1 group H member 4) (Retinoid X receptor-interacting protein 14) (RXR-interacting protein 14)	NR1H4 BAR FXR HRR1 RIP14	7967;	9606.ENSP00000447149;
P28062	PSB8_HUMAN	reviewed	Evidence at protein level	5 out of 5	Proteasome subunit beta type-8 (EC 3.4.25.1) (Low molecular mass protein 7) (Macropain subunit C13) (Multicatalytic endopeptidase complex subunit C13) (Proteasome component C13) (Proteasome subunit beta-5i) (Really interesting new gene 10 protein)	PSMB8 LMP7 PSMB5i RING10 Y2	9545;	9606.ENSP00000364016;
Q96NI6	LRFN5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Leucine-rich repeat and fibronectin type-III domain-containing protein 5	LRFN5 C14orf146 SALM5	20360;	9606.ENSP00000298119;
P09960	LKHA4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Leukotriene A-4 hydrolase (LTA-4 hydrolase) (EC 3.3.2.6) (Leukotriene A(4) hydrolase) (Tripeptide aminopeptidase LTA4H) (EC 3.4.11.4)	LTA4H LTA4	6710;	9606.ENSP00000228740;
Q12851	M4K2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mitogen-activated protein kinase kinase kinase kinase 2 (EC 2.7.11.1) (B lymphocyte serine/threonine-protein kinase) (Germinal center kinase) (GC kinase) (MAPK/ERK kinase kinase kinase 2) (MEK kinase kinase 2) (MEKKK 2) (Rab8-interacting protein)	MAP4K2 GCK RAB8IP	6864;	9606.ENSP00000294066;
Q13133	NR1H3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Oxysterols receptor LXR-alpha (Liver X receptor alpha) (Nuclear receptor subfamily 1 group H member 3)	NR1H3 LXRA	7966;	9606.ENSP00000477707;
Q29983	MICA_HUMAN	reviewed	Evidence at protein level	5 out of 5	MHC class I polypeptide-related sequence A (MIC-A)	MICA PERB11.1	7090;	9606.ENSP00000413079;
P08183	MDR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)	ABCB1 MDR1 PGY1	40;	9606.ENSP00000478255;
P14555	PA2GA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Phospholipase A2, membrane associated (EC 3.1.1.4) (GIIC sPLA2) (Group IIA phospholipase A2) (Non-pancreatic secretory phospholipase A2) (NPS-PLA2) (Phosphatidylcholine 2-acylhydrolase 2A)	PLA2G2A PLA2B PLA2L RASF-A	9031;	9606.ENSP00000383364;
Q9NRA1	PDGFC_HUMAN	reviewed	Evidence at protein level	5 out of 5	Platelet-derived growth factor C (PDGF-C) (Fallotein) (Spinal cord-derived growth factor) (SCDGF) (VEGF-E) [Cleaved into: Platelet-derived growth factor C, latent form (PDGFC latent form); Platelet-derived growth factor C, receptor-binding form (PDGFC receptor-binding form)]	PDGFC SCDGF UNQ174/PRO200	8801;	9606.ENSP00000422464;
Q8N2K0	ABD12_HUMAN	reviewed	Evidence at protein level	5 out of 5	Lysophosphatidylserine lipase ABHD12 (EC 3.1.-.-) (2-arachidonoylglycerol hydrolase ABHD12) (Abhydrolase domain-containing protein 12) (hABHD12) (Monoacylglycerol lipase ABHD12) (EC 3.1.1.23) (Oxidized phosphatidylserine lipase ABHD12) (EC 3.1.-.-)	ABHD12 C20orf22	15868;	9606.ENSP00000365725;
Q5T5X7	BEND3_HUMAN	reviewed	Evidence at protein level	5 out of 5	BEN domain-containing protein 3	BEND3 KIAA1553	23040;	9606.ENSP00000411268;
P33897	ABCD1_HUMAN	reviewed	Evidence at protein level	5 out of 5	ATP-binding cassette sub-family D member 1 (EC 3.1.2.-) (EC 7.6.2.-) (Adrenoleukodystrophy protein) (ALDP)	ABCD1 ALD	61;	9606.ENSP00000218104;
P04083	ANXA1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Annexin A1 (Annexin I) (Annexin-1) (Calpactin II) (Calpactin-2) (Chromobindin-9) (Lipocortin I) (Phospholipase A2 inhibitory protein) (p35) [Cleaved into: Annexin Ac2-26]	ANXA1 ANX1 LPC1	533;	9606.ENSP00000366109;
P28039	AOAH_HUMAN	reviewed	Evidence at protein level	5 out of 5	Acyloxyacyl hydrolase (EC 3.1.1.77) [Cleaved into: Acyloxyacyl hydrolase small subunit; Acyloxyacyl hydrolase large subunit]	AOAH	548;	9606.ENSP00000479664;
P34810	CD68_HUMAN	reviewed	Evidence at protein level	5 out of 5	Macrosialin (Gp110) (CD antigen CD68)	CD68	1693;	9606.ENSP00000250092;
P30203	CD6_HUMAN	reviewed	Evidence at protein level	5 out of 5	T-cell differentiation antigen CD6 (T12) (TP120) (CD antigen CD6) [Cleaved into: Soluble CD6]	CD6	1691;	9606.ENSP00000323280;
P17693	HLAG_HUMAN	reviewed	Evidence at protein level	5 out of 5	HLA class I histocompatibility antigen, alpha chain G (HLA G antigen) (MHC class I antigen G) [Cleaved into: Soluble HLA class I histocompatibility antigen, alpha chain G (sHLA-G)]	HLA-G HLA-6.0 HLAG	4964;	9606.ENSP00000412927;
P35228	NOS2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nitric oxide synthase, inducible (EC 1.14.13.39) (Hepatocyte NOS) (HEP-NOS) (Inducible NO synthase) (Inducible NOS) (iNOS) (NOS type II) (Peptidyl-cysteine S-nitrosylase NOS2)	NOS2 NOS2A	7873;	9606.ENSP00000327251;
Q9Y5S8	NOX1_HUMAN	reviewed	Evidence at protein level	5 out of 5	NADPH oxidase 1 (NOX-1) (EC 1.-.-.-) (Mitogenic oxidase 1) (MOX-1) (NADH/NADPH mitogenic oxidase subunit P65-MOX) (NOH-1)	NOX1 MOX1 NOH1	7889;	9606.ENSP00000362057;
P11182	ODB2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial (EC 2.3.1.168) (52 kDa mitochondrial autoantigen of primary biliary cirrhosis) (Branched chain 2-oxo-acid dehydrogenase complex component E2) (BCOADC-E2) (Branched-chain alpha-keto acid dehydrogenase complex component E2) (BCKAD-E2) (BCKADE2) (Dihydrolipoamide acetyltransferase component of branched-chain alpha-keto acid dehydrogenase complex) (Dihydrolipoamide branched chain transacylase) (Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase)	DBT BCATE2	2698;	9606.ENSP00000359151;
Q9UM07	PADI4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein-arginine deiminase type-4 (EC 3.5.3.15) (HL-60 PAD) (Peptidylarginine deiminase IV) (Protein-arginine deiminase type IV)	PADI4 PAD4 PADI5 PDI5	18368;	9606.ENSP00000364597;
Q6GQQ9	OTU7B_HUMAN	reviewed	Evidence at protein level	5 out of 5	OTU domain-containing protein 7B (EC 3.4.19.12) (Cellular zinc finger anti-NF-kappa-B protein) (Cezanne) (Zinc finger A20 domain-containing protein 1) (Zinc finger protein Cezanne)	OTUD7B ZA20D1	16683;	9606.ENSP00000462729;
P16234	PGFRA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (CD140a antigen) (Platelet-derived growth factor alpha receptor) (Platelet-derived growth factor receptor 2) (PDGFR-2) (CD antigen CD140a)	PDGFRA PDGFR2 RHEPDGFRA	8803;	9606.ENSP00000257290;
O00571	DDX3X_HUMAN	reviewed	Evidence at protein level	5 out of 5	ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (CAP-Rf) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (DBX) (Helicase-like protein 2) (HLP2)	DDX3X DBX DDX3	2745;	9606.ENSP00000382840;
Q5VWQ8	DAB2P_HUMAN	reviewed	Evidence at protein level	5 out of 5	Disabled homolog 2-interacting protein (DAB2 interaction protein) (DAB2-interacting protein) (ASK-interacting protein 1) (AIP-1) (DOC-2/DAB-2 interactive protein)	DAB2IP AF9Q34 AIP1 KIAA1743	17294;	9606.ENSP00000259371;
A0A0C5B5G6	MOTSC_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mitochondrial-derived peptide MOTS-c (Mitochondrial open reading frame of the 12S rRNA-c)	MT-RNR1	7470;	
Q9H306	MMP27_HUMAN	reviewed	Evidence at protein level	5 out of 5	Matrix metalloproteinase-27 (MMP-27) (EC 3.4.24.-)	MMP27 UNQ2503/PRO5992	14250;	9606.ENSP00000260229;
Q9NPA2	MMP25_HUMAN	reviewed	Evidence at protein level	5 out of 5	Matrix metalloproteinase-25 (MMP-25) (EC 3.4.24.-) (Leukolysin) (Membrane-type matrix metalloproteinase 6) (MT-MMP 6) (MTMMP6) (Membrane-type-6 matrix metalloproteinase) (MT6-MMP) (MT6MMP)	MMP25 MMP20 MMPL1 MT6MMP	14246;	9606.ENSP00000337816;
Q13164	MK07_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mitogen-activated protein kinase 7 (MAP kinase 7) (MAPK 7) (EC 2.7.11.24) (Big MAP kinase 1) (BMK-1) (Extracellular signal-regulated kinase 5) (ERK-5)	MAPK7 BMK1 ERK5 PRKM7	6880;	9606.ENSP00000311005;
P14780	MMP9_HUMAN	reviewed	Evidence at protein level	5 out of 5	Matrix metalloproteinase-9 (MMP-9) (EC 3.4.24.35) (92 kDa gelatinase) (92 kDa type IV collagenase) (Gelatinase B) (GELB) [Cleaved into: 67 kDa matrix metalloproteinase-9; 82 kDa matrix metalloproteinase-9]	MMP9 CLG4B	7176;	9606.ENSP00000361405;
P45984	MK09_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (EC 2.7.11.24) (JNK-55) (Stress-activated protein kinase 1a) (SAPK1a) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2)	MAPK9 JNK2 PRKM9 SAPK1A	6886;	9606.ENSP00000394560;
O43586	PPIP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Proline-serine-threonine phosphatase-interacting protein 1 (PEST phosphatase-interacting protein 1) (CD2-binding protein 1) (H-PIP)	PSTPIP1 CD2BP1	9580;	9606.ENSP00000452746;
Q04721	NOTC2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)]	NOTCH2	7882;	9606.ENSP00000256646;
Q8IV08	PLD3_HUMAN	reviewed	Evidence at protein level	5 out of 5	5'-3' exonuclease PLD3 (EC 3.1.16.1) (Choline phosphatase 3) (HindIII K4L homolog) (Hu-K4) (Phosphatidylcholine-hydrolyzing phospholipase D3) (Phospholipase D3) (PLD 3)	PLD3	17158;	9606.ENSP00000387050;
P35222	CTNB1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Catenin beta-1 (Beta-catenin)	CTNNB1 CTNNB OK/SW-cl.35 PRO2286	2514;	9606.ENSP00000344456;
Q5D862	FILA2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Filaggrin-2 (FLG-2) (Intermediate filament-associated and psoriasis-susceptibility protein) (Ifapsoriasin)	FLG2 IFPS	33276;	9606.ENSP00000373370;
P01906	DQA2_HUMAN	reviewed	Evidence at protein level	5 out of 5	HLA class II histocompatibility antigen, DQ alpha 2 chain (DX alpha chain) (HLA class II histocompatibility antigen, DQ(6) alpha chain) (HLA-DQA1) (MHC class II DQA2)	HLA-DQA2 HLA-DXA	4943;	9606.ENSP00000364076;
P01583	IL1A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-1 alpha (IL-1 alpha) (Hematopoietin-1)	IL1A IL1F1	5991;	9606.ENSP00000263339;
P14902	I23O1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Indoleamine 2,3-dioxygenase 1 (IDO-1) (EC 1.13.11.52) (Indoleamine-pyrrole 2,3-dioxygenase)	IDO1 IDO INDO	6059;	9606.ENSP00000430950;
Q96F46	I17RA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-17 receptor A (IL-17 receptor A) (IL-17RA) (CDw217) (CD antigen CD217)	IL17RA IL17R	5985;	9606.ENSP00000320936;
P01584	IL1B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-1 beta (IL-1 beta) (Catabolin)	IL1B IL1F2	5992;	9606.ENSP00000263341;
Q8WWZ1	IL1FA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-1 family member 10 (IL-1F10) (Family of interleukin 1-theta) (FIL1 theta) (Interleukin-1 HY2) (IL-1HY2) (Interleukin-1 theta) (IL-1 theta) (Interleukin-38) (IL-38)	IL1F10 FIL1T IL1HY2 IL38 FKSG75 UNQ6119/PRO20041	15552;	9606.ENSP00000376893;
O60684	IMA7_HUMAN	reviewed	Evidence at protein level	5 out of 5	Importin subunit alpha-7 (Karyopherin subunit alpha-6)	KPNA6 IPOA7	6399;	9606.ENSP00000362728;
P35372	OPRM_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)	OPRM1 MOR1	8156;	9606.ENSP00000394624;
P13747	HLAE_HUMAN	reviewed	Evidence at protein level	5 out of 5	HLA class I histocompatibility antigen, alpha chain E (MHC class I antigen E) [Cleaved into: Soluble HLA class I histocompatibility antigen, alpha chain E (sHLA-E)]	HLA-E HLA-6.2 HLAE	4962;	9606.ENSP00000365817;
Q13478	IL18R_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-18 receptor 1 (IL-18R-1) (IL-18R1) (EC 3.2.2.6) (CD218 antigen-like family member A) (CDw218a) (IL1 receptor-related protein) (IL-1Rrp) (IL1R-rp) (Interleukin-18 receptor alpha) (IL-18R-alpha) (IL-18Ralpha) (CD antigen CD218a)	IL18R1 IL1RRP	5988;	9606.ENSP00000387211;
O95256	I18RA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-18 receptor accessory protein (IL-18 receptor accessory protein) (IL-18RAcP) (EC 3.2.2.6) (Accessory protein-like) (AcPL) (CD218 antigen-like family member B) (CDw218b) (IL-1R accessory protein-like) (IL-1RAcPL) (Interleukin-1 receptor 7) (IL-1R-7) (IL-1R7) (Interleukin-18 receptor accessory protein-like) (Interleukin-18 receptor beta) (IL-18R-beta) (IL-18Rbeta) (CD antigen CD218b)	IL18RAP IL1R7	5989;	9606.ENSP00000264260;
Q12891	HYAL2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Hyaluronidase-2 (Hyal-2) (EC 3.2.1.35) (Hyaluronoglucosaminidase-2) (Lung carcinoma protein 2) (LuCa-2)	HYAL2 LUCA2	5321;	9606.ENSP00000401853;
P17612	KAPCA_HUMAN	reviewed	Evidence at protein level	5 out of 5	cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11)	PRKACA PKACA	9380;	9606.ENSP00000309591;
O43474	KLF4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Krueppel-like factor 4 (Epithelial zinc finger protein EZF) (Gut-enriched krueppel-like factor)	KLF4 EZF GKLF	6348;	9606.ENSP00000363804;
Q9BR39	JPH2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Junctophilin-2 (JP-2) (Junctophilin type 2) [Cleaved into: Junctophilin-2 N-terminal fragment (JP2NT)]	JPH2 JP2	14202;	9606.ENSP00000362071;
Q15759	MK11_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mitogen-activated protein kinase 11 (MAP kinase 11) (MAPK 11) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 beta) (MAP kinase p38 beta) (p38b) (Stress-activated protein kinase 2b) (SAPK2b) (p38-2)	MAPK11 PRKM11 SAPK2 SAPK2B	6873;	9606.ENSP00000333685;
P18428	LBP_HUMAN	reviewed	Evidence at protein level	5 out of 5	Lipopolysaccharide-binding protein (LBP)	LBP	6517;	9606.ENSP00000217407;
Q15139	KPCD1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu)	PRKD1 PKD PKD1 PRKCM	9407;	9606.ENSP00000333568;
Q04759	KPCT_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein kinase C theta type (EC 2.7.11.13) (nPKC-theta)	PRKCQ PRKCT	9410;	9606.ENSP00000263125;
P58215	LOXL3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Lysyl oxidase homolog 3 (EC 1.4.3.-) (EC 1.4.3.13) (Lysyl oxidase-like protein 3)	LOXL3 LOXL	13869;	9606.ENSP00000264094;
A6NI73	LIRA5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Leukocyte immunoglobulin-like receptor subfamily A member 5 (CD85 antigen-like family member F) (Immunoglobulin-like transcript 11) (ILT-11) (Leukocyte immunoglobulin-like receptor 9) (LIR-9) (CD antigen CD85f)	LILRA5 ILT11 LILRB7 LIR9	16309;	9606.ENSP00000404236;
Q15746	MYLK_HUMAN	reviewed	Evidence at protein level	5 out of 5	Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]	MYLK MLCK MLCK1 MYLK1	7590;	9606.ENSP00000353452;
P46531	NOTC1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]	NOTCH1 TAN1	7881;	9606.ENSP00000277541;
O15552	FFAR2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Free fatty acid receptor 2 (G-protein coupled receptor 43)	FFAR2 FFA2 GPCR43 GPR43	4501;	9606.ENSP00000473159;
P43026	GDF5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Growth/differentiation factor 5 (GDF-5) (Bone morphogenetic protein 14) (BMP-14) (Cartilage-derived morphogenetic protein 1) (CDMP-1) (Lipopolysaccharide-associated protein 4) (LAP-4) (LPS-associated protein 4) (Radotermin)	GDF5 BMP14 CDMP1	4220;	9606.ENSP00000363492;
Q9Y4H4	GPSM3_HUMAN	reviewed	Evidence at protein level	5 out of 5	G-protein-signaling modulator 3 (Activator of G-protein signaling 4) (G18.1b) (Protein G18)	GPSM3 AGS4 C6orf9 G18	13945;	9606.ENSP00000364180;
O43194	GPR39_HUMAN	reviewed	Evidence at protein level	5 out of 5	G-protein coupled receptor 39	GPR39	4496;	9606.ENSP00000327417;
P56524	HDAC4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Histone deacetylase 4 (HD4) (EC 3.5.1.98)	HDAC4 KIAA0288	14063;	9606.ENSP00000264606;
P22888	LSHR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Lutropin-choriogonadotropic hormone receptor (LH/CG-R) (Luteinizing hormone receptor) (LHR) (LSH-R)	LHCGR LCGR LGR2 LHRHR	6585;	9606.ENSP00000294954;
Q9BYH8	IKBZ_HUMAN	reviewed	Evidence at protein level	5 out of 5	NF-kappa-B inhibitor zeta (I-kappa-B-zeta) (IkB-zeta) (IkappaBzeta) (IL-1 inducible nuclear ankyrin-repeat protein) (INAP) (Molecule possessing ankyrin repeats induced by lipopolysaccharide) (MAIL)	NFKBIZ IKBZ INAP MAIL	29805;	9606.ENSP00000325663;
P04201	MAS_HUMAN	reviewed	Evidence at protein level	5 out of 5	Proto-oncogene Mas	MAS1 MAS	6899;	9606.ENSP00000252660;
Q7Z434	MAVS_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mitochondrial antiviral-signaling protein (MAVS) (CARD adapter inducing interferon beta) (Cardif) (Interferon beta promoter stimulator protein 1) (IPS-1) (Putative NF-kappa-B-activating protein 031N) (Virus-induced-signaling adapter) (VISA)	MAVS IPS1 KIAA1271 VISA	29233;	9606.ENSP00000401980;
P61626	LYSC_HUMAN	reviewed	Evidence at protein level	5 out of 5	Lysozyme C (EC 3.2.1.17) (1,4-beta-N-acetylmuramidase C)	LYZ LZM	6740;	9606.ENSP00000261267;
Q8NEM0	MCPH1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Microcephalin	MCPH1	6954;	9606.ENSP00000342924;
P49137	MAPK2_HUMAN	reviewed	Evidence at protein level	5 out of 5	MAP kinase-activated protein kinase 2 (MAPK-activated protein kinase 2) (MAPKAP kinase 2) (MAPKAP-K2) (MAPKAPK-2) (MK-2) (MK2) (EC 2.7.11.1)	MAPKAPK2	6887;	9606.ENSP00000356070;
Q16644	MAPK3_HUMAN	reviewed	Evidence at protein level	5 out of 5	MAP kinase-activated protein kinase 3 (MAPK-activated protein kinase 3) (MAPKAP kinase 3) (MAPKAP-K3) (MAPKAPK-3) (MK-3) (EC 2.7.11.1) (Chromosome 3p kinase) (3pK)	MAPKAPK3	6888;	9606.ENSP00000396467;
Q30154	DRB5_HUMAN	reviewed	Evidence at protein level	5 out of 5	HLA class II histocompatibility antigen, DR beta 5 chain (DR beta-5) (DR2-beta-2) (Dw2) (MHC class II antigen DRB5)	HLA-DRB5	4953;	9606.ENSP00000364114;
P09429	HMGB1_HUMAN	reviewed	Evidence at protein level	5 out of 5	High mobility group protein B1 (High mobility group protein 1) (HMG-1)	HMGB1 HMG1	4983;	9606.ENSP00000345347;
P00738	HPT_HUMAN	reviewed	Evidence at protein level	5 out of 5	Haptoglobin (Zonulin) [Cleaved into: Haptoglobin alpha chain; Haptoglobin beta chain]	HP	5141;	9606.ENSP00000348170;
P53779	MK10_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (MAP kinase p49 3F12) (Stress-activated protein kinase 1b) (SAPK1b) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3)	MAPK10 JNK3 JNK3A PRKM10 SAPK1B	6872;	9606.ENSP00000352157;
P09382	LEG1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Galectin-1 (Gal-1) (14 kDa laminin-binding protein) (HLBP14) (14 kDa lectin) (Beta-galactoside-binding lectin L-14-I) (Galaptin) (HBL) (HPL) (Lactose-binding lectin 1) (Lectin galactoside-binding soluble 1) (Putative MAPK-activating protein PM12) (S-Lac lectin 1)	LGALS1	6561;	9606.ENSP00000215909;
Q9HBL8	NMRL1_HUMAN	reviewed	Evidence at protein level	5 out of 5	NmrA-like family domain-containing protein 1	NMRAL1 HSCARG	24987;	9606.ENSP00000458762;
O14931	NCTR3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Natural cytotoxicity triggering receptor 3 (Activating natural killer receptor p30) (Natural killer cell p30-related protein) (NK-p30) (NKp30) (CD antigen CD337)	NCR3 1C7 LY117	19077;	9606.ENSP00000342156;
O95711	LY86_HUMAN	reviewed	Evidence at protein level	5 out of 5	Lymphocyte antigen 86 (Ly-86) (Protein MD-1)	LY86 MD1	16837;	9606.ENSP00000369286;
P19878	NCF2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Neutrophil cytosol factor 2 (NCF-2) (67 kDa neutrophil oxidase factor) (NADPH oxidase activator 2) (Neutrophil NADPH oxidase factor 2) (p67-phox)	NCF2 NOXA2 P67PHOX	7661;	9606.ENSP00000356505;
Q7RTR2	NLRC3_HUMAN	reviewed	Evidence at protein level	5 out of 5	NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)	NLRC3 NOD3	29889;	9606.ENSP00000352039;
Q9NPP4	NLRC4_HUMAN	reviewed	Evidence at protein level	5 out of 5	NLR family CARD domain-containing protein 4 (CARD, LRR, and NACHT-containing protein) (CED-4-like protein Clan) (Caspase recruitment domain-containing protein 12) (Ice protease-activating factor) (Ipaf)	NLRC4 CARD12 CLAN CLAN1 IPAF UNQ6189/PRO20215	16412;	9606.ENSP00000385090;
Q6P1Q0	LTMD1_HUMAN	reviewed	Evidence at protein level	5 out of 5	LETM1 domain-containing protein 1 (Cervical cancer 1 proto-oncogene protein p40) (Cervical cancer proto-oncogene 2 protein) (HCCR-1) (HCRR-2)	LETMD1	24241;	9606.ENSP00000389903;
P09769	FGR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog) (Proto-oncogene c-Fgr) (p55-Fgr) (p58-Fgr) (p58c-Fgr)	FGR SRC2	3697;	9606.ENSP00000363117;
Q9BZS1	FOXP3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Forkhead box protein P3 (Scurfin) [Cleaved into: Forkhead box protein P3, C-terminally processed; Forkhead box protein P3 41 kDa form]	FOXP3 IPEX JM2	6106;	9606.ENSP00000365380;
Q99684	GFI1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Zinc finger protein Gfi-1 (Growth factor independent protein 1) (Zinc finger protein 163)	GFI1 ZNF163	4237;	9606.ENSP00000359357;
P08754	GNAI3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Guanine nucleotide-binding protein G(i) subunit alpha-3 (G(i) alpha-3)	GNAI3	4387;	9606.ENSP00000358867;
O14920	IKKB_HUMAN	reviewed	Evidence at protein level	5 out of 5	Inhibitor of nuclear factor kappa-B kinase subunit beta (I-kappa-B-kinase beta) (IKK-B) (IKK-beta) (IkBKB) (EC 2.7.11.10) (I-kappa-B kinase 2) (IKK2) (Nuclear factor NF-kappa-B inhibitor kinase beta) (NFKBIKB) (Serine/threonine protein kinase IKBKB) (EC 2.7.11.1)	IKBKB IKKB	5960;	9606.ENSP00000430684;
P22301	IL10_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-10 (IL-10) (Cytokine synthesis inhibitory factor) (CSIF)	IL10	5962;	9606.ENSP00000412237;
Q99685	MGLL_HUMAN	reviewed	Evidence at protein level	5 out of 5	Monoglyceride lipase (MGL) (EC 3.1.1.23) (HU-K5) (Lysophospholipase homolog) (Lysophospholipase-like) (Monoacylglycerol lipase) (MAGL)	MGLL	17038;	9606.ENSP00000265052;
Q9Y4C4	MFHA1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Malignant fibrous histiocytoma-amplified sequence 1 (Malignant fibrous histiocytoma-amplified sequence with leucine-rich tandem repeats 1)	MFHAS1 MASL1	16982;	9606.ENSP00000276282;
O43187	IRAK2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-1 receptor-associated kinase-like 2 (IRAK-2)	IRAK2	6113;	9606.ENSP00000256458;
P10721	KIT_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Piebald trait protein) (PBT) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (p145 c-kit) (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (CD antigen CD117)	KIT SCFR	6342;	9606.ENSP00000288135;
Q9UDY8	MALT1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (EC 3.4.22.-) (MALT lymphoma-associated translocation) (Paracaspase)	MALT1 MLT	6819;	9606.ENSP00000319279;
P33992	MCM5_HUMAN	reviewed	Evidence at protein level	5 out of 5	DNA replication licensing factor MCM5 (EC 3.6.4.12) (CDC46 homolog) (P1-CDC46)	MCM5 CDC46	6948;	9606.ENSP00000216122;
Q09328	MGT5A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.155) (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase V) (GlcNAc-T V) (GNT-V) (Mannoside acetylglucosaminyltransferase 5) (N-acetylglucosaminyl-transferase V) [Cleaved into: Secreted alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (Secreted beta-1,6-N-acetylglucosaminyltransferase V) (Secreted GNT-V)]	MGAT5 GGNT5	7049;	9606.ENSP00000386377;
Q6W5P4	NPSR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14) (G-protein coupled receptor for asthma susceptibility)	NPSR1 GPR154 GPRA PGR14	23631;	9606.ENSP00000370950;
P01100	FOS_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein c-Fos (Cellular oncogene fos) (Fos proto-oncogene, AP-1 transcription factor subunit) (G0/G1 switch regulatory protein 7) (Proto-oncogene c-Fos) (Transcription factor AP-1 subunit c-Fos)	FOS G0S7	3796;	9606.ENSP00000306245;
Q8NI17	IL31R_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-31 receptor subunit alpha (IL-31 receptor subunit alpha) (IL-31R subunit alpha) (IL-31R-alpha) (IL-31RA) (Cytokine receptor-like 3) (GLM-R) (hGLM-R) (Gp130-like monocyte receptor) (Gp130-like receptor) (ZcytoR17)	IL31RA CRL3 GPL UNQ6368/PRO21073/PRO21384	18969;	9606.ENSP00000415900;
Q9NVR5	KTU_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein kintoun (Dynein assembly factor 2, axonemal)	DNAAF2 C14orf104 KTU	20188;	9606.ENSP00000298292;
P16150	LEUK_HUMAN	reviewed	Evidence at protein level	5 out of 5	Leukosialin (GPL115) (Galactoglycoprotein) (GALGP) (Leukocyte sialoglycoprotein) (Sialophorin) (CD antigen CD43) [Cleaved into: CD43 cytoplasmic tail (CD43-ct) (CD43ct)]	SPN CD43	11249;	9606.ENSP00000353238;
Q05655	KPCD_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)]	PRKCD PKCD	9399;	9606.ENSP00000378217;
Q8NHJ6	LIRB4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Leukocyte immunoglobulin-like receptor subfamily B member 4 (B4) (CD85 antigen-like family member K) (Immunoglobulin-like transcript 3) (ILT-3) (Leukocyte immunoglobulin-like receptor 5) (LIR-5) (Monocyte inhibitory receptor HM18) (CD antigen CD85k)	LILRB4 ILT3 LIR5	6608;	9606.ENSP00000375616;
Q86W26	NAL10_HUMAN	reviewed	Evidence at protein level	5 out of 5	NACHT, LRR and PYD domains-containing protein 10 (Nucleotide-binding oligomerization domain protein 8)	NLRP10 NALP10 NOD8 PYNOD	21464;	9606.ENSP00000327763;
Q8TDU6	GPBAR_HUMAN	reviewed	Evidence at protein level	5 out of 5	G-protein coupled bile acid receptor 1 (G-protein coupled receptor GPCR19) (hGPCR19) (Membrane-type receptor for bile acids) (M-BAR) (hBG37) (BG37)	GPBAR1 TGR5	19680;	9606.ENSP00000430886;
P43220	GLP1R_HUMAN	reviewed	Evidence at protein level	5 out of 5	Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R)	GLP1R	4324;	9606.ENSP00000362353;
Q9NPH3	IL1AP_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-1 receptor accessory protein (IL-1 receptor accessory protein) (IL-1RAcP) (EC 3.2.2.6) (Interleukin-1 receptor 3) (IL-1R-3) (IL-1R3)	IL1RAP C3orf13 IL1R3	5995;	
Q8NI38	IKBD_HUMAN	reviewed	Evidence at protein level	5 out of 5	NF-kappa-B inhibitor delta (NFKB inhibitor delta) (I-kappa-B-delta) (IkB-delta) (IkappaBdelta) (IkappaBNS) (T-cell activation NFKB-like protein) (TA-NFKBH)	NFKBID IKBNS	15671;	9606.ENSP00000380109;
P40933	IL15_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-15 (IL-15)	IL15	5977;	9606.ENSP00000296545;
Q9NQ38	ISK5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Serine protease inhibitor Kazal-type 5 (Lympho-epithelial Kazal-type-related inhibitor) (LEKTI) [Cleaved into: Hemofiltrate peptide HF6478; Hemofiltrate peptide HF7665]	SPINK5	15464;	9606.ENSP00000352936;
Q16566	KCC4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Calcium/calmodulin-dependent protein kinase type IV (CaMK IV) (EC 2.7.11.17) (CaM kinase-GR)	CAMK4 CAMK CAMK-GR CAMKIV	1464;	9606.ENSP00000282356;
P21741	MK_HUMAN	reviewed	Evidence at protein level	5 out of 5	Midkine (MK) (Amphiregulin-associated protein) (ARAP) (Midgestation and kidney protein) (Neurite outgrowth-promoting factor 2) (Neurite outgrowth-promoting protein)	MDK MK1 NEGF2	6972;	9606.ENSP00000385451;
P02533	K1C14_HUMAN	reviewed	Evidence at protein level	5 out of 5	Keratin, type I cytoskeletal 14 (Cytokeratin-14) (CK-14) (Keratin-14) (K14)	KRT14	6416;	9606.ENSP00000167586;
Q16539	MK14_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (Cytokine suppressive anti-inflammatory drug-binding protein) (CSAID-binding protein) (CSBP) (MAP kinase MXI2) (MAX-interacting protein 2) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha) (Stress-activated protein kinase 2a) (SAPK2a)	MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A	6876;	9606.ENSP00000229795;
P43405	KSYK_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72-Syk)	SYK	11491;	9606.ENSP00000364907;
P26583	HMGB2_HUMAN	reviewed	Evidence at protein level	5 out of 5	High mobility group protein B2 (High mobility group protein 2) (HMG-2)	HMGB2 HMG2	5000;	9606.ENSP00000296503;
Q9BZ67	FRMD8_HUMAN	reviewed	Evidence at protein level	5 out of 5	FERM domain-containing protein 8 (Band4.1 inhibitor LRP interactor) (Bili) (iRhom tail-associated protein) (iTAP)	FRMD8 FKSG44	25462;	9606.ENSP00000319726;
P35637	FUS_HUMAN	reviewed	Evidence at protein level	5 out of 5	RNA-binding protein FUS (75 kDa DNA-pairing protein) (Oncogene FUS) (Oncogene TLS) (POMp75) (Translocated in liposarcoma protein)	FUS TLS	4010;	9606.ENSP00000254108;
P22083	FUT4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Alpha-(1,3)-fucosyltransferase 4 (4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase) (EC 2.4.1.152) (ELAM-1 ligand fucosyltransferase) (Fucosyltransferase 4) (Fucosyltransferase IV) (Fuc-TIV) (FucT-IV) (Galactoside 3-L-fucosyltransferase)	FUT4 ELFT FCT3A	4015;	9606.ENSP00000351602;
P25090	FPR2_HUMAN	reviewed	Evidence at protein level	5 out of 5	N-formyl peptide receptor 2 (FMLP-related receptor I) (FMLP-R-I) (Formyl peptide receptor-like 1) (HM63) (Lipoxin A4 receptor) (LXA4 receptor) (RFP)	FPR2 FPRH1 FPRL1 LXA4R	3827;	9606.ENSP00000468897;
Q16665	HIF1A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8)	HIF1A BHLHE78 MOP1 PASD8	4910;	9606.ENSP00000437955;
Q9UHD0	IL19_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-19 (IL-19) (Melanoma differentiation-associated protein-like protein) (NG.1)	IL19 ZMDA1	5990;	9606.ENSP00000343000;
Q9BYM8	HOIL1_HUMAN	reviewed	Evidence at protein level	5 out of 5	RanBP-type and C3HC4-type zinc finger-containing protein 1 (EC 2.3.2.31) (HBV-associated factor 4) (Heme-oxidized IRP2 ubiquitin ligase 1) (HOIL-1) (Hepatitis B virus X-associated protein 4) (RING finger protein 54) (RING-type E3 ubiquitin transferase HOIL-1) (Ubiquitin-conjugating enzyme 7-interacting protein 3)	RBCK1 C20orf18 RNF54 UBCE7IP3 XAP3 XAP4	15864;	9606.ENSP00000348632;
O15111	IKKA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Inhibitor of nuclear factor kappa-B kinase subunit alpha (I-kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) (Transcription factor 16) (TCF-16)	CHUK IKKA TCF16	1974;	9606.ENSP00000359424;
O43561	LAT_HUMAN	reviewed	Evidence at protein level	5 out of 5	Linker for activation of T-cells family member 1 (36 kDa phospho-tyrosine adapter protein) (pp36) (p36-38)	LAT	18874;	
Q8N386	LRC25_HUMAN	reviewed	Evidence at protein level	5 out of 5	Leucine-rich repeat-containing protein 25 (Monocyte and plasmacytoid-activated protein)	LRRC25 MAPA UNQ6169/PRO20174	29806;	9606.ENSP00000340983;
Q9BYJ1	LOXE3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Hydroperoxide isomerase ALOXE3 (Epidermis-type lipoxygenase 3) (Epidermal LOX-3) (e-LOX-3) (eLOX-3) (Hydroperoxy dehydratase ALOXE3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152) (Hydroperoxy icosatetraenoate isomerase) (EC 5.4.4.7)	ALOXE3	13743;	9606.ENSP00000314879;
Q07954	LRP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (Apolipoprotein E receptor) (APOER) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)]	LRP1 A2MR APR	6692;	9606.ENSP00000243077;
P01229	LSHB_HUMAN	reviewed	Evidence at protein level	5 out of 5	Lutropin subunit beta (Lutropin beta chain) (Luteinizing hormone subunit beta) (LH-B) (LSH-B) (LSH-beta)	LHB	6584;	9606.ENSP00000221421;
Q99731	CCL19_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C motif chemokine 19 (Beta-chemokine exodus-3) (CK beta-11) (Epstein-Barr virus-induced molecule 1 ligand chemokine) (EBI1 ligand chemokine) (ELC) (Macrophage inflammatory protein 3 beta) (MIP-3-beta) (Small-inducible cytokine A19)	CCL19 ELC MIP3B SCYA19	10617;	9606.ENSP00000308815;
Q92485	ASM3B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-)	SMPDL3B ASML3B ASMLPD	21416;	9606.ENSP00000363001;
P54707	AT12A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Potassium-transporting ATPase alpha chain 2 (HK alpha 2) (Non-gastric H(+)/K(+) ATPase subunit alpha) (EC 7.2.2.19) (Non-gastric Na(+)/K(+) ATPase subunit alpha) (EC 7.2.2.13) (Proton pump) (Sodium pump)	ATP12A ATP1AL1	13816;	9606.ENSP00000218548;
O75882	ATRN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Attractin (DPPT-L) (Mahogany homolog)	ATRN KIAA0548 MGCA	885;	9606.ENSP00000262919;
Q9NR63	CP26B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cytochrome P450 26B1 (EC 1.14.13.-) (Cytochrome P450 26A2) (Cytochrome P450 retinoic acid-inactivating 2) (Cytochrome P450RAI-2) (Retinoic acid-metabolizing cytochrome)	CYP26B1 CYP26A2 P450RAI2	20581;	9606.ENSP00000001146;
A1A4Y4	IRGM_HUMAN	reviewed	Evidence at protein level	5 out of 5	Immunity-related GTPase family M protein (EC 3.6.5.-) (Immunity-related GTPase family M protein 1) (Interferon-inducible protein 1) (LPS-stimulated RAW 264.7 macrophage protein 47 homolog) (LRG-47)	IRGM IFI1 IRGM1 LRG47	29597;	9606.ENSP00000428220;
Q6VAB6	KSR2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Kinase suppressor of Ras 2 (hKSR2) (EC 2.7.11.1)	KSR2	18610;	9606.ENSP00000389715;
P17931	LEG3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Galectin-3 (Gal-3) (35 kDa lectin) (Carbohydrate-binding protein 35) (CBP 35) (Galactose-specific lectin 3) (Galactoside-binding protein) (GALBP) (IgE-binding protein) (L-31) (Laminin-binding protein) (Lectin L-29) (Mac-2 antigen)	LGALS3 MAC2	6563;	9606.ENSP00000254301;
O00182	LEG9_HUMAN	reviewed	Evidence at protein level	5 out of 5	Galectin-9 (Gal-9) (Ecalectin) (Tumor antigen HOM-HD-21)	LGALS9	6570;	9606.ENSP00000378856;
Q9UKG1	DP13A_HUMAN	reviewed	Evidence at protein level	5 out of 5	DCC-interacting protein 13-alpha (Dip13-alpha) (Adapter protein containing PH domain, PTB domain and leucine zipper motif 1)	APPL1 APPL DIP13A KIAA1428	24035;	9606.ENSP00000288266;
Q14164	IKKE_HUMAN	reviewed	Evidence at protein level	5 out of 5	Inhibitor of nuclear factor kappa-B kinase subunit epsilon (I-kappa-B kinase epsilon) (IKK-E) (IKK-epsilon) (IkBKE) (EC 2.7.11.10) (Inducible I kappa-B kinase) (IKK-i)	IKBKE IKKE IKKI KIAA0151	14552;	9606.ENSP00000464030;
Q9NRM6	I17RB_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-17 receptor B (IL-17 receptor B) (IL-17RB) (Cytokine receptor-like 4) (IL-17 receptor homolog 1) (IL-17Rh1) (IL17Rh1) (Interleukin-17B receptor) (IL-17B receptor)	IL17RB CRL4 EVI27 IL17BR UNQ2501/PRO19612	18015;	9606.ENSP00000288167;
Q8NFR9	I17RE_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-17 receptor E (IL-17 receptor E) (IL-17RE)	IL17RE UNQ3056/PRO9877	18439;	9606.ENSP00000373325;
O15054	KDM6B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Lysine-specific demethylase 6B (EC 1.14.11.68) (JmjC domain-containing protein 3) (Jumonji domain-containing protein 3) (Lysine demethylase 6B) ([histone H3]-trimethyl-L-lysine(27) demethylase 6B)	KDM6B JMJD3 KIAA0346	29012;	9606.ENSP00000254846;
Q92633	LPAR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Lysophosphatidic acid receptor 1 (LPA receptor 1) (LPA-1) (Lysophosphatidic acid receptor Edg-2)	LPAR1 EDG2 LPA1	3166;	9606.ENSP00000363553;
P55212	CASP6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Caspase-6 (CASP-6) (CSP-6) (EC 3.4.22.59) (Apoptotic protease Mch-2) [Cleaved into: Caspase-6 subunit p18 (Caspase-6 subunit p20); Caspase-6 subunit p11 (Caspase-6 subunit p10)]	CASP6 MCH2	1507;	9606.ENSP00000265164;
P08174	DAF_HUMAN	reviewed	Evidence at protein level	5 out of 5	Complement decay-accelerating factor (CD antigen CD55)	CD55 CR DAF	2665;	9606.ENSP00000356030;
O95786	DDX58_HUMAN	reviewed	Evidence at protein level	5 out of 5	Antiviral innate immune response receptor RIG-I (ATP-dependent RNA helicase DDX58) (EC 3.6.4.13) (DEAD box protein 58) (RIG-I-like receptor 1) (RLR-1) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I)	DDX58	19102;	9606.ENSP00000369213;
Q86X55	CARM1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Histone-arginine methyltransferase CARM1 (EC 2.1.1.319) (Coactivator-associated arginine methyltransferase 1) (Protein arginine N-methyltransferase 4)	CARM1 PRMT4	23393;	9606.ENSP00000325690;
Q30KQ6	DB114_HUMAN	reviewed	Evidence at protein level	5 out of 5	Beta-defensin 114 (Beta-defensin 14) (DEFB-14) (Defensin, beta 114)	DEFB114 DEFB14	18095;	9606.ENSP00000312702;
Q86SJ6	DSG4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Desmoglein-4 (Cadherin family member 13)	DSG4 CDHF13	21307;	9606.ENSP00000352785;
Q9NRD8	DUOX2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (Large NOX 2) (Long NOX 2) (NADH/NADPH thyroid oxidase p138-tox) (NADPH oxidase/peroxidase DUOX2) (NADPH thyroid oxidase 2) (Thyroid oxidase 2) (p138 thyroid oxidase)	DUOX2 LNOX2 THOX2	13273;	9606.ENSP00000475084;
Q9Y6W6	DUS10_HUMAN	reviewed	Evidence at protein level	5 out of 5	Dual specificity protein phosphatase 10 (EC 3.1.3.16) (EC 3.1.3.48) (Mitogen-activated protein kinase phosphatase 5) (MAP kinase phosphatase 5) (MKP-5)	DUSP10 MKP5	3065;	9606.ENSP00000355866;
P36222	CH3L1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Chitinase-3-like protein 1 (39 kDa synovial protein) (Cartilage glycoprotein 39) (CGP-39) (GP-39) (hCGP-39) (YKL-40)	CHI3L1	1932;	9606.ENSP00000255409;
P13236	CCL4_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C motif chemokine 4 (G-26 T-lymphocyte-secreted protein) (HC21) (Lymphocyte activation gene 1 protein) (LAG-1) (MIP-1-beta(1-69)) (Macrophage inflammatory protein 1-beta) (MIP-1-beta) (PAT 744) (Protein H400) (SIS-gamma) (Small-inducible cytokine A4) (T-cell activation protein 2) (ACT-2) [Cleaved into: MIP-1-beta(3-69)]	CCL4 LAG1 MIP1B SCYA4	10630;	9606.ENSP00000482259;
P13498	CY24A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cytochrome b-245 light chain (Cytochrome b(558) alpha chain) (Cytochrome b558 subunit alpha) (Neutrophil cytochrome b 22 kDa polypeptide) (Superoxide-generating NADPH oxidase light chain subunit) (p22 phagocyte B-cytochrome) (p22-phox) (p22phox)	CYBA	2577;	9606.ENSP00000261623;
Q92499	DDX1_HUMAN	reviewed	Evidence at protein level	5 out of 5	ATP-dependent RNA helicase DDX1 (EC 3.6.4.13) (DEAD box protein 1) (DEAD box protein retinoblastoma) (DBP-RB)	DDX1	2734;	9606.ENSP00000370745;
P05538	DQB2_HUMAN	reviewed	Evidence at protein level	5 out of 5	HLA class II histocompatibility antigen, DQ beta 2 chain (HLA class II histocompatibility antigen, DX beta chain) (MHC class II antigen DQB2)	HLA-DQB2 HLA-DXB	4945;	
P18146	EGR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Early growth response protein 1 (EGR-1) (AT225) (Nerve growth factor-induced protein A) (NGFI-A) (Transcription factor ETR103) (Transcription factor Zif268) (Zinc finger protein 225) (Zinc finger protein Krox-24)	EGR1 KROX24 ZNF225	3238;	9606.ENSP00000239938;
O60506	HNRPQ_HUMAN	reviewed	Evidence at protein level	5 out of 5	Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein)	SYNCRIP HNRPQ NSAP1	16918;	9606.ENSP00000358635;
Q15653	IKBB_HUMAN	reviewed	Evidence at protein level	5 out of 5	NF-kappa-B inhibitor beta (NF-kappa-BIB) (I-kappa-B-beta) (IkB-B) (IkB-beta) (IkappaBbeta) (Thyroid receptor-interacting protein 9) (TR-interacting protein 9) (TRIP-9)	NFKBIB IKBB TRIP9	7798;	9606.ENSP00000312988;
P41279	M3K8_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mitogen-activated protein kinase kinase kinase 8 (EC 2.7.11.25) (Cancer Osaka thyroid oncogene) (Proto-oncogene c-Cot) (Serine/threonine-protein kinase cot) (Tumor progression locus 2) (TPL-2)	MAP3K8 COT ESTF	6860;	9606.ENSP00000263056;
P29376	LTK_HUMAN	reviewed	Evidence at protein level	5 out of 5	Leukocyte tyrosine kinase receptor (EC 2.7.10.1) (Protein tyrosine kinase 1)	LTK TYK1	6721;	9606.ENSP00000263800;
P29323	EPHB2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ephrin type-B receptor 2 (EC 2.7.10.1) (Developmentally-regulated Eph-related tyrosine kinase) (ELK-related tyrosine kinase) (EPH tyrosine kinase 3) (EPH-like kinase 5) (EK5) (hEK5) (Renal carcinoma antigen NY-REN-47) (Tyrosine-protein kinase TYRO5) (Tyrosine-protein kinase receptor EPH-3) [Cleaved into: EphB2/CTF1; EphB2/CTF2]	EPHB2 DRT EPHT3 EPTH3 ERK HEK5 TYRO5	3393;	9606.ENSP00000363763;
P14921	ETS1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein C-ets-1 (p54)	ETS1 EWSR2	3488;	9606.ENSP00000376436;
Q15910	EZH2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Histone-lysine N-methyltransferase EZH2 (EC 2.1.1.356) (ENX-1) (Enhancer of zeste homolog 2) (Lysine N-methyltransferase 6)	EZH2 KMT6	3527;	9606.ENSP00000320147;
Q5NUL3	FFAR4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Free fatty acid receptor 4 (G-protein coupled receptor 120) (G-protein coupled receptor 129) (G-protein coupled receptor GT01) (G-protein coupled receptor PGR4) (Omega-3 fatty acid receptor 1)	FFAR4 GPR120 GPR129 O3FAR1 PGR4	19061;	9606.ENSP00000360538;
P10321	HLAC_HUMAN	reviewed	Evidence at protein level	5 out of 5	HLA class I histocompatibility antigen, C alpha chain (HLA-C) (HLA-Cw) (Human leukocyte antigen C)	HLA-C HLAC	4933;	9606.ENSP00000365402;
P0DMV9	HS71B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Heat shock 70 kDa protein 1B (Heat shock 70 kDa protein 2) (HSP70-2) (HSP70.2)	HSPA1B HSP72	5233;	
P43088	PF2R_HUMAN	reviewed	Evidence at protein level	5 out of 5	Prostaglandin F2-alpha receptor (PGF receptor) (PGF2-alpha receptor) (Prostanoid FP receptor)	PTGFR	9600;	9606.ENSP00000359793;
P10720	PF4V_HUMAN	reviewed	Evidence at protein level	5 out of 5	Platelet factor 4 variant (C-X-C motif chemokine 4 variant) (CXCL4L1) (PF4alt) (PF4var1) [Cleaved into: Platelet factor 4 variant(4-74); Platelet factor 4 variant(5-74); Platelet factor 4 variant(6-74)]	PF4V1 CXCL4V1 SCYB4V1	8862;	9606.ENSP00000226524;
O15534	PER1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Period circadian protein homolog 1 (hPER1) (Circadian clock protein PERIOD 1) (Circadian pacemaker protein Rigui)	PER1 KIAA0482 PER RIGUI	8845;	9606.ENSP00000314420;
O15055	PER2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Period circadian protein homolog 2 (hPER2) (Circadian clock protein PERIOD 2)	PER2 KIAA0347	8846;	9606.ENSP00000254657;
P12004	PCNA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Proliferating cell nuclear antigen (PCNA) (Cyclin)	PCNA	8729;	9606.ENSP00000368458;
Q15116	PDCD1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Programmed cell death protein 1 (Protein PD-1) (hPD-1) (CD antigen CD279)	PDCD1 PD1	8760;	9606.ENSP00000335062;
Q53EL6	PDCD4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Programmed cell death protein 4 (Neoplastic transformation inhibitor protein) (Nuclear antigen H731-like) (Protein 197/15a)	PDCD4 H731	8763;	9606.ENSP00000280154;
Q13526	PIN1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase Pin1) (PPIase Pin1) (Rotamase Pin1)	PIN1	8988;	9606.ENSP00000247970;
Q6ZWH5	NEK10_HUMAN	reviewed	Evidence at protein level	5 out of 5	Serine/threonine-protein kinase Nek10 (EC 2.7.11.1) (Never in mitosis A-related kinase 10) (NimA-related protein kinase 10)	NEK10	18592;	9606.ENSP00000343847;
P03372	ESR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1)	ESR1 ESR NR3A1	3467;	9606.ENSP00000405330;
P80217	IN35_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interferon-induced 35 kDa protein (IFP 35) (Ifi-35)	IFI35 IFP35	5399;	9606.ENSP00000395590;
P18564	ITB6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Integrin beta-6	ITGB6	6161;	9606.ENSP00000283249;
P04264	K2C1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Keratin, type II cytoskeletal 1 (67 kDa cytokeratin) (Cytokeratin-1) (CK-1) (Hair alpha protein) (Keratin-1) (K1) (Type-II keratin Kb1)	KRT1 KRTA	6412;	9606.ENSP00000252244;
P06858	LIPL_HUMAN	reviewed	Evidence at protein level	5 out of 5	Lipoprotein lipase (LPL) (EC 3.1.1.34) (Phospholipase A1) (EC 3.1.1.32)	LPL LIPD	6677;	9606.ENSP00000309757;
Q96GV9	MACIR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Macrophage immunometabolism regulator	MACIR C5orf30	25052;	9606.ENSP00000326110;
Q16873	LTC4S_HUMAN	reviewed	Evidence at protein level	5 out of 5	Leukotriene C4 synthase (LTC4 synthase) (EC 4.4.1.20) (Glutathione S-transferase LTC4) (EC 2.5.1.-) (Leukotriene-C(4) synthase) (Leukotriene-C4 synthase)	LTC4S	6719;	9606.ENSP00000292596;
O14733	MP2K7_HUMAN	reviewed	Evidence at protein level	5 out of 5	Dual specificity mitogen-activated protein kinase kinase 7 (MAP kinase kinase 7) (MAPKK 7) (EC 2.7.12.2) (JNK-activating kinase 2) (MAPK/ERK kinase 7) (MEK 7) (Stress-activated protein kinase kinase 4) (SAPK kinase 4) (SAPKK-4) (SAPKK4) (c-Jun N-terminal kinase kinase 2) (JNK kinase 2) (JNKK 2)	MAP2K7 JNKK2 MEK7 MKK7 PRKMK7 SKK4	6847;	9606.ENSP00000381070;
P45983	MK08_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (JNK-46) (Stress-activated protein kinase 1c) (SAPK1c) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1)	MAPK8 JNK1 PRKM8 SAPK1 SAPK1C	6881;	9606.ENSP00000378974;
P10515	ODP2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial (EC 2.3.1.12) (70 kDa mitochondrial autoantigen of primary biliary cirrhosis) (PBC) (Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex) (M2 antigen complex 70 kDa subunit) (Pyruvate dehydrogenase complex component E2) (PDC-E2) (PDCE2)	DLAT DLTA	2896;	9606.ENSP00000280346;
Q99497	PARK7_HUMAN	reviewed	Evidence at protein level	5 out of 5	Parkinson disease protein 7 (Maillard deglycase) (Oncogene DJ1) (Parkinsonism-associated deglycase) (Protein DJ-1) (DJ-1) (Protein/nucleic acid deglycase DJ-1) (EC 3.1.2.-) (EC 3.5.1.-) (EC 3.5.1.124)	PARK7	16369;	9606.ENSP00000418770;
Q92614	MY18A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus) (MAJN) (Myosin containing a PDZ domain) (Surfactant protein receptor SP-R210) (SP-R210)	MYO18A CD245 KIAA0216 MYSPDZ TIAF1	31104;	9606.ENSP00000437073;
Q32MK0	MYLK3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Myosin light chain kinase 3 (EC 2.7.11.18) (Cardiac-MyBP-C-associated Ca/CaM kinase) (Cardiac-MLCK)	MYLK3 MLCK	29826;	9606.ENSP00000378288;
O00408	PDE2A_HUMAN	reviewed	Evidence at protein level	5 out of 5	cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP-stimulated phosphodiesterase) (CGS-PDE) (cGSPDE)	PDE2A	8777;	9606.ENSP00000334910;
P43115	PE2R3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Prostaglandin E2 receptor EP3 subtype (PGE receptor EP3 subtype) (PGE2 receptor EP3 subtype) (PGE2-R) (Prostanoid EP3 receptor)	PTGER3	9595;	9606.ENSP00000349003;
Q07343	PDE4B_HUMAN	reviewed	Evidence at protein level	5 out of 5	cAMP-specific 3',5'-cyclic phosphodiesterase 4B (EC 3.1.4.53) (DPDE4) (PDE32)	PDE4B DPDE4	8781;	9606.ENSP00000332116;
P35408	PE2R4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Prostaglandin E2 receptor EP4 subtype (PGE receptor EP4 subtype) (PGE2 receptor EP4 subtype) (Prostanoid EP4 receptor)	PTGER4 PTGER2	9596;	9606.ENSP00000302846;
O75594	PGRP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Peptidoglycan recognition protein 1 (Peptidoglycan recognition protein short) (PGRP-S)	PGLYRP1 PGLYRP PGRP TNFSF3L SBBI68 UNQ639/PRO1269	8904;	9606.ENSP00000008938;
Q96PD5	PGRP2_HUMAN	reviewed	Evidence at protein level	5 out of 5	N-acetylmuramoyl-L-alanine amidase (EC 3.5.1.28) (Peptidoglycan recognition protein 2) (Peptidoglycan recognition protein long) (PGRP-L)	PGLYRP2 PGLYRPL PGRPL UNQ3103/PRO10102	30013;	9606.ENSP00000345968;
P16284	PECA1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Platelet endothelial cell adhesion molecule (PECAM-1) (EndoCAM) (GPIIA') (PECA1) (CD antigen CD31)	PECAM1	8823;	9606.ENSP00000457421;
P14598	NCF1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Neutrophil cytosol factor 1 (NCF-1) (47 kDa autosomal chronic granulomatous disease protein) (47 kDa neutrophil oxidase factor) (NCF-47K) (Neutrophil NADPH oxidase factor 1) (Nox organizer 2) (Nox-organizing protein 2) (SH3 and PX domain-containing protein 1A) (p47-phox)	NCF1 NOXO2 SH3PXD1A	7660;	9606.ENSP00000289473;
Q9C000	NLRP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	NACHT, LRR and PYD domains-containing protein 1 (EC 3.4.-.-) (EC 3.6.4.-) (Caspase recruitment domain-containing protein 7) (Death effector filament-forming ced-4-like apoptosis protein) (Nucleotide-binding domain and caspase recruitment domain) [Cleaved into: NACHT, LRR and PYD domains-containing protein 1, C-terminus (NLRP1-CT); NACHT, LRR and PYD domains-containing protein 1, N-terminus (NLRP1-NT)]	NLRP1 CARD7 DEFCAP KIAA0926 NAC NALP1	14374;	9606.ENSP00000478516;
Q9NST1	PLPL3_HUMAN	reviewed	Evidence at protein level	5 out of 5	1-acylglycerol-3-phosphate O-acyltransferase PNPLA3 (EC 2.3.1.51) (Acylglycerol transacylase) (Adiponutrin) (ADPN) (Calcium-independent phospholipase A2-epsilon) (iPLA2-epsilon) (EC 3.1.1.4) (Lysophosphatidic acid acyltransferase) (Patatin-like phospholipase domain-containing protein 3) (EC 3.1.1.3)	PNPLA3 ADPN C22orf20	18590;	9606.ENSP00000216180;
Q16236	NF2L2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nrf-2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2)	NFE2L2 NRF2	7782;	9606.ENSP00000380252;
P25025	CXCR2_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-X-C chemokine receptor type 2 (CXC-R2) (CXCR-2) (CDw128b) (GRO/MGSA receptor) (High affinity interleukin-8 receptor B) (IL-8R B) (IL-8 receptor type 2) (CD antigen CD182)	CXCR2 IL8RB	6027;	9606.ENSP00000319635;
P30273	FCERG_HUMAN	reviewed	Evidence at protein level	5 out of 5	High affinity immunoglobulin epsilon receptor subunit gamma (Fc receptor gamma-chain) (FcRgamma) (Fc-epsilon RI-gamma) (IgE Fc receptor subunit gamma) (FceRI gamma)	FCER1G	3611;	9606.ENSP00000289902;
P30046	DOPD_HUMAN	reviewed	Evidence at protein level	5 out of 5	D-dopachrome decarboxylase (EC 4.1.1.84) (D-dopachrome tautomerase) (Phenylpyruvate tautomerase II)	DDT	2732;	9606.ENSP00000381386;
Q14315	FLNC_HUMAN	reviewed	Evidence at protein level	5 out of 5	Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin)	FLNC ABPL FLN2	3756;	9606.ENSP00000327145;
Q11130	FUT7_HUMAN	reviewed	Evidence at protein level	5 out of 5	Alpha-(1,3)-fucosyltransferase 7 (EC 2.4.1.-) (Fucosyltransferase 7) (Fucosyltransferase VII) (Fuc-TVII) (FucT-VII) (Galactoside 3-L-fucosyltransferase) (Selectin ligand synthase)	FUT7	4018;	9606.ENSP00000318142;
Q9H334	FOXP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Forkhead box protein P1 (Mac-1-regulated forkhead) (MFH)	FOXP1 HSPC215	3823;	
Q9UM44	HHLA2_HUMAN	reviewed	Evidence at protein level	5 out of 5	HERV-H LTR-associating protein 2 (Human endogenous retrovirus-H long terminal repeat-associating protein 2)	HHLA2	4905;	9606.ENSP00000350402;
P31269	HXA9_HUMAN	reviewed	Evidence at protein level	5 out of 5	Homeobox protein Hox-A9 (Homeobox protein Hox-1G)	HOXA9 HOX1G	5109;	9606.ENSP00000343619;
Q14005	IL16_HUMAN	reviewed	Evidence at protein level	5 out of 5	Pro-interleukin-16 [Cleaved into: Interleukin-16 (IL-16) (Lymphocyte chemoattractant factor) (LCF)]	IL16	5980;	9606.ENSP00000302935;
O43318	M3K7_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25) (Transforming growth factor-beta-activated kinase 1) (TGF-beta-activated kinase 1)	MAP3K7 TAK1	6859;	9606.ENSP00000358335;
A1E959	ODAM_HUMAN	reviewed	Evidence at protein level	5 out of 5	Odontogenic ameloblast-associated protein (Apin)	ODAM APIN	26043;	9606.ENSP00000379401;
Q13324	CRFR2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Corticotropin-releasing factor receptor 2 (CRF-R-2) (CRF-R2) (CRFR-2) (Corticotropin-releasing hormone receptor 2) (CRH-R-2) (CRH-R2)	CRHR2 CRF2R CRH2R	2358;	9606.ENSP00000340943;
P01189	COLI_HUMAN	reviewed	Evidence at protein level	5 out of 5	Pro-opiomelanocortin (POMC) (Corticotropin-lipotropin) [Cleaved into: NPP; Melanotropin gamma (Gamma-MSH); Potential peptide; Corticotropin (Adrenocorticotropic hormone) (ACTH); Melanocyte-stimulating hormone alpha (Alpha-MSH) (Melanotropin alpha); Corticotropin-like intermediary peptide (CLIP); Lipotropin beta (Beta-LPH); Lipotropin gamma (Gamma-LPH); Melanocyte-stimulating hormone beta (Beta-MSH) (Melanotropin beta); Beta-endorphin; Met-enkephalin]	POMC	9201;	9606.ENSP00000384092;
O43293	DAPK3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Death-associated protein kinase 3 (DAP kinase 3) (EC 2.7.11.1) (DAP-like kinase) (Dlk) (MYPT1 kinase) (Zipper-interacting protein kinase) (ZIP-kinase)	DAPK3 ZIPK	2676;	9606.ENSP00000442973;
P35225	IL13_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-13 (IL-13)	IL13 NC30	5973;	9606.ENSP00000304915;
Q86SG6	NEK8_HUMAN	reviewed	Evidence at protein level	5 out of 5	Serine/threonine-protein kinase Nek8 (EC 2.7.11.1) (Never in mitosis A-related kinase 8) (NimA-related protein kinase 8) (Nima-related protein kinase 12a)	NEK8 JCK NEK12A	13387;	9606.ENSP00000268766;
Q12986	NFX1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transcriptional repressor NF-X1 (EC 2.3.2.-) (Nuclear transcription factor, X box-binding protein 1)	NFX1 NFX2	7803;	9606.ENSP00000368856;
Q15080	NCF4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Neutrophil cytosol factor 4 (NCF-4) (Neutrophil NADPH oxidase factor 4) (SH3 and PX domain-containing protein 4) (p40-phox) (p40phox)	NCF4 SH3PXD4	7662;	9606.ENSP00000380334;
P42356	PI4KA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (EC 2.7.1.67) (Phosphatidylinositol 4-Kinase III alpha)	PI4KA PIK4 PIK4CA	8983;	9606.ENSP00000255882;
P55160	NCKPL_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nck-associated protein 1-like (Hematopoietic protein 1) (Membrane-associated protein HEM-1)	NCKAP1L HEM1	4862;	9606.ENSP00000293373;
Q9Y239	NOD1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nucleotide-binding oligomerization domain-containing protein 1 (Caspase recruitment domain-containing protein 4)	NOD1 CARD4	16390;	9606.ENSP00000222823;
P52848	NDST1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1 (Glucosaminyl N-deacetylase/N-sulfotransferase 1) (NDST-1) (N-heparan sulfate sulfotransferase 1) (N-HSST 1) ([Heparan sulfate]-glucosamine N-sulfotransferase 1) (HSNST 1) [Includes: Heparan sulfate N-deacetylase 1 (EC 3.5.1.-); Heparan sulfate N-sulfotransferase 1 (EC 2.8.2.8)]	NDST1 HSST HSST1	7680;	9606.ENSP00000261797;
Q9NYR9	KBRS2_HUMAN	reviewed	Evidence at protein level	5 out of 5	NF-kappa-B inhibitor-interacting Ras-like protein 2 (I-kappa-B-interacting Ras-like protein 2) (Kappa B-Ras protein 2) (KappaB-Ras2)	NKIRAS2 KBRAS2	17898;	9606.ENSP00000303580;
P49862	KLK7_HUMAN	reviewed	Evidence at protein level	5 out of 5	Kallikrein-7 (hK7) (EC 3.4.21.117) (Serine protease 6) (Stratum corneum chymotryptic enzyme) (hSCCE)	KLK7 PRSS6 SCCE	6368;	9606.ENSP00000375683;
P08779	K1C16_HUMAN	reviewed	Evidence at protein level	5 out of 5	Keratin, type I cytoskeletal 16 (Cytokeratin-16) (CK-16) (Keratin-16) (K16)	KRT16 KRT16A	6423;	9606.ENSP00000301653;
O15264	MK13_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mitogen-activated protein kinase 13 (MAP kinase 13) (MAPK 13) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 delta) (MAP kinase p38 delta) (Stress-activated protein kinase 4)	MAPK13 PRKM13 SAPK4	6875;	9606.ENSP00000211287;
Q8IV20	LACC1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Purine nucleoside phosphorylase LACC1 (EC 2.4.2.1) (Adenosine deaminase LACC1) (EC 3.5.4.4) (Fatty acid metabolism-immunity nexus) (Guanosine phosphorylase LACC1) (Laccase domain-containing protein 1) (S-methyl-5'-thioadenosine phosphorylase LACC1) (EC 2.4.2.28)	LACC1 C13orf31 FAMIN	26789;	9606.ENSP00000391747;
Q05315	LEG10_HUMAN	reviewed	Evidence at protein level	5 out of 5	Galectin-10 (Gal-10) (Charcot-Leyden crystal protein) (CLC) (Eosinophil lysophospholipase) (Lysolecithin acylhydrolase)	CLC LGALS10 LGALS10A	2014;	9606.ENSP00000221804;
P41159	LEP_HUMAN	reviewed	Evidence at protein level	5 out of 5	Leptin (Obese protein) (Obesity factor)	LEP OB OBS	6553;	9606.ENSP00000312652;
Q99836	MYD88_HUMAN	reviewed	Evidence at protein level	5 out of 5	Myeloid differentiation primary response protein MyD88	MYD88	7562;	9606.ENSP00000401399;
P50851	LRBA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Lipopolysaccharide-responsive and beige-like anchor protein (Beige-like protein) (CDC4-like protein)	LRBA BGL CDC4L LBA	1742;	9606.ENSP00000349629;
P16050	LOX15_HUMAN	reviewed	Evidence at protein level	5 out of 5	Polyunsaturated fatty acid lipoxygenase ALOX15 (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate 15-lipoxygenase) (15-LOX) (15-LOX-1) (EC 1.13.11.33) (Arachidonate omega-6 lipoxygenase) (Hepoxilin A3 synthase Alox15) (EC 1.13.11.-) (Linoleate 13S-lipoxygenase) (EC 1.13.11.12)	ALOX15 LOG15	433;	9606.ENSP00000458832;
Q96LR2	LURA1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Leucine rich adaptor protein 1 (Leucine repeat adapter protein 35A)	LURAP1 C1orf190 LRAP35A LRP35A	32327;	9606.ENSP00000361048;
P11226	MBL2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mannose-binding protein C (MBP-C) (Collectin-1) (MBP1) (Mannan-binding protein) (Mannose-binding lectin)	MBL2 COLEC1 MBL	6922;	9606.ENSP00000363079;
O60449	LY75_HUMAN	reviewed	Evidence at protein level	5 out of 5	Lymphocyte antigen 75 (Ly-75) (C-type lectin domain family 13 member B) (DEC-205) (gp200-MR6) (CD antigen CD205)	LY75 CD205 CLEC13B	6729;	9606.ENSP00000263636;
P16581	LYAM2_HUMAN	reviewed	Evidence at protein level	5 out of 5	E-selectin (CD62 antigen-like family member E) (Endothelial leukocyte adhesion molecule 1) (ELAM-1) (Leukocyte-endothelial cell adhesion molecule 2) (LECAM2) (CD antigen CD62E)	SELE ELAM1	10718;	9606.ENSP00000331736;
Q6P1A2	MBOA5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Lysophospholipid acyltransferase 5 (LPLAT 5) (EC 2.3.1.-) (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (1-acylglycerophosphoethanolamine O-acyltransferase) (EC 2.3.1.n7) (1-acylglycerophosphoserine O-acyltransferase) (EC 2.3.1.n6) (Lysophosphatidylcholine acyltransferase) (LPCAT) (Lyso-PC acyltransferase) (Lysophosphatidylcholine acyltransferase 3) (Lyso-PC acyltransferase 3) (Lysophosphatidylserine acyltransferase) (LPSAT) (Lyso-PS acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 5) (O-acyltransferase domain-containing protein 5)	LPCAT3 MBOAT5 OACT5	30244;	9606.ENSP00000261407;
Q9Y6K9	NEMO_HUMAN	reviewed	Evidence at protein level	5 out of 5	NF-kappa-B essential modulator (NEMO) (FIP-3) (IkB kinase-associated protein 1) (IKKAP1) (Inhibitor of nuclear factor kappa-B kinase subunit gamma) (I-kappa-B kinase subunit gamma) (IKK-gamma) (IKKG) (IkB kinase subunit gamma) (NF-kappa-B essential modifier)	IKBKG FIP3 NEMO	5961;	9606.ENSP00000483825;
P56270	MAZ_HUMAN	reviewed	Evidence at protein level	5 out of 5	Myc-associated zinc finger protein (MAZI) (Pur-1) (Purine-binding transcription factor) (Serum amyloid A-activating factor-1) (SAF-1) (Transcription factor Zif87) (ZF87) (Zinc finger protein 801)	MAZ ZNF801	6914;	9606.ENSP00000219782;
P35354	PGH2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Prostaglandin G/H synthase 2 (EC 1.14.99.1) (Cyclooxygenase-2) (COX-2) (PHS II) (Prostaglandin H2 synthase 2) (PGH synthase 2) (PGHS-2) (Prostaglandin-endoperoxide synthase 2)	PTGS2 COX2	9605;	9606.ENSP00000356438;
Q8NEV8	EXPH5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Exophilin-5 (Synaptotagmin-like protein homolog lacking C2 domains b) (SlaC2-b) (Slp homolog lacking C2 domains b)	EXPH5 KIAA0624 SLAC2B	30578;	9606.ENSP00000265843;
O43766	LIAS_HUMAN	reviewed	Evidence at protein level	5 out of 5	Lipoyl synthase, mitochondrial (EC 2.8.1.8) (Lipoate synthase) (LS) (Lip-syn) (Lipoic acid synthase)	LIAS LAS HUSSY-01	16429;	9606.ENSP00000261434;
Q9BXB1	LGR4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Leucine-rich repeat-containing G-protein coupled receptor 4 (G-protein coupled receptor 48)	LGR4 GPR48	13299;	9606.ENSP00000368516;
Q06413	MEF2C_HUMAN	reviewed	Evidence at protein level	5 out of 5	Myocyte-specific enhancer factor 2C (Myocyte enhancer factor 2C)	MEF2C	6996;	9606.ENSP00000340874;
Q8TD46	MO2R1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cell surface glycoprotein CD200 receptor 1 (CD200 cell surface glycoprotein receptor) (Cell surface glycoprotein OX2 receptor 1)	CD200R1 CD200R CRTR2 MOX2R OX2R UNQ2522/PRO6015	24235;	
P62879	GBB2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 (G protein subunit beta-2) (Transducin beta chain 2)	GNB2	4398;	9606.ENSP00000305260;
P16520	GBB3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 (Transducin beta chain 3)	GNB3	4400;	9606.ENSP00000229264;
Q9HAV0	GBB4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Guanine nucleotide-binding protein subunit beta-4 (Transducin beta chain 4)	GNB4	20731;	9606.ENSP00000232564;
Q96PP8	GBP5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Guanylate-binding protein 5 (EC 3.6.5.-) (GBP-TA antigen) (GTP-binding protein 5) (GBP-5) (Guanine nucleotide-binding protein 5)	GBP5 UNQ2427/PRO4987	19895;	9606.ENSP00000359488;
Q8N8V2	GBP7_HUMAN	reviewed	Evidence at protein level	5 out of 5	Guanylate-binding protein 7 (EC 3.6.5.-) (GTP-binding protein 7) (GBP-7) (Guanine nucleotide-binding protein 7) (Guanylate-binding protein 4-like)	GBP7 GBP4L	29606;	9606.ENSP00000294671;
Q9P2W3	GBG13_HUMAN	reviewed	Evidence at protein level	5 out of 5	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13	GNG13	14131;	9606.ENSP00000248150;
P50151	GBG10_HUMAN	reviewed	Evidence at protein level	5 out of 5	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10	GNG10 GNGT10	4402;	9606.ENSP00000363411;
P63211	GBG1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Guanine nucleotide-binding protein G(T) subunit gamma-T1 (Transducin gamma chain)	GNGT1	4411;	9606.ENSP00000248572;
P50150	GBG4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4	GNG4 GNGT4	4407;	9606.ENSP00000375727;
P63218	GBG5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5	GNG5 GNGT5	4408;	9606.ENSP00000359675;
P04150	GCR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Glucocorticoid receptor (GR) (Nuclear receptor subfamily 3 group C member 1)	NR3C1 GRL	7978;	9606.ENSP00000231509;
Q969J5	I22R2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-22 receptor subunit alpha-2 (IL-22 receptor subunit alpha-2) (IL-22R-alpha-2) (IL-22RA2) (Cytokine receptor class-II member 10) (Cytokine receptor family 2 member 10) (CRF2-10) (Cytokine receptor family type 2, soluble 1) (CRF2-S1) (Interleukin-22-binding protein) (IL-22BP) (IL22BP) (ZcytoR16)	IL22RA2 UNQ5793/PRO19598/PRO19822	14901;	9606.ENSP00000296980;
P01275	GLUC_HUMAN	reviewed	Evidence at protein level	5 out of 5	Pro-glucagon [Cleaved into: Glicentin; Glicentin-related polypeptide (GRPP); Oxyntomodulin (OXM) (OXY); Glucagon; Glucagon-like peptide 1 (GLP-1) (Incretin hormone); Glucagon-like peptide 1(7-37) (GLP-1(7-37)); Glucagon-like peptide 1(7-36) (GLP-1(7-36)); Glucagon-like peptide 2 (GLP-2)]	GCG	4191;	9606.ENSP00000387662;
P25963	IKBA_HUMAN	reviewed	Evidence at protein level	5 out of 5	NF-kappa-B inhibitor alpha (I-kappa-B-alpha) (IkB-alpha) (IkappaBalpha) (Major histocompatibility complex enhancer-binding protein MAD3)	NFKBIA IKBA MAD3 NFKBI	7797;	9606.ENSP00000216797;
P16871	IL7RA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-7 receptor subunit alpha (IL-7 receptor subunit alpha) (IL-7R subunit alpha) (IL-7R-alpha) (IL-7RA) (CDw127) (CD antigen CD127)	IL7R	6024;	9606.ENSP00000306157;
Q13651	I10R1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-10 receptor subunit alpha (IL-10 receptor subunit alpha) (IL-10R subunit alpha) (IL-10RA) (CDw210a) (Interleukin-10 receptor subunit 1) (IL-10R subunit 1) (IL-10R1) (CD antigen CD210)	IL10RA IL10R	5964;	9606.ENSP00000227752;
P22413	ENPP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (E-NPP 1) (Membrane component chromosome 6 surface marker 1) (Phosphodiesterase I/nucleotide pyrophosphatase 1) (Plasma-cell membrane glycoprotein PC-1) [Cleaved into: Ectonucleotide pyrophosphatase/phosphodiesterase family member 1, secreted form] [Includes: Alkaline phosphodiesterase I (EC 3.1.4.1); Nucleotide pyrophosphatase (NPPase) (EC 3.6.1.9) (Nucleotide diphosphatase)]	ENPP1 M6S1 NPPS PC1 PDNP1	3356;	9606.ENSP00000354238;
Q9UMN6	KMT2B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Histone-lysine N-methyltransferase 2B (Lysine N-methyltransferase 2B) (EC 2.1.1.364) (Myeloid/lymphoid or mixed-lineage leukemia protein 4) (Trithorax homolog 2) (WW domain-binding protein 7) (WBP-7)	KMT2B HRX2 KIAA0304 MLL2 MLL4 TRX2 WBP7	15840;	9606.ENSP00000398837;
P05162	LEG2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Galectin-2 (Gal-2) (Beta-galactoside-binding lectin L-14-II) (HL14) (Lactose-binding lectin 2) (S-Lac lectin 2)	LGALS2	6562;	9606.ENSP00000215886;
O75676	KS6A4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ribosomal protein S6 kinase alpha-4 (S6K-alpha-4) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 4) (Nuclear mitogen- and stress-activated protein kinase 2) (Ribosomal protein kinase B) (RSKB)	RPS6KA4 MSK2	10433;	9606.ENSP00000333896;
O75582	KS6A5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ribosomal protein S6 kinase alpha-5 (S6K-alpha-5) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 5) (Nuclear mitogen- and stress-activated protein kinase 1) (RSK-like protein kinase) (RSKL)	RPS6KA5 MSK1	10434;	9606.ENSP00000479667;
P05129	KPCG_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein kinase C gamma type (PKC-gamma) (EC 2.7.11.13)	PRKCG PKCG	9402;	9606.ENSP00000263431;
P35579	MYH9_HUMAN	reviewed	Evidence at protein level	5 out of 5	Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA)	MYH9	7579;	9606.ENSP00000216181;
Q9NX02	NALP2_HUMAN	reviewed	Evidence at protein level	5 out of 5	NACHT, LRR and PYD domains-containing protein 2 (Nucleotide-binding site protein 1) (PYRIN domain and NACHT domain-containing protein 1) (PYRIN-containing APAF1-like protein 2)	NLRP2 NALP2 NBS1 PAN1 PYPAF2	22948;	9606.ENSP00000445135;
Q96MN2	NALP4_HUMAN	reviewed	Evidence at protein level	5 out of 5	NACHT, LRR and PYD domains-containing protein 4 (Cancer/testis antigen 58) (CT58) (PAAD and NACHT-containing protein 2) (PAN2) (PYRIN and NACHT-containing protein 2) (PYRIN-containing APAF1-like protein 4) (PYPAF4) (Ribonuclease inhibitor 2)	NLRP4 NALP4 PAN2 PYPAF4 RNH2	22943;	9606.ENSP00000301295;
P59047	NALP5_HUMAN	reviewed	Evidence at protein level	5 out of 5	NACHT, LRR and PYD domains-containing protein 5 (Mater protein homolog) (Maternal Antigen that Embryos Require)	NLRP5 MATER NALP5	21269;	9606.ENSP00000375063;
O15553	MEFV_HUMAN	reviewed	Evidence at protein level	5 out of 5	Pyrin (Marenostrin)	MEFV MEF TRIM20	6998;	9606.ENSP00000219596;
Q29980	MICB_HUMAN	reviewed	Evidence at protein level	5 out of 5	MHC class I polypeptide-related sequence B (MIC-B)	MICB PERB11.2	7091;	9606.ENSP00000252229;
P14174	MIF_HUMAN	reviewed	Evidence at protein level	5 out of 5	Macrophage migration inhibitory factor (MIF) (EC 5.3.2.1) (Glycosylation-inhibiting factor) (GIF) (L-dopachrome isomerase) (L-dopachrome tautomerase) (EC 5.3.3.12) (Phenylpyruvate tautomerase)	MIF GLIF MMIF	7097;	9606.ENSP00000215754;
Q9UNI1	CELA1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Chymotrypsin-like elastase family member 1 (EC 3.4.21.36) (Elastase-1) (Pancreatic elastase 1)	CELA1 ELA1	3308;	9606.ENSP00000293636;
Q16627	CCL14_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C motif chemokine 14 (Chemokine CC-1/CC-3) (HCC-1/HCC-3) (HCC-1(1-74)) (NCC-2) (Small-inducible cytokine A14) [Cleaved into: HCC-1(3-74); HCC-1(4-74); HCC-1(9-74)]	CCL14 NCC2 SCYA14	10612;	
Q9UHC3	ASIC3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Acid-sensing ion channel 3 (ASIC3) (hASIC3) (Amiloride-sensitive cation channel 3) (Neuronal amiloride-sensitive cation channel 3) (Testis sodium channel 1) (hTNaC1)	ASIC3 ACCN3 SLNAC1 TNAC1	101;	9606.ENSP00000297512;
P14210	HGF_HUMAN	reviewed	Evidence at protein level	5 out of 5	Hepatocyte growth factor (Hepatopoietin-A) (Scatter factor) (SF) [Cleaved into: Hepatocyte growth factor alpha chain; Hepatocyte growth factor beta chain]	HGF HPTA	4893;	9606.ENSP00000222390;
Q9Y616	IRAK3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-1 receptor-associated kinase 3 (IRAK-3) (IL-1 receptor-associated kinase M) (IRAK-M) (Inactive IL-1 receptor-associated kinase 3)	IRAK3	17020;	9606.ENSP00000261233;
Q13568	IRF5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interferon regulatory factor 5 (IRF-5)	IRF5	6120;	9606.ENSP00000349770;
P57087	JAM2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Junctional adhesion molecule B (JAM-B) (Junctional adhesion molecule 2) (JAM-2) (Vascular endothelial junction-associated molecule) (VE-JAM) (CD antigen CD322)	JAM2 C21orf43 VEJAM UNQ219/PRO245	14686;	9606.ENSP00000383376;
Q9BX67	JAM3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Junctional adhesion molecule C (JAM-C) (JAM-2) (Junctional adhesion molecule 3) (JAM-3) [Cleaved into: Soluble form of JAM-C (sJAM-C)]	JAM3 UNQ859/PRO1868	15532;	9606.ENSP00000299106;
Q92985	IRF7_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interferon regulatory factor 7 (IRF-7)	IRF7	6122;	9606.ENSP00000380697;
P0C869	PA24B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cytosolic phospholipase A2 beta (cPLA2-beta) (EC 3.1.1.4) (Lysophospholipase A1 group IVB) (EC 3.1.1.5) (Phospholipase A2 group IVB)	PLA2G4B	9036;	9606.ENSP00000396045;
P16885	PLCG2_HUMAN	reviewed	Evidence at protein level	5 out of 5	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-gamma-2) (Phospholipase C-IV) (PLC-IV) (Phospholipase C-gamma-2) (PLC-gamma-2)	PLCG2	9066;	9606.ENSP00000482457;
P25786	PSA1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Proteasome subunit alpha type-1 (30 kDa prosomal protein) (PROS-30) (Macropain subunit C2) (Multicatalytic endopeptidase complex subunit C2) (Proteasome component C2) (Proteasome nu chain)	PSMA1 HC2 NU PROS30 PSC2	9530;	9606.ENSP00000414359;
P18054	LOX12_HUMAN	reviewed	Evidence at protein level	5 out of 5	Polyunsaturated fatty acid lipoxygenase ALOX12 (EC 1.13.11.-) (Arachidonate (12S)-lipoxygenase) (12S-LOX) (12S-lipoxygenase) (EC 1.13.11.31) (Arachidonate (15S)-lipoxygenase) (EC 1.13.11.33) (Linoleate (13S)-lipoxygenase) (Lipoxin synthase 12-LO) (EC 3.3.2.-) (Platelet-type lipoxygenase 12)	ALOX12 12LO LOG12	429;	9606.ENSP00000251535;
Q9UBC1	IKBL1_HUMAN	reviewed	Evidence at protein level	5 out of 5	NF-kappa-B inhibitor-like protein 1 (Inhibitor of kappa B-like protein) (I-kappa-B-like protein) (IkappaBL) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1)	NFKBIL1 IKBL	7800;	9606.ENSP00000365318;
Q86UT6	NLRX1_HUMAN	reviewed	Evidence at protein level	5 out of 5	NLR family member X1 (Caterpiller protein 11.3) (CLR11.3) (Nucleotide-binding oligomerization domain protein 26) (Nucleotide-binding oligomerization domain protein 5) (Nucleotide-binding oligomerization domain protein 9)	NLRX1 NOD26 NOD5 NOD9	29890;	9606.ENSP00000387334;
O15527	OGG1_HUMAN	reviewed	Evidence at protein level	5 out of 5	N-glycosylase/DNA lyase [Includes: 8-oxoguanine DNA glycosylase (EC 3.2.2.-); DNA-(apurinic or apyrimidinic site) lyase (AP lyase) (EC 4.2.99.18)]	OGG1 MMH MUTM OGH1	8125;	9606.ENSP00000306561;
Q9UKK3	PARP4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein mono-ADP-ribosyltransferase PARP4 (EC 2.4.2.-) (193 kDa vault protein) (ADP-ribosyltransferase diphtheria toxin-like 4) (ARTD4) (PARP-related/IalphaI-related H5/proline-rich) (PH5P) (Poly [ADP-ribose] polymerase 4) (PARP-4) (Vault poly(ADP-ribose) polymerase) (VPARP)	PARP4 ADPRTL1 KIAA0177 PARPL	271;	9606.ENSP00000371419;
O15496	PA2GX_HUMAN	reviewed	Evidence at protein level	5 out of 5	Group 10 secretory phospholipase A2 (EC 3.1.1.4) (Group X secretory phospholipase A2) (GX sPLA2) (sPLA2-X) (Phosphatidylcholine 2-acylhydrolase 10)	PLA2G10	9029;	9606.ENSP00000393847;
P23219	PGH1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)	PTGS1 COX1	9604;	9606.ENSP00000354612;
P24158	PRTN3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Myeloblastin (EC 3.4.21.76) (AGP7) (C-ANCA antigen) (Leukocyte proteinase 3) (PR-3) (PR3) (Neutrophil proteinase 4) (NP-4) (P29) (Wegener autoantigen)	PRTN3 MBN	9495;	9606.ENSP00000234347;
P06850	CRF_HUMAN	reviewed	Evidence at protein level	5 out of 5	Corticoliberin (Corticotropin-releasing factor) (CRF) (Corticotropin-releasing hormone)	CRH	2355;	9606.ENSP00000276571;
Q96PH6	DB118_HUMAN	reviewed	Evidence at protein level	5 out of 5	Defensin beta 118 (Beta-defensin 18) (DEFB-18) (Epididymal secretory protein 13.6) (ESP13.6)	DEFB118 C20orf63 DEFB18 ESC42	16196;	9606.ENSP00000253381;
Q16552	IL17_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-17A (IL-17) (IL-17A) (Cytotoxic T-lymphocyte-associated antigen 8) (CTLA-8)	IL17A CTLA8 IL17	5981;	9606.ENSP00000344192;
P51617	IRAK1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-1 receptor-associated kinase 1 (IRAK-1) (EC 2.7.11.1)	IRAK1 IRAK	6112;	9606.ENSP00000358997;
Q9NY59	NSMA2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Sphingomyelin phosphodiesterase 3 (EC 3.1.4.12) (Neutral sphingomyelinase 2) (nSMase-2) (nSMase2) (Neutral sphingomyelinase II)	SMPD3	14240;	9606.ENSP00000219334;
P78380	OLR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Oxidized low-density lipoprotein receptor 1 (Ox-LDL receptor 1) (C-type lectin domain family 8 member A) (Lectin-like oxidized LDL receptor 1) (LOX-1) (Lectin-like oxLDL receptor 1) (hLOX-1) (Lectin-type oxidized LDL receptor 1) [Cleaved into: Oxidized low-density lipoprotein receptor 1, soluble form]	OLR1 CLEC8A LOX1	8133;	9606.ENSP00000309124;
Q9BZM2	PA2GF_HUMAN	reviewed	Evidence at protein level	5 out of 5	Group IIF secretory phospholipase A2 (GIIF sPLA2) (sPLA2-IIF) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase 2F)	PLA2G2F	30040;	9606.ENSP00000364243;
P01225	FSHB_HUMAN	reviewed	Evidence at protein level	5 out of 5	Follitropin subunit beta (Follicle-stimulating hormone beta subunit) (FSH-B) (FSH-beta) (Follitropin beta chain)	FSHB	3964;	9606.ENSP00000416606;
P19367	HXK1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Hexokinase-1 (EC 2.7.1.1) (Brain form hexokinase) (Hexokinase type I) (HK I) (Hexokinase-A)	HK1	4922;	9606.ENSP00000402103;
Q8TDB8	GTR14_HUMAN	reviewed	Evidence at protein level	5 out of 5	Solute carrier family 2, facilitated glucose transporter member 14 (Glucose transporter type 14) (GLUT-14)	SLC2A14 GLUT14	18301;	9606.ENSP00000445929;
Q9UGQ3	GTR6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Solute carrier family 2, facilitated glucose transporter member 6 (Glucose transporter type 6) (GLUT-6)	SLC2A6 GLUT6	11011;	9606.ENSP00000360966;
Q9Y2T6	GPR55_HUMAN	reviewed	Evidence at protein level	5 out of 5	G-protein coupled receptor 55	GPR55	4511;	9606.ENSP00000375894;
Q9NYM4	GPR83_HUMAN	reviewed	Evidence at protein level	5 out of 5	G-protein coupled receptor 83 (G-protein coupled receptor 72)	GPR83 GPR72 JP05 KIAA1540	4523;	9606.ENSP00000243673;
P01889	HLAB_HUMAN	reviewed	Evidence at protein level	5 out of 5	HLA class I histocompatibility antigen, B alpha chain (Human leukocyte antigen B) (HLA-B)	HLA-B HLAB	4932;	9606.ENSP00000399168;
P29460	IL12B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-12 subunit beta (IL-12B) (Cytotoxic lymphocyte maturation factor 40 kDa subunit) (CLMF p40) (IL-12 subunit p40) (NK cell stimulatory factor chain 2) (NKSF2)	IL12B NKSF2	5970;	9606.ENSP00000231228;
P00995	ISK1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Serine protease inhibitor Kazal-type 1 (Pancreatic secretory trypsin inhibitor) (Tumor-associated trypsin inhibitor) (TATI)	SPINK1 PSTI	11244;	9606.ENSP00000296695;
P17301	ITA2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Integrin alpha-2 (CD49 antigen-like family member B) (Collagen receptor) (Platelet membrane glycoprotein Ia) (GPIa) (VLA-2 subunit alpha) (CD antigen CD49b)	ITGA2 CD49B	6137;	9606.ENSP00000296585;
O94916	NFAT5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nuclear factor of activated T-cells 5 (NF-AT5) (T-cell transcription factor NFAT5) (Tonicity-responsive enhancer-binding protein) (TonE-binding protein) (TonEBP)	NFAT5 KIAA0827 TONEBP	7774;	9606.ENSP00000457593;
Q96M63	ODAD1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Outer dynein arm-docking complex subunit 1 (Coiled-coil domain-containing protein 114)	ODAD1 CCDC114	26560;	9606.ENSP00000318429;
P32119	PRDX2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Peroxiredoxin-2 (EC 1.11.1.24) (Natural killer cell-enhancing factor B) (NKEF-B) (PRP) (Thiol-specific antioxidant protein) (TSA) (Thioredoxin peroxidase 1) (Thioredoxin-dependent peroxide reductase 1) (Thioredoxin-dependent peroxiredoxin 2)	PRDX2 NKEFB TDPX1	9353;	9606.ENSP00000301522;
Q99623	PHB2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Prohibitin-2 (B-cell receptor-associated protein BAP37) (D-prohibitin) (Repressor of estrogen receptor activity)	PHB2 BAP REA	30306;	9606.ENSP00000441875;
Q9Y5Y4	PD2R2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Prostaglandin D2 receptor 2 (Chemoattractant receptor-homologous molecule expressed on Th2 cells) (G-protein coupled receptor 44) (CD antigen CD294)	PTGDR2 CRTH2 DL1R GPR44	4502;	9606.ENSP00000332812;
Q6R327	RICTR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Rapamycin-insensitive companion of mTOR (AVO3 homolog) (hAVO3)	RICTOR KIAA1999	28611;	9606.ENSP00000296782;
Q86WR0	CCD25_HUMAN	reviewed	Evidence at protein level	5 out of 5	Coiled-coil domain-containing protein 25	CCDC25	25591;	9606.ENSP00000348933;
Q9UBG3	CRNN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cornulin (53 kDa putative calcium-binding protein) (53 kDa squamous epithelial-induced stress protein) (58 kDa heat shock protein) (Squamous epithelial heat shock protein 53) (Tumor-related protein)	CRNN C1orf10 DRC1 PDRC1 SEP53	1230;	9606.ENSP00000271835;
O43927	CXL13_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-X-C motif chemokine 13 (Angie) (B cell-attracting chemokine 1) (BCA-1) (B lymphocyte chemoattractant) (CXC chemokine BLC) (Small-inducible cytokine B13)	CXCL13 BCA1 BLC SCYB13	10639;	9606.ENSP00000286758;
O95715	CXL14_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-X-C motif chemokine 14 (Chemokine BRAK) (MIP-2G) (Small-inducible cytokine B14)	CXCL14 MIP2G NJAC SCYB14 PSEC0212 UNQ240/PRO273	10640;	9606.ENSP00000337065;
P09884	DPOLA_HUMAN	reviewed	Evidence at protein level	5 out of 5	DNA polymerase alpha catalytic subunit (EC 2.7.7.7) (DNA polymerase alpha catalytic subunit p180)	POLA1 POLA	9173;	9606.ENSP00000368349;
Q01469	FABP5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Fatty acid-binding protein 5 (Epidermal-type fatty acid-binding protein) (E-FABP) (Fatty acid-binding protein, epidermal) (Psoriasis-associated fatty acid-binding protein homolog) (PA-FABP)	FABP5	3560;	9606.ENSP00000297258;
P46093	GPR4_HUMAN	reviewed	Evidence at protein level	5 out of 5	G-protein coupled receptor 4 (G-protein coupled receptor 6C.l) (GPR6C.l)	GPR4	4497;	9606.ENSP00000319744;
O15379	HDAC3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Histone deacetylase 3 (HD3) (EC 3.5.1.98) (Protein deacetylase HDAC3) (EC 3.5.1.-) (Protein deacylase HDAC3) (EC 3.5.1.-) (RPD3-2) (SMAP45)	HDAC3	4854;	9606.ENSP00000302967;
Q9Y251	HPSE_HUMAN	reviewed	Evidence at protein level	5 out of 5	Heparanase (EC 3.2.1.166) (Endo-glucoronidase) (Heparanase-1) (Hpa1) [Cleaved into: Heparanase 8 kDa subunit; Heparanase 50 kDa subunit]	HPSE HEP HPA HPA1 HPR1 HPSE1 HSE1	5164;	9606.ENSP00000384262;
P10997	IAPP_HUMAN	reviewed	Evidence at protein level	5 out of 5	Islet amyloid polypeptide (Amylin) (Diabetes-associated peptide) (DAP) (Insulinoma amyloid peptide)	IAPP	5329;	9606.ENSP00000240652;
Q9NZ42	PEN2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Gamma-secretase subunit PEN-2 (Presenilin enhancer protein 2)	PSENEN PEN2 MDS033	30100;	9606.ENSP00000468411;
Q6UXL0	I20RB_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-20 receptor subunit beta (IL-20 receptor subunit beta) (IL-20R-beta) (IL-20RB) (Fibronectin type III domain containing 6) (FNDC6) (IL-20R2)	IL20RB DIRS1 UNQ557/PRO1114	6004;	9606.ENSP00000328133;
Q9UBH0	I36RA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-36 receptor antagonist protein (IL-36Ra) (FIL1 delta) (IL-1-related protein 3) (IL-1RP3) (Interleukin-1 HY1) (IL-1HY1) (Interleukin-1 delta) (IL-1 delta) (Interleukin-1 family member 5) (IL-1F5) (Interleukin-1 receptor antagonist homolog 1) (IL-1ra homolog 1) (Interleukin-1-like protein 1) (IL-1L1)	IL36RN FIL1D IL1F5 IL1HY1 IL1L1 IL1RP3 UNQ1896/PRO4342	15561;	9606.ENSP00000376896;
Q96PD4	IL17F_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-17F (IL-17F) (Cytokine ML-1)	IL17F	16404;	9606.ENSP00000337432;
D6RGH6	MCIN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Multicilin (Multiciliate differentiation and DNA synthesis-associated cell cycle protein) (McIdas protein) (Protein Idas)	MCIDAS IDAS MCI MCIN	40050;	9606.ENSP00000426359;
Q15722	LT4R1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Leukotriene B4 receptor 1 (LTB4-R 1) (LTB4-R1) (Chemoattractant receptor-like 1) (G-protein coupled receptor 16) (P2Y purinoceptor 7) (P2Y7)	LTB4R BLT BLT1 BLTR CMKRL1 GPR16 P2RY7	6713;	9606.ENSP00000380008;
P33993	MCM7_HUMAN	reviewed	Evidence at protein level	5 out of 5	DNA replication licensing factor MCM7 (EC 3.6.4.12) (CDC47 homolog) (P1.1-MCM3)	MCM7 CDC47 MCM2	6950;	9606.ENSP00000307288;
Q9NPH5	NOX4_HUMAN	reviewed	Evidence at protein level	5 out of 5	NADPH oxidase 4 (EC 1.6.3.-) (Kidney oxidase-1) (KOX-1) (Kidney superoxide-producing NADPH oxidase) (Renal NAD(P)H-oxidase)	NOX4 RENOX	7891;	9606.ENSP00000263317;
P41586	PACR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Pituitary adenylate cyclase-activating polypeptide type I receptor (PACAP type I receptor) (PACAP-R-1) (PACAP-R1)	ADCYAP1R1	242;	9606.ENSP00000483721;
Q13093	PAFA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Platelet-activating factor acetylhydrolase (PAF acetylhydrolase) (EC 3.1.1.47) (1-alkyl-2-acetylglycerophosphocholine esterase) (2-acetyl-1-alkylglycerophosphocholine esterase) (Group-VIIA phospholipase A2) (gVIIA-PLA2) (LDL-associated phospholipase A2) (LDL-PLA(2)) (PAF 2-acylhydrolase)	PLA2G7 PAFAH	9040;	9606.ENSP00000274793;
P16112	PGCA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2]	ACAN AGC1 CSPG1 MSK16	319;	9606.ENSP00000387356;
Q13519	PNOC_HUMAN	reviewed	Evidence at protein level	5 out of 5	Prepronociceptin [Cleaved into: Nocistatin; Nociceptin (Orphanin FQ) (PPNOC); Orphanin FQ2]	PNOC OFQ	9163;	9606.ENSP00000301908;
Q14953	KI2S5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Killer cell immunoglobulin-like receptor 2DS5 (CD158 antigen-like family member G) (Natural killer-associated transcript 9) (NKAT-9) (CD antigen CD158g)	KIR2DS5 CD158G NKAT9	6337;	
Q92982	NINJ1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ninjurin-1 (Nerve injury-induced protein 1) [Cleaved into: Secreted ninjurin-1 (Soluble ninjurin-1)]	NINJ1	7824;	9606.ENSP00000364595;
P25116	PAR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Proteinase-activated receptor 1 (PAR-1) (Coagulation factor II receptor) (Thrombin receptor)	F2R CF2R PAR1 TR	3537;	9606.ENSP00000321326;
P01215	GLHA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Glycoprotein hormones alpha chain (Anterior pituitary glycoprotein hormones common subunit alpha) (Choriogonadotropin alpha chain) (Chorionic gonadotrophin subunit alpha) (CG-alpha) (Follicle-stimulating hormone alpha chain) (FSH-alpha) (Follitropin alpha chain) (Luteinizing hormone alpha chain) (LSH-alpha) (Lutropin alpha chain) (Thyroid-stimulating hormone alpha chain) (TSH-alpha) (Thyrotropin alpha chain)	CGA	1885;	
P04062	GLCM_HUMAN	reviewed	Evidence at protein level	5 out of 5	Lysosomal acid glucosylceramidase (Lysosomal acid GCase) (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (Cholesterol glucosyltransferase) (SGTase) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase) (EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase) (EC 3.2.1.46) (Lysosomal glycosylceramidase)	GBA GC GLUC	4177;	9606.ENSP00000314508;
O75144	ICOSL_HUMAN	reviewed	Evidence at protein level	5 out of 5	ICOS ligand (B7 homolog 2) (B7-H2) (B7-like protein Gl50) (B7-related protein 1) (B7RP-1) (CD antigen CD275)	ICOSLG B7H2 B7RP1 ICOSL KIAA0653	17087;	
P52292	IMA1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Importin subunit alpha-1 (Karyopherin subunit alpha-2) (RAG cohort protein 1) (SRP1-alpha)	KPNA2 RCH1 SRP1	6395;	9606.ENSP00000438483;
Q9Y244	POMP_HUMAN	reviewed	Evidence at protein level	5 out of 5	Proteasome maturation protein (Proteassemblin) (Protein UMP1 homolog) (hUMP1) (Voltage-gated K channel beta subunit 4.1)	POMP C13orf12 UMP1 HSPC014 HSPC036 PNAS-110	20330;	9606.ENSP00000370222;
Q7L5N7	PCAT2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Lysophosphatidylcholine acyltransferase 2 (LPC acyltransferase 2) (LPCAT-2) (LysoPC acyltransferase 2) (EC 2.3.1.23) (1-acylglycerol-3-phosphate O-acyltransferase 11) (1-AGP acyltransferase 11) (1-AGPAT 11) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkenylglycerophosphocholine O-acyltransferase) (EC 2.3.1.25) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 1) (Lysophosphatidic acid acyltransferase alpha) (LPAAT-alpha)	LPCAT2 AGPAT11 AYTL1	26032;	9606.ENSP00000262134;
P49023	PAXI_HUMAN	reviewed	Evidence at protein level	5 out of 5	Paxillin	PXN	9718;	9606.ENSP00000267257;
Q8IZE3	PACE1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein-associating with the carboxyl-terminal domain of ezrin (Ezrin-binding protein PACE-1) (SCY1-like protein 3)	SCYL3 PACE1	19285;	9606.ENSP00000356746;
Q99706	KI2L4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Killer cell immunoglobulin-like receptor 2DL4 (CD158 antigen-like family member D) (G9P) (Killer cell inhibitory receptor 103AS) (KIR-103AS) (MHC class I NK cell receptor KIR103AS) (CD antigen CD158d)	KIR2DL4 CD158D KIR103AS	6332;	9606.ENSP00000339634;
P25205	MCM3_HUMAN	reviewed	Evidence at protein level	5 out of 5	DNA replication licensing factor MCM3 (EC 3.6.4.12) (DNA polymerase alpha holoenzyme-associated protein P1) (P1-MCM3) (RLF subunit beta) (p102)	MCM3	6945;	9606.ENSP00000480987;
O15439	MRP4_HUMAN	reviewed	Evidence at protein level	5 out of 5	ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B) (Multidrug resistance-associated protein 4)	ABCC4 MOATB MRP4	55;	9606.ENSP00000366084;
P30044	PRDX5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Peroxiredoxin-5, mitochondrial (EC 1.11.1.24) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin-dependent peroxiredoxin 5)	PRDX5 ACR1 SBBI10	9355;	9606.ENSP00000265462;
P13727	PRG2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Bone marrow proteoglycan (BMPG) (Proteoglycan 2) [Cleaved into: Eosinophil granule major basic protein (EMBP) (MBP) (Pregnancy-associated major basic protein)]	PRG2 MBP	9362;	9606.ENSP00000312134;
P04070	PROC_HUMAN	reviewed	Evidence at protein level	5 out of 5	Vitamin K-dependent protein C (EC 3.4.21.69) (Anticoagulant protein C) (Autoprothrombin IIA) (Blood coagulation factor XIV) [Cleaved into: Vitamin K-dependent protein C light chain; Vitamin K-dependent protein C heavy chain; Activation peptide]	PROC	9451;	9606.ENSP00000234071;
O60927	PP1RB_HUMAN	reviewed	Evidence at protein level	5 out of 5	E3 ubiquitin-protein ligase PPP1R11 (EC 2.3.2.27) (Hemochromatosis candidate gene V protein) (HCG V) (Protein phosphatase 1 regulatory subunit 11) (Protein phosphatase inhibitor 3)	PPP1R11 HCGV TCTE5	9285;	9606.ENSP00000365963;
Q9HC23	PROK2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Prokineticin-2 (PK2) (Protein Bv8 homolog)	PROK2 BV8	18455;	9606.ENSP00000295619;
P18509	PACA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Pituitary adenylate cyclase-activating polypeptide (PACAP) [Cleaved into: PACAP-related peptide (PRP-48); Pituitary adenylate cyclase-activating polypeptide 27 (PACAP-27) (PACAP27); Pituitary adenylate cyclase-activating polypeptide 38 (PACAP-38) (PACAP38)]	ADCYAP1	241;	9606.ENSP00000462647;
Q460N5	PAR14_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2) (Poly [ADP-ribose] polymerase 14) (PARP-14)	PARP14 BAL2 KIAA1268	29232;	9606.ENSP00000418194;
P55085	PAR2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2]	F2RL1 GPR11 PAR2	3538;	9606.ENSP00000296677;
O15350	P73_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tumor protein p73 (p53-like transcription factor) (p53-related protein)	TP73 P73	12003;	9606.ENSP00000367545;
Q9HB29	ILRL2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-1 receptor-like 2 (EC 3.2.2.6) (IL-36 receptor) (IL-36R) (Interleukin-1 receptor-related protein 2) (IL-1Rrp2) (IL1R-rp2)	IL1RL2 IL1RRP2	5999;	9606.ENSP00000264257;
P08648	ITA5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Integrin alpha-5 (CD49 antigen-like family member E) (Fibronectin receptor subunit alpha) (Integrin alpha-F) (VLA-5) (CD antigen CD49e) [Cleaved into: Integrin alpha-5 heavy chain; Integrin alpha-5 light chain]	ITGA5 FNRA	6141;	9606.ENSP00000293379;
P05107	ITB2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Integrin beta-2 (Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta) (Complement receptor C3 subunit beta) (CD antigen CD18)	ITGB2 CD18 MFI7	6155;	9606.ENSP00000380948;
Q96J02	ITCH_HUMAN	reviewed	Evidence at protein level	5 out of 5	E3 ubiquitin-protein ligase Itchy homolog (Itch) (EC 2.3.2.26) (Atrophin-1-interacting protein 4) (AIP4) (HECT-type E3 ubiquitin transferase Itchy homolog) (NFE2-associated polypeptide 1) (NAPP1)	ITCH	13890;	9606.ENSP00000480499;
Q9BT67	NFIP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	NEDD4 family-interacting protein 1 (Breast cancer-associated protein SGA-1M) (NEDD4 WW domain-binding protein 5) (Putative MAPK-activating protein PM13) (Putative NF-kappa-B-activating protein 164) (Putative NFKB and MAPK-activating protein)	NDFIP1 N4WBP5 PSEC0192 PSEC0223	17592;	9606.ENSP00000253814;
P20393	NR1D1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nuclear receptor subfamily 1 group D member 1 (Rev-erbA-alpha) (V-erbA-related protein 1) (EAR-1)	NR1D1 EAR1 HREV THRAL	7962;	9606.ENSP00000246672;
Q9UP65	PA24C_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cytosolic phospholipase A2 gamma (cPLA2-gamma) (EC 3.1.1.4) (Cytosolic lysophospholipase) (EC 3.1.1.5) (Cytosolic lysophospholipid O-acyltransferase) (EC 2.3.1.-) (Phospholipase A2 group IVC)	PLA2G4C	9037;	9606.ENSP00000472546;
Q9NZK7	PA2GE_HUMAN	reviewed	Evidence at protein level	5 out of 5	Group IIE secretory phospholipase A2 (GIIE sPLA2) (sPLA2-IIE) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase 2E)	PLA2G2E	13414;	9606.ENSP00000364257;
Q96BN8	OTUL_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ubiquitin thioesterase otulin (EC 3.4.19.12) (Deubiquitinating enzyme otulin) (OTU domain-containing deubiquitinase with linear linkage specificity) (Ubiquitin thioesterase Gumby)	OTULIN FAM105B	25118;	9606.ENSP00000284274;
Q99572	P2RX7_HUMAN	reviewed	Evidence at protein level	5 out of 5	P2X purinoceptor 7 (P2X7) (ATP receptor) (P2Z receptor) (Purinergic receptor)	P2RX7	8537;	9606.ENSP00000330696;
Q92900	RENT1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Regulator of nonsense transcripts 1 (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent helicase RENT1) (Nonsense mRNA reducing factor 1) (NORF1) (Up-frameshift suppressor 1 homolog) (hUpf1)	UPF1 KIAA0221 RENT1	9962;	9606.ENSP00000470142;
Q9BXJ4	C1QT3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Complement C1q tumor necrosis factor-related protein 3 (Collagenous repeat-containing sequence 26 kDa protein) (CORS26) (Secretory protein CORS26)	C1QTNF3 CTRP3 UNQ753/PRO1484	14326;	
P23771	GATA3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Trans-acting T-cell-specific transcription factor GATA-3 (GATA-binding factor 3)	GATA3	4172;	9606.ENSP00000368632;
O43826	G6PT1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Glucose-6-phosphate exchanger SLC37A4 (Glucose-5-phosphate transporter) (Glucose-6-phosphate translocase) (Solute carrier family 37 member 4) (Transformation-related gene 19 protein) (TRG-19)	SLC37A4 G6PT G6PT1 PRO0685 TRG19	4061;	9606.ENSP00000476176;
Q92908	GATA6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transcription factor GATA-6 (GATA-binding factor 6)	GATA6	4174;	9606.ENSP00000269216;
Q9P2D7	DYH1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Dynein axonemal heavy chain 1 (Axonemal beta dynein heavy chain 1) (Ciliary dynein heavy chain 1) (Heat shock regulated protein 1) (HSRF-1) (hDHC7)	DNAH1 DHC7 DNAHC1 KIAA1410	2940;	9606.ENSP00000401514;
P01920	DQB1_HUMAN	reviewed	Evidence at protein level	5 out of 5	HLA class II histocompatibility antigen, DQ beta 1 chain (MHC class II antigen DQB1)	HLA-DQB1 HLA-DQB	4944;	9606.ENSP00000364080;
Q1HG44	DOXA2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Dual oxidase maturation factor 2 (Dual oxidase activator 2)	DUOXA2	32698;	9606.ENSP00000319705;
P00533	EGFR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1)	EGFR ERBB ERBB1 HER1	3236;	9606.ENSP00000275493;
Q08462	ADCY2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2)	ADCY2 KIAA1060	233;	9606.ENSP00000342952;
Q08828	ADCY1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Adenylate cyclase type 1 (EC 4.6.1.1) (ATP pyrophosphate-lyase 1) (Adenylate cyclase type I) (Adenylyl cyclase 1) (Ca(2+)/calmodulin-activated adenylyl cyclase)	ADCY1	232;	9606.ENSP00000297323;
P57076	CF298_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cilia- and flagella-associated protein 298 (Protein kurly homolog)	CFAP298 C21orf48 C21orf59	1301;	9606.ENSP00000290155;
P08571	CD14_HUMAN	reviewed	Evidence at protein level	5 out of 5	Monocyte differentiation antigen CD14 (Myeloid cell-specific leucine-rich glycoprotein) (CD antigen CD14) [Cleaved into: Monocyte differentiation antigen CD14, urinary form; Monocyte differentiation antigen CD14, membrane-bound form]	CD14	1628;	9606.ENSP00000304236;
P07333	CSF1R_HUMAN	reviewed	Evidence at protein level	5 out of 5	Macrophage colony-stimulating factor 1 receptor (CSF-1 receptor) (CSF-1-R) (CSF-1R) (M-CSF-R) (EC 2.7.10.1) (Proto-oncogene c-Fms) (CD antigen CD115)	CSF1R FMS	2433;	9606.ENSP00000286301;
P08631	HCK_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tyrosine-protein kinase HCK (EC 2.7.10.2) (Hematopoietic cell kinase) (Hemopoietic cell kinase) (p59-HCK/p60-HCK) (p59Hck) (p61Hck)	HCK	4840;	9606.ENSP00000444986;
Q9NZC3	GDE1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Glycerophosphodiester phosphodiesterase 1 (Glycerophosphoinositol glycerophosphodiesterase GDE1) (EC 3.1.4.44) (Lysophospholipase D GDE1) (EC 3.1.4.-) (Membrane-interacting protein of RGS16) (RGS16-interacting membrane protein)	GDE1 MIR16	29644;	9606.ENSP00000261386;
Q9H6K1	ILRUN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein ILRUN (Inflammation and lipid regulator with UBA-like and NBR1-like domains protein)	ILRUN C6orf106	21215;	9606.ENSP00000363135;
P60568	IL2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-2 (IL-2) (T-cell growth factor) (TCGF) (Aldesleukin)	IL2	6001;	9606.ENSP00000226730;
Q01638	ILRL1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-1 receptor-like 1 (EC 3.2.2.6) (Protein ST2)	IL1RL1 DER4 ST2 T1	5998;	9606.ENSP00000233954;
O95760	IL33_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-33 (IL-33) (Interleukin-1 family member 11) (IL-1F11) (Nuclear factor from high endothelial venules) (NF-HEV) [Cleaved into: Interleukin-33 (95-270); Interleukin-33 (99-270); Interleukin-33 (109-270)]	IL33 C9orf26 IL1F11 NFHEV	16028;	9606.ENSP00000370842;
Q6ZMJ4	IL34_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-34 (IL-34)	IL34 C16orf77	28529;	9606.ENSP00000397863;
Q9UHA7	IL36A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-36 alpha (FIL1 epsilon) (Interleukin-1 epsilon) (IL-1 epsilon) (Interleukin-1 family member 6) (IL-1F6)	IL36A FIL1E IL1E IL1F6	15562;	9606.ENSP00000259211;
Q9NZH7	IL36B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-36 beta (FIL1 eta) (Interleukin-1 eta) (IL-1 eta) (Interleukin-1 family member 8) (IL-1F8) (Interleukin-1 homolog 2) (IL-1H2)	IL36B IL1F8 IL1H2	15564;	9606.ENSP00000259213;
Q9NZH8	IL36G_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-36 gamma (IL-1-related protein 2) (IL-1RP2) (Interleukin-1 epsilon) (IL-1 epsilon) (Interleukin-1 family member 9) (IL-1F9) (Interleukin-1 homolog 1) (IL-1H1)	IL36G IL1E IL1F9 IL1H1 IL1RP2 UNQ2456/PRO5737	15741;	9606.ENSP00000259205;
Q9NZH6	IL37_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-37 (IL-37) (FIL1 zeta) (IL-1X) (Interleukin-1 family member 7) (IL-1F7) (Interleukin-1 homolog 4) (IL-1H) (IL-1H4) (Interleukin-1 zeta) (IL-1 zeta) (Interleukin-1-related protein) (IL-1RP1) (Interleukin-23) (IL-23)	IL37 FIL1Z IL1F7 IL1H4 IL1RP1	15563;	9606.ENSP00000263326;
Q4G0P3	HYDIN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Hydrocephalus-inducing protein homolog	HYDIN HYDIN1 KIAA1864	19368;	9606.ENSP00000377197;
P24394	IL4RA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-4 receptor subunit alpha (IL-4 receptor subunit alpha) (IL-4R subunit alpha) (IL-4R-alpha) (IL-4RA) (CD antigen CD124) [Cleaved into: Soluble interleukin-4 receptor subunit alpha (Soluble IL-4 receptor subunit alpha) (Soluble IL-4R-alpha) (sIL4Ralpha/prot) (IL-4-binding protein) (IL4-BP)]	IL4R IL4RA 582J2.1	6015;	9606.ENSP00000379111;
P05112	IL4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-4 (IL-4) (B-cell stimulatory factor 1) (BSF-1) (Binetrakin) (Lymphocyte stimulatory factor 1) (Pitrakinra)	IL4	6014;	9606.ENSP00000231449;
Q01344	IL5RA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-5 receptor subunit alpha (IL-5 receptor subunit alpha) (IL-5R subunit alpha) (IL-5R-alpha) (IL-5RA) (CDw125) (CD antigen CD125)	IL5RA IL5R	6017;	9606.ENSP00000412209;
P05113	IL5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-5 (IL-5) (B-cell differentiation factor I) (Eosinophil differentiation factor) (T-cell replacing factor) (TRF)	IL5	6016;	9606.ENSP00000231454;
P08887	IL6RA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-6 receptor subunit alpha (IL-6 receptor subunit alpha) (IL-6R subunit alpha) (IL-6R-alpha) (IL-6RA) (IL-6R 1) (Membrane glycoprotein 80) (gp80) (CD antigen CD126) [Cleaved into: Soluble interleukin-6 receptor subunit alpha (sIL6R)]	IL6R	6019;	9606.ENSP00000357470;
P40189	IL6RB_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-6 receptor subunit beta (IL-6 receptor subunit beta) (IL-6R subunit beta) (IL-6R-beta) (IL-6RB) (CDw130) (Interleukin-6 signal transducer) (Membrane glycoprotein 130) (gp130) (Oncostatin-M receptor subunit alpha) (CD antigen CD130)	IL6ST	6021;	9606.ENSP00000370698;
P19086	GNAZ_HUMAN	reviewed	Evidence at protein level	5 out of 5	Guanine nucleotide-binding protein G(z) subunit alpha (G(x) alpha chain) (Gz-alpha)	GNAZ	4395;	9606.ENSP00000478892;
P22694	KAPCB_HUMAN	reviewed	Evidence at protein level	5 out of 5	cAMP-dependent protein kinase catalytic subunit beta (PKA C-beta) (EC 2.7.11.11)	PRKACB	9381;	9606.ENSP00000359719;
P22612	KAPCG_HUMAN	reviewed	Evidence at protein level	5 out of 5	cAMP-dependent protein kinase catalytic subunit gamma (PKA C-gamma) (EC 2.7.11.11)	PRKACG	9382;	9606.ENSP00000366488;
Q96E93	KLRG1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Killer cell lectin-like receptor subfamily G member 1 (C-type lectin domain family 15 member A) (ITIM-containing receptor MAFA-L) (MAFA-like receptor) (Mast cell function-associated antigen)	KLRG1 CLEC15A MAFA MAFAL	6380;	9606.ENSP00000349477;
Q9NP55	BPIA1_HUMAN	reviewed	Evidence at protein level	5 out of 5	BPI fold-containing family A member 1 (Lung-specific protein X) (Nasopharyngeal carcinoma-related protein) (Palate lung and nasal epithelium clone protein) (Secretory protein in upper respiratory tracts) (Short PLUNC1) (SPLUNC1) (Tracheal epithelium-enriched protein) (Von Ebner protein Hl)	BPIFA1 LUNX NASG PLUNC SPLUNC1 SPURT UNQ787/PRO1606	15749;	9606.ENSP00000346251;
Q8WV28	BLNK_HUMAN	reviewed	Evidence at protein level	5 out of 5	B-cell linker protein (B-cell adapter containing a SH2 domain protein) (B-cell adapter containing a Src homology 2 domain protein) (Cytoplasmic adapter protein) (Src homology 2 domain-containing leukocyte protein of 65 kDa) (SLP-65)	BLNK BASH SLP65	14211;	9606.ENSP00000224337;
Q8NHW4	CC4L_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C motif chemokine 4-like (Lymphocyte activation gene 1 protein) (LAG-1) (Macrophage inflammatory protein 1-beta) (MIP-1-beta) (Monocyte adherence-induced protein 5-alpha) (Small-inducible cytokine A4-like)	CCL4L1 CCL4L LAG1 SCYA4L1; CCL4L2 CCL4L SCYA4L2	10631;24066;	9606.ENSP00000483609;
P19875	CXCL2_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-X-C motif chemokine 2 (Growth-regulated protein beta) (Gro-beta) (Macrophage inflammatory protein 2-alpha) (MIP2-alpha) [Cleaved into: GRO-beta(5-73) (GRO-beta-T) (Hematopoietic synergistic factor) (HSF) (SB-251353)]	CXCL2 GRO2 GROB MIP2A SCYB2	4603;	9606.ENSP00000427279;
Q99895	CTRC_HUMAN	reviewed	Evidence at protein level	5 out of 5	Chymotrypsin-C (EC 3.4.21.2) (Caldecrin)	CTRC CLCR	2523;	9606.ENSP00000365116;
P29466	CASP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Caspase-1 (CASP-1) (EC 3.4.22.36) (Interleukin-1 beta convertase) (IL-1BC) (Interleukin-1 beta-converting enzyme) (ICE) (IL-1 beta-converting enzyme) (p45) [Cleaved into: Caspase-1 subunit p20; Caspase-1 subunit p10]	CASP1 IL1BC IL1BCE	1499;	9606.ENSP00000433138;
P51878	CASP5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Caspase-5 (CASP-5) (EC 3.4.22.58) (ICE(rel)-III) (Protease ICH-3) (Protease TY) [Cleaved into: Caspase-5 subunit p20; Caspase-5 subunit p10]	CASP5 ICH3	1506;	9606.ENSP00000376849;
Q9BXL6	CAR14_HUMAN	reviewed	Evidence at protein level	5 out of 5	Caspase recruitment domain-containing protein 14 (CARD-containing MAGUK protein 2) (Carma 2)	CARD14 CARMA2	16446;	9606.ENSP00000458715;
P15169	CBPN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Carboxypeptidase N catalytic chain (CPN) (EC 3.4.17.3) (Anaphylatoxin inactivator) (Arginine carboxypeptidase) (Carboxypeptidase N polypeptide 1) (Carboxypeptidase N small subunit) (Kininase-1) (Lysine carboxypeptidase) (Plasma carboxypeptidase B) (Serum carboxypeptidase N) (SCPN)	CPN1 ACBP	2312;	9606.ENSP00000359446;
P20023	CR2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Complement receptor type 2 (Cr2) (Complement C3d receptor) (Epstein-Barr virus receptor) (EBV receptor) (CD antigen CD21)	CR2 C3DR	2336;	9606.ENSP00000356024;
Q92874	DNSL2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Deoxyribonuclease-1-like 2 (EC 3.1.21.-) (DNase I homolog protein DHP1) (Deoxyribonuclease I-like 2) (DNase I-like 2)	DNASE1L2 DHP1 DNAS1L2	2958;	9606.ENSP00000454562;
Q13609	DNSL3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Deoxyribonuclease gamma (DNase gamma) (EC 3.1.21.-) (DNase I homolog protein DHP2) (Deoxyribonuclease I-like 3) (DNase I-like 3) (Liver and spleen DNase) (LS-DNase) (LSD)	DNASE1L3 DHP2 DNAS1L3	2959;	9606.ENSP00000378053;
P09603	CSF1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Macrophage colony-stimulating factor 1 (CSF-1) (M-CSF) (MCSF) (Lanimostim) [Cleaved into: Processed macrophage colony-stimulating factor 1]	CSF1	2432;	9606.ENSP00000327513;
P35221	CTNA1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Catenin alpha-1 (Alpha E-catenin) (Cadherin-associated protein) (Renal carcinoma antigen NY-REN-13)	CTNNA1	2509;	9606.ENSP00000304669;
Q8N9W5	DAAF3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Dynein axonemal assembly factor 3	DNAAF3 C19orf51	30492;	9606.ENSP00000436975;
O14842	FFAR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Free fatty acid receptor 1 (G-protein coupled receptor 40)	FFAR1 GPR40	4498;	9606.ENSP00000246553;
Q9UBI6	GBG12_HUMAN	reviewed	Evidence at protein level	5 out of 5	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12	GNG12	19663;	9606.ENSP00000360021;
Q9Y223	GLCNE_HUMAN	reviewed	Evidence at protein level	5 out of 5	Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (UDP-GlcNAc-2-epimerase/ManAc kinase) [Includes: UDP-N-acetylglucosamine 2-epimerase (hydrolyzing) (EC 3.2.1.183) (UDP-GlcNAc-2-epimerase) (Uridine diphosphate-N-acetylglucosamine-2-epimerase); N-acetylmannosamine kinase (EC 2.7.1.60) (ManAc kinase)]	GNE GLCNE	23657;	9606.ENSP00000379839;
Q5XLA6	CAR17_HUMAN	reviewed	Evidence at protein level	5 out of 5	Caspase recruitment domain-containing protein 17 (Caspase-1 inhibitor INCA) (Inhibitory caspase recruitment domain protein)	CARD17 INCA	33827;	9606.ENSP00000364859;
Q9P296	C5AR2_HUMAN	reviewed	Evidence at protein level	5 out of 5	C5a anaphylatoxin chemotactic receptor 2 (Complement component 5a receptor 2) (G-protein coupled receptor 77)	C5AR2 C5L2 GPR77	4527;	9606.ENSP00000472620;
P48745	CCN3_HUMAN	reviewed	Evidence at protein level	5 out of 5	CCN family member 3 (Cellular communication network factor 3) (Insulin-like growth factor-binding protein 9) (IBP-9) (IGF-binding protein 9) (IGFBP-9) (Nephro blastoma-overexpressed gene protein homolog) (Protein NOV homolog) (NovH)	CCN3 IGFBP9 NOV NOVH	7885;	9606.ENSP00000259526;
P51677	CCR3_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C chemokine receptor type 3 (C C CKR3) (C-C CKR-3) (CC-CKR-3) (CCR-3) (CCR3) (CKR 3) (CKR3) (Eosinophil eotaxin receptor) (CD antigen CD193)	CCR3 CMKBR3	1604;	9606.ENSP00000441600;
P16070	CD44_HUMAN	reviewed	Evidence at protein level	5 out of 5	CD44 antigen (CDw44) (Epican) (Extracellular matrix receptor III) (ECMR-III) (GP90 lymphocyte homing/adhesion receptor) (HUTCH-I) (Heparan sulfate proteoglycan) (Hermes antigen) (Hyaluronate receptor) (Phagocytic glycoprotein 1) (PGP-1) (Phagocytic glycoprotein I) (PGP-I) (CD antigen CD44)	CD44 LHR MDU2 MDU3 MIC4	1681;	9606.ENSP00000398632;
P49716	CEBPD_HUMAN	reviewed	Evidence at protein level	5 out of 5	CCAAT/enhancer-binding protein delta (C/EBP delta) (Nuclear factor NF-IL6-beta) (NF-IL6-beta)	CEBPD	1835;	9606.ENSP00000386165;
P11511	CP19A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Aromatase (EC 1.14.14.14) (CYPXIX) (Cytochrome P-450AROM) (Cytochrome P450 19A1) (Estrogen synthase)	CYP19A1 ARO1 CYAR CYP19	2594;	9606.ENSP00000379683;
P24387	CRHBP_HUMAN	reviewed	Evidence at protein level	5 out of 5	Corticotropin-releasing factor-binding protein (CRF-BP) (CRF-binding protein) (Corticotropin-releasing hormone-binding protein) (CRH-BP)	CRHBP CRFBP	2356;	9606.ENSP00000274368;
Q8TDB6	DTX3L_HUMAN	reviewed	Evidence at protein level	5 out of 5	E3 ubiquitin-protein ligase DTX3L (EC 2.3.2.27) (B-lymphoma- and BAL-associated protein) (Protein deltex-3-like) (RING-type E3 ubiquitin transferase DTX3L) (Rhysin-2) (Rhysin2)	DTX3L BBAP	30323;	9606.ENSP00000296161;
P62873	GBB1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 (Transducin beta chain 1)	GNB1	4396;	9606.ENSP00000481878;
Q9BQI3	E2AK1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Eukaryotic translation initiation factor 2-alpha kinase 1 (EC 2.7.11.1) (Heme-controlled repressor) (HCR) (Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase) (Heme-regulated inhibitor) (hHRI) (Hemin-sensitive initiation factor 2-alpha kinase)	EIF2AK1 HRI KIAA1369 PRO1362	24921;	9606.ENSP00000199389;
P19525	E2AK2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interferon-induced, double-stranded RNA-activated protein kinase (EC 2.7.11.1) (Eukaryotic translation initiation factor 2-alpha kinase 2) (eIF-2A protein kinase 2) (Interferon-inducible RNA-dependent protein kinase) (P1/eIF-2A protein kinase) (Protein kinase RNA-activated) (PKR) (Protein kinase R) (Tyrosine-protein kinase EIF2AK2) (EC 2.7.10.2) (p68 kinase)	EIF2AK2 PKR PRKR	9437;	9606.ENSP00000233057;
Q9UBU3	GHRL_HUMAN	reviewed	Evidence at protein level	5 out of 5	Appetite-regulating hormone (Growth hormone secretagogue) (Growth hormone-releasing peptide) (Motilin-related peptide) (Protein M46) [Cleaved into: Ghrelin-27; Ghrelin-28 (Ghrelin); Obestatin]	GHRL MTLRP UNQ524/PRO1066	18129;	9606.ENSP00000335074;
Q92847	GHSR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor)	GHSR	4267;	9606.ENSP00000241256;
Q96T91	GPHA2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Glycoprotein hormone alpha-2 (Putative secreted protein Zsig51) (Thyrostimulin subunit alpha)	GPHA2 GPA2 ZSIG51	18054;	9606.ENSP00000279168;
Q86YW7	GPHB5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Glycoprotein hormone beta-5 (Thyrostimulin subunit beta)	GPHB5 GPB5 ZLUT1	18055;	9606.ENSP00000478993;
Q9H8Y5	ANKZ1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ankyrin repeat and zinc finger domain-containing protein 1 (Zinc finger protein 744)	ANKZF1 ZNF744	25527;	9606.ENSP00000321617;
P32246	CCR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C chemokine receptor type 1 (C-C CKR-1) (CC-CKR-1) (CCR-1) (CCR1) (HM145) (LD78 receptor) (Macrophage inflammatory protein 1-alpha receptor) (MIP-1alpha-R) (RANTES-R) (CD antigen CD191)	CCR1 CMKBR1 CMKR1 SCYAR1	1602;	9606.ENSP00000296140;
P13500	CCL2_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C motif chemokine 2 (HC11) (Monocyte chemoattractant protein 1) (Monocyte chemotactic and activating factor) (MCAF) (Monocyte chemotactic protein 1) (MCP-1) (Monocyte secretory protein JE) (Small-inducible cytokine A2)	CCL2 MCP1 SCYA2	10618;	9606.ENSP00000225831;
O14638	ENPP3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 (E-NPP 3) (NPP3) (Phosphodiesterase I beta) (PD-Ibeta) (Phosphodiesterase I/nucleotide pyrophosphatase 3) (CD antigen CD203c) [Includes: Alkaline phosphodiesterase I (EC 3.1.4.1); Nucleotide pyrophosphatase (NPPase) (EC 3.6.1.9) (Nucleotide diphosphatase)]	ENPP3 PDNP3	3358;	9606.ENSP00000406261;
P02765	FETUA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Alpha-2-HS-glycoprotein (Alpha-2-Z-globulin) (Ba-alpha-2-glycoprotein) (Fetuin-A) [Cleaved into: Alpha-2-HS-glycoprotein chain A; Alpha-2-HS-glycoprotein chain B]	AHSG FETUA PRO2743	349;	9606.ENSP00000393887;
Q8NCG7	DGLB_HUMAN	reviewed	Evidence at protein level	5 out of 5	Diacylglycerol lipase-beta (DAGL-beta) (DGL-beta) (EC 3.1.1.116) (KCCR13L) (PUFA-specific triacylglycerol lipase) (EC 3.1.1.3) (Sn1-specific diacylglycerol lipase beta)	DAGLB	28923;	9606.ENSP00000297056;
P35555	FBN1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Fibrillin-1 [Cleaved into: Asprosin]	FBN1 FBN	3603;	9606.ENSP00000325527;
Q16878	CDO1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cysteine dioxygenase type 1 (EC 1.13.11.20) (Cysteine dioxygenase type I) (CDO) (CDO-I)	CDO1	1795;	9606.ENSP00000250535;
P51685	CCR8_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C chemokine receptor type 8 (C-C CKR-8) (CC-CKR-8) (CCR-8) (CC chemokine receptor CHEMR1) (CMKBRL2) (Chemokine receptor-like 1) (CKR-L1) (GPR-CY6) (GPRCY6) (TER1) (CD antigen CDw198)	CCR8 CKRL1 CMKBR8 CMKBRL2	1609;	9606.ENSP00000326432;
Q9UNE7	CHIP_HUMAN	reviewed	Evidence at protein level	5 out of 5	E3 ubiquitin-protein ligase CHIP (EC 2.3.2.27) (Antigen NY-CO-7) (CLL-associated antigen KW-8) (Carboxy terminus of Hsp70-interacting protein) (RING-type E3 ubiquitin transferase CHIP) (STIP1 homology and U box-containing protein 1)	STUB1 CHIP PP1131	11427;	9606.ENSP00000219548;
P49715	CEBPA_HUMAN	reviewed	Evidence at protein level	5 out of 5	CCAAT/enhancer-binding protein alpha (C/EBP alpha)	CEBPA CEBP	1833;	9606.ENSP00000427514;
P16671	CD36_HUMAN	reviewed	Evidence at protein level	5 out of 5	Platelet glycoprotein 4 (Fatty acid translocase) (FAT) (Glycoprotein IIIb) (GPIIIB) (Leukocyte differentiation antigen CD36) (PAS IV) (PAS-4) (Platelet collagen receptor) (Platelet glycoprotein IV) (GPIV) (Thrombospondin receptor) (CD antigen CD36)	CD36 GP3B GP4	1663;	9606.ENSP00000399421;
P53621	COPA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) (HEP-COP) (HEPCOP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin]	COPA	2230;	9606.ENSP00000357048;
P24855	DNAS1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Deoxyribonuclease-1 (EC 3.1.21.1) (Deoxyribonuclease I) (DNase I) (Dornase alfa)	DNASE1 DNL1 DRNI	2956;	9606.ENSP00000385905;
Q8NHY3	GA2L2_HUMAN	reviewed	Evidence at protein level	5 out of 5	GAS2-like protein 2 (GAS2-related protein on chromosome 17) (Growth arrest-specific protein 2-like 2)	GAS2L2 GAR17	24846;	9606.ENSP00000474529;
P09958	FURIN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Furin (EC 3.4.21.75) (Dibasic-processing enzyme) (Paired basic amino acid residue-cleaving enzyme) (PACE)	FURIN FUR PACE PCSK3	8568;	9606.ENSP00000483552;
Q9H2U1	DHX36_HUMAN	reviewed	Evidence at protein level	5 out of 5	ATP-dependent DNA/RNA helicase DHX36 (EC 3.6.4.12) (EC 3.6.4.13) (DEAD/H box polypeptide 36) (DEAH-box protein 36) (G4-resolvase-1) (G4R1) (MLE-like protein 1) (RNA helicase associated with AU-rich element protein)	DHX36 DDX36 KIAA1488 MLEL1 RHAU	14410;	9606.ENSP00000417078;
P29317	EPHA2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ephrin type-A receptor 2 (EC 2.7.10.1) (Epithelial cell kinase) (Tyrosine-protein kinase receptor ECK)	EPHA2 ECK	3386;	9606.ENSP00000351209;
O15360	FANCA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Fanconi anemia group A protein (Protein FACA)	FANCA FAA FACA FANCH	3582;	9606.ENSP00000373952;
P06241	FYN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene Syn) (Proto-oncogene c-Fyn) (Src-like kinase) (SLK) (p59-Fyn)	FYN	4037;	9606.ENSP00000346671;
P22466	GALA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Galanin peptides [Cleaved into: Galanin; Galanin message-associated peptide (GMAP)]	GAL GAL1 GALN GLNN	4114;	9606.ENSP00000265643;
O95999	BCL10_HUMAN	reviewed	Evidence at protein level	5 out of 5	B-cell lymphoma/leukemia 10 (B-cell CLL/lymphoma 10) (Bcl-10) (CARD-containing molecule enhancing NF-kappa-B) (CARD-like apoptotic protein) (hCLAP) (CED-3/ICH-1 prodomain homologous E10-like regulator) (CIPER) (Cellular homolog of vCARMEN) (cCARMEN) (Cellular-E10) (c-E10) (Mammalian CARD-containing adapter molecule E10) (mE10)	BCL10 CIPER CLAP	989;	9606.ENSP00000359612;
P17676	CEBPB_HUMAN	reviewed	Evidence at protein level	5 out of 5	CCAAT/enhancer-binding protein beta (C/EBP beta) (Liver activator protein) (LAP) (Liver-enriched inhibitory protein) (LIP) (Nuclear factor NF-IL6) (Transcription factor 5) (TCF-5)	CEBPB TCF5 PP9092	1834;	9606.ENSP00000305422;
P01031	CO5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Complement C5 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4) [Cleaved into: Complement C5 beta chain; Complement C5 alpha chain; C5a anaphylatoxin; Complement C5 alpha' chain]	C5 CPAMD4	1331;	9606.ENSP00000223642;
P02778	CXL10_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-X-C motif chemokine 10 (10 kDa interferon gamma-induced protein) (Gamma-IP10) (IP-10) (Small-inducible cytokine B10) [Cleaved into: CXCL10(1-73)]	CXCL10 INP10 SCYB10	10637;	9606.ENSP00000305651;
P06756	ITAV_HUMAN	reviewed	Evidence at protein level	5 out of 5	Integrin alpha-V (Vitronectin receptor) (Vitronectin receptor subunit alpha) (CD antigen CD51) [Cleaved into: Integrin alpha-V heavy chain; Integrin alpha-V light chain]	ITGAV MSK8 VNRA VTNR	6150;	9606.ENSP00000261023;
P05154	IPSP_HUMAN	reviewed	Evidence at protein level	5 out of 5	Plasma serine protease inhibitor (Acrosomal serine protease inhibitor) (Plasminogen activator inhibitor 3) (PAI-3) (PAI3) (Protein C inhibitor) (PCI) (Serpin A5)	SERPINA5 PCI PLANH3 PROCI	8723;	9606.ENSP00000333203;
Q4G0X9	CCD40_HUMAN	reviewed	Evidence at protein level	5 out of 5	Coiled-coil domain-containing protein 40	CCDC40 KIAA1640	26090;	9606.ENSP00000380679;
P12110	CO6A2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Collagen alpha-2(VI) chain	COL6A2	2212;	9606.ENSP00000300527;
Q02318	CP27A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Sterol 26-hydroxylase, mitochondrial (EC 1.14.15.15) (5-beta-cholestane-3-alpha,7-alpha,12-alpha-triol 26-hydroxylase) (Cytochrome P-450C27/25) (Cytochrome P450 27) (Sterol 27-hydroxylase) (Vitamin D(3) 25-hydroxylase)	CYP27A1 CYP27	2605;	9606.ENSP00000258415;
Q9BSK4	FEM1A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein fem-1 homolog A (FEM1a) (FEM1-alpha) (Prostaglandin E receptor 4-associated protein)	FEM1A EPRAP	16934;	9606.ENSP00000269856;
O14843	FFAR3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Free fatty acid receptor 3 (G-protein coupled receptor 41)	FFAR3 GPR41	4499;	9606.ENSP00000328230;
Q13158	FADD_HUMAN	reviewed	Evidence at protein level	5 out of 5	FAS-associated death domain protein (FAS-associating death domain-containing protein) (Growth-inhibiting gene 3 protein) (Mediator of receptor induced toxicity)	FADD MORT1 GIG3	3573;	9606.ENSP00000301838;
Q9HBE4	IL21_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-21 (IL-21) (Za11)	IL21	6005;	9606.ENSP00000264497;
O43820	HYAL3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Hyaluronidase-3 (Hyal-3) (EC 3.2.1.35) (Hyaluronoglucosaminidase-3) (Lung carcinoma protein 3) (LuCa-3)	HYAL3 LUCA3	5322;	9606.ENSP00000337425;
Q9NPF7	IL23A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-23 subunit alpha (IL-23 subunit alpha) (IL-23-A) (Interleukin-23 subunit p19) (IL-23p19)	IL23A SGRF UNQ2498/PRO5798	15488;	9606.ENSP00000228534;
Q5VWK5	IL23R_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-23 receptor (IL-23 receptor) (IL-23R)	IL23R	19100;	9606.ENSP00000321345;
Q9NPH9	IL26_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-26 (IL-26) (Protein AK155)	IL26 AK155	17119;	9606.ENSP00000229134;
Q8NEV9	IL27A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-27 subunit alpha (IL-27 subunit alpha) (IL-27-A) (IL27-A) (Interleukin-30) (p28)	IL27 IL27A IL30	19157;	9606.ENSP00000349365;
Q14213	IL27B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-27 subunit beta (IL-27 subunit beta) (IL-27B) (Epstein-Barr virus-induced gene 3 protein) (EBV-induced gene 3 protein)	EBI3 IL27B	3129;	9606.ENSP00000221847;
Q9BYX4	IFIH1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interferon-induced helicase C domain-containing protein 1 (EC 3.6.4.13) (Clinically amyopathic dermatomyositis autoantigen 140 kDa) (CADM-140 autoantigen) (Helicase with 2 CARD domains) (Helicard) (Interferon-induced with helicase C domain protein 1) (Melanoma differentiation-associated protein 5) (MDA-5) (Murabutide down-regulated protein) (RIG-I-like receptor 2) (RLR-2) (RNA helicase-DEAD box protein 116)	IFIH1 MDA5 RH116	18873;	9606.ENSP00000263642;
P35613	BASI_HUMAN	reviewed	Evidence at protein level	5 out of 5	Basigin (5F7) (Collagenase stimulatory factor) (Extracellular matrix metalloproteinase inducer) (EMMPRIN) (Hepatoma-associated antigen) (HAb18G) (Leukocyte activation antigen M6) (OK blood group antigen) (Tumor cell-derived collagenase stimulatory factor) (TCSF) (CD antigen CD147)	BSG UNQ6505/PRO21383	1116;	9606.ENSP00000333769;
P22004	BMP6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Bone morphogenetic protein 6 (BMP-6) (VG-1-related protein) (VG-1-R) (VGR-1)	BMP6 VGR	1073;	9606.ENSP00000283147;
Q9BQA9	CYBC1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cytochrome b-245 chaperone 1 (Essential for reactive oxygen species protein) (Eros)	CYBC1 C17orf62 EROS	28672;	9606.ENSP00000388909;
Q9Y2G2	CARD8_HUMAN	reviewed	Evidence at protein level	5 out of 5	Caspase recruitment domain-containing protein 8 (EC 3.4.-.-) (CARD-inhibitor of NF-kappa-B-activating ligand) (CARDINAL) (Tumor up-regulated CARD-containing antagonist of CASP9) (TUCAN) [Cleaved into: Caspase recruitment domain-containing protein 8, C-terminus (CARD8-CT); Caspase recruitment domain-containing protein 8, N-terminus (CARD8-NT)]	CARD8 DACAR KIAA0955 NDPP1	17057;	9606.ENSP00000375767;
P57730	CAR18_HUMAN	reviewed	Evidence at protein level	5 out of 5	Caspase recruitment domain-containing protein 18 (Caspase-1 inhibitor Iceberg)	CARD18 ICEBERG UNQ5804/PRO19611	28861;	9606.ENSP00000436691;
P80075	CCL8_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C motif chemokine 8 (HC14) (Monocyte chemoattractant protein 2) (Monocyte chemotactic protein 2) (MCP-2) (Small-inducible cytokine A8) [Cleaved into: MCP-2(6-76)]	CCL8 MCP2 SCYA10 SCYA8	10635;	9606.ENSP00000378118;
P02741	CRP_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-reactive protein [Cleaved into: C-reactive protein(1-205)]	CRP PTX1	2367;	9606.ENSP00000255030;
Q96C10	DHX58_HUMAN	reviewed	Evidence at protein level	5 out of 5	ATP-dependent RNA helicase DHX58 (EC 3.6.4.13) (ATP-dependent helicase LGP2) (Protein D11Lgp2 homolog) (RIG-I-like receptor 3) (RLR-3) (RIG-I-like receptor LGP2) (RLR)	DHX58 D11LGP2E LGP2	29517;	9606.ENSP00000251642;
P14207	FOLR2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Folate receptor beta (FR-beta) (Folate receptor 2) (Folate receptor, fetal/placental) (Placental folate-binding protein) (FBP)	FOLR2	3793;	9606.ENSP00000298223;
P01911	DRB1_HUMAN	reviewed	Evidence at protein level	5 out of 5	HLA class II histocompatibility antigen, DRB1 beta chain (Human leukocyte antigen DRB1) (HLA-DRB1)	HLA-DRB1	4948;	9606.ENSP00000353099;
Q92949	FOXJ1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Forkhead box protein J1 (Forkhead-related protein FKHL13) (Hepatocyte nuclear factor 3 forkhead homolog 4) (HFH-4)	FOXJ1 FKHL13 HFH4	3816;	9606.ENSP00000323880;
P36269	GGT5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Glutathione hydrolase 5 proenzyme (EC 3.4.19.13) (Gamma-glutamyl transpeptidase-related enzyme) (GGT-rel) (Gamma-glutamyltransferase 5) (GGT 5) (EC 2.3.2.2) (Gamma-glutamyltransferase-like activity 1) (Gamma-glutamyltranspeptidase 5) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) [Cleaved into: Glutathione hydrolase 5 heavy chain; Glutathione hydrolase 5 light chain]	GGT5 GGTLA1	4260;	9606.ENSP00000381340;
Q03113	GNA12_HUMAN	reviewed	Evidence at protein level	5 out of 5	Guanine nucleotide-binding protein subunit alpha-12 (G alpha-12) (G-protein subunit alpha-12)	GNA12	4380;	9606.ENSP00000275364;
P63092	GNAS2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (Adenylate cyclase-stimulating G alpha protein)	GNAS GNAS1 GSP	4392;	
P09211	GSTP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Glutathione S-transferase P (EC 2.5.1.18) (GST class-pi) (GSTP1-1)	GSTP1 FAEES3 GST3	4638;	9606.ENSP00000381607;
P08908	5HT1A_HUMAN	reviewed	Evidence at protein level	5 out of 5	5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)	HTR1A ADRB2RL1 ADRBRL1	5286;	9606.ENSP00000316244;
Q13639	5HT4R_HUMAN	reviewed	Evidence at protein level	5 out of 5	5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)	HTR4	5299;	9606.ENSP00000353915;
Q9BYF1	ACE2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Angiotensin-converting enzyme 2 (EC 3.4.17.23) (Angiotensin-converting enzyme homolog) (ACEH) (Angiotensin-converting enzyme-related carboxypeptidase) (ACE-related carboxypeptidase) (EC 3.4.17.-) (Metalloprotease MPROT15) [Cleaved into: Processed angiotensin-converting enzyme 2]	ACE2 UNQ868/PRO1885	13557;	9606.ENSP00000389326;
Q7Z591	AKNA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Microtubule organization protein AKNA (AT-hook-containing transcription factor)	AKNA KIAA1968	24108;	9606.ENSP00000303769;
O60266	ADCY3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Adenylate cyclase type 3 (EC 4.6.1.1) (ATP pyrophosphate-lyase 3) (Adenylate cyclase type III) (AC-III) (Adenylate cyclase, olfactive type) (Adenylyl cyclase 3) (AC3)	ADCY3 KIAA0511	234;	9606.ENSP00000260600;
Q9NZK5	ADA2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Adenosine deaminase 2 (EC 3.5.4.4) (Cat eye syndrome critical region protein 1)	ADA2 ADGF CECR1 IDGFL	1839;	9606.ENSP00000382731;
O60503	ADCY9_HUMAN	reviewed	Evidence at protein level	5 out of 5	Adenylate cyclase type 9 (EC 4.6.1.1) (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX) (ACIX) (Adenylyl cyclase 9) (AC9)	ADCY9 KIAA0520	240;	9606.ENSP00000294016;
O95236	APOL3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Apolipoprotein L3 (Apolipoprotein L-III) (ApoL-III) (TNF-inducible protein CG12-1) (CG12_1)	APOL3	14868;	9606.ENSP00000344577;
O15033	AREL1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Apoptosis-resistant E3 ubiquitin protein ligase 1 (EC 2.3.2.26) (Apoptosis-resistant HECT-type E3 ubiquitin transferase 1)	AREL1 KIAA0317	20363;	9606.ENSP00000348714;
O14744	ANM5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein arginine N-methyltransferase 5 (PRMT5) (EC 2.1.1.320) (72 kDa ICln-binding protein) (Histone-arginine N-methyltransferase PRMT5) (Jak-binding protein 1) (Shk1 kinase-binding protein 1 homolog) (SKB1 homolog) (SKB1Hs) [Cleaved into: Protein arginine N-methyltransferase 5, N-terminally processed]	PRMT5 HRMT1L5 IBP72 JBP1 SKB1	10894;	9606.ENSP00000319169;
P41597	CCR2_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C chemokine receptor type 2 (C-C CKR-2) (CC-CKR-2) (CCR-2) (CCR2) (Monocyte chemoattractant protein 1 receptor) (MCP-1-R) (CD antigen CD192)	CCR2 CMKBR2	1603;	9606.ENSP00000292301;
Q6ZMG9	CERS6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ceramide synthase 6 (CerS6) (LAG1 longevity assurance homolog 6) (Sphingoid base N-palmitoyltransferase CERS6) (EC 2.3.1.291)	CERS6 LASS6	23826;	9606.ENSP00000376453;
Q8TD31	CCHCR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Coiled-coil alpha-helical rod protein 1 (Alpha-helical coiled-coil rod protein) (Putative gene 8 protein) (Pg8)	CCHCR1 C6orf18 HCR	13930;	9606.ENSP00000379566;
Q99741	CDC6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cell division control protein 6 homolog (CDC6-related protein) (Cdc18-related protein) (HsCdc18) (p62(cdc6)) (HsCDC6)	CDC6 CDC18L	1744;	9606.ENSP00000209728;
P13501	CCL5_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C motif chemokine 5 (EoCP) (Eosinophil chemotactic cytokine) (SIS-delta) (Small-inducible cytokine A5) (T cell-specific protein P228) (TCP228) (T-cell-specific protein RANTES) [Cleaved into: RANTES(3-68); RANTES(4-68)]	CCL5 D17S136E SCYA5	10632;	9606.ENSP00000474412;
P10147	CCL3_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C motif chemokine 3 (G0/G1 switch regulatory protein 19-1) (Macrophage inflammatory protein 1-alpha) (MIP-1-alpha) (PAT 464.1) (SIS-beta) (Small-inducible cytokine A3) (Tonsillar lymphocyte LD78 alpha protein) [Cleaved into: MIP-1-alpha(4-69) (LD78-alpha(4-69))]	CCL3 G0S19-1 MIP1A SCYA3	10627;	9606.ENSP00000477908;
Q8NEU8	DP13B_HUMAN	reviewed	Evidence at protein level	5 out of 5	DCC-interacting protein 13-beta (Dip13-beta) (Adapter protein containing PH domain, PTB domain and leucine zipper motif 2)	APPL2 DIP13B	18242;	9606.ENSP00000446917;
P21554	CNR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)	CNR1 CNR	2159;	9606.ENSP00000358513;
P78329	CP4F2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cytochrome P450 4F2 (EC 1.14.14.1) (20-hydroxyeicosatetraenoic acid synthase) (20-HETE synthase) (Arachidonic acid omega-hydroxylase) (CYPIVF2) (Cytochrome P450-LTB-omega) (Docosahexaenoic acid omega-hydroxylase) (EC 1.14.14.79) (Leukotriene-B(4) 20-monooxygenase 1) (Leukotriene-B(4) omega-hydroxylase 1) (EC 1.14.14.94) (Phylloquinone omega-hydroxylase CYP4F2) (EC 1.14.14.78)	CYP4F2	2645;	9606.ENSP00000221700;
P34998	CRFR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Corticotropin-releasing factor receptor 1 (CRF-R-1) (CRF-R1) (CRFR-1) (Corticotropin-releasing hormone receptor 1) (CRH-R-1) (CRH-R1)	CRHR1 CRFR CRFR1 CRHR	2357;	9606.ENSP00000381333;
P13762	DRB4_HUMAN	reviewed	Evidence at protein level	5 out of 5	HLA class II histocompatibility antigen, DR beta 4 chain (MHC class II antigen DRB4)	HLA-DRB4	4952;	
P41182	BCL6_HUMAN	reviewed	Evidence at protein level	5 out of 5	B-cell lymphoma 6 protein (BCL-6) (B-cell lymphoma 5 protein) (BCL-5) (Protein LAZ-3) (Zinc finger and BTB domain-containing protein 27) (Zinc finger protein 51)	BCL6 BCL5 LAZ3 ZBTB27 ZNF51	1001;	9606.ENSP00000384371;
P55210	CASP7_HUMAN	reviewed	Evidence at protein level	5 out of 5	Caspase-7 (CASP-7) (EC 3.4.22.60) (Apoptotic protease Mch-3) (CMH-1) (ICE-like apoptotic protease 3) (ICE-LAP3) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11]	CASP7 MCH3	1508;	9606.ENSP00000358327;
Q14790	CASP8_HUMAN	reviewed	Evidence at protein level	5 out of 5	Caspase-8 (CASP-8) (EC 3.4.22.61) (Apoptotic cysteine protease) (Apoptotic protease Mch-5) (CAP4) (FADD-homologous ICE/ced-3-like protease) (FADD-like ICE) (FLICE) (ICE-like apoptotic protease 5) (MORT1-associated ced-3 homolog) (MACH) [Cleaved into: Caspase-8 subunit p18; Caspase-8 subunit p10]	CASP8 MCH5	1509;	9606.ENSP00000351273;
P49913	CAMP_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cathelicidin antimicrobial peptide (18 kDa cationic antimicrobial protein) (CAP-18) (hCAP-18) [Cleaved into: Antibacterial peptide FALL-39 (FALL-39 peptide antibiotic); Antibacterial peptide LL-37]	CAMP CAP18 FALL39 HSD26	1472;	9606.ENSP00000296435;
P16220	CREB1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cyclic AMP-responsive element-binding protein 1 (CREB-1) (cAMP-responsive element-binding protein 1)	CREB1	2345;	9606.ENSP00000387699;
O60427	FADS1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Acyl-CoA (8-3)-desaturase (EC 1.14.19.44) (Delta(5) fatty acid desaturase) (D5D) (Delta(5) desaturase) (Delta-5 desaturase) (Fatty acid desaturase 1)	FADS1 FADSD5	3574;	9606.ENSP00000322229;
Q86X45	DAA11_HUMAN	reviewed	Evidence at protein level	5 out of 5	Dynein axonemal assembly factor 11 (DNAAF11) (Leucine-rich repeat-containing protein 6) (Leucine-rich testis-specific protein) (Protein tilB homolog) (Testis-specific leucine-rich repeat protein)	DNAAF11 LRRC6 LRTP TSLRP	16725;	9606.ENSP00000484634;
Q02643	GHRHR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Growth hormone-releasing hormone receptor (GHRH receptor) (Growth hormone-releasing factor receptor) (GRF receptor) (GRFR)	GHRHR	4266;	9606.ENSP00000320180;
Q08334	I10R2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-10 receptor subunit beta (IL-10 receptor subunit beta) (IL-10R subunit beta) (IL-10RB) (Cytokine receptor class-II member 4) (Cytokine receptor family 2 member 4) (CRF2-4) (Interleukin-10 receptor subunit 2) (IL-10R subunit 2) (IL-10R2) (CD antigen CDw210b)	IL10RB CRFB4 D21S58 D21S66	5965;	9606.ENSP00000290200;
P04439	HLAA_HUMAN	reviewed	Evidence at protein level	5 out of 5	HLA class I histocompatibility antigen, A alpha chain (Human leukocyte antigen A) (HLA-A)	HLA-A HLAA	4931;	9606.ENSP00000379873;
Q99698	LYST_HUMAN	reviewed	Evidence at protein level	5 out of 5	Lysosomal-trafficking regulator (Beige homolog)	LYST CHS CHS1	1968;	9606.ENSP00000374443;
P01589	IL2RA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-2 receptor subunit alpha (IL-2 receptor subunit alpha) (IL-2-RA) (IL-2R subunit alpha) (IL2-RA) (TAC antigen) (p55) (CD antigen CD25)	IL2RA	6008;	9606.ENSP00000369293;
Q96P31	FCRL3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Fc receptor-like protein 3 (FcR-like protein 3) (FcRL3) (Fc receptor homolog 3) (FcRH3) (IFGP family protein 3) (hIFGP3) (Immune receptor translocation-associated protein 3) (SH2 domain-containing phosphatase anchor protein 2) (CD antigen CD307c)	FCRL3 FCRH3 IFGP3 IRTA3 SPAP2	18506;	9606.ENSP00000357167;
P01563	IFNA2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interferon alpha-2 (IFN-alpha-2) (Interferon alpha-A) (LeIF A)	IFNA2 IFNA2A IFNA2B IFNA2C	5423;	9606.ENSP00000369554;
Q16666	IF16_HUMAN	reviewed	Evidence at protein level	5 out of 5	Gamma-interferon-inducible protein 16 (Ifi-16) (Interferon-inducible myeloid differentiation transcriptional activator)	IFI16 IFNGIP1	5395;	9606.ENSP00000357113;
Q9Y6Y9	LY96_HUMAN	reviewed	Evidence at protein level	5 out of 5	Lymphocyte antigen 96 (Ly-96) (ESOP-1) (Protein MD-2)	LY96 ESOP1 MD2	17156;	9606.ENSP00000284818;
P16109	LYAM3_HUMAN	reviewed	Evidence at protein level	5 out of 5	P-selectin (CD62 antigen-like family member P) (Granule membrane protein 140) (GMP-140) (Leukocyte-endothelial cell adhesion molecule 3) (LECAM3) (Platelet activation dependent granule-external membrane protein) (PADGEM) (CD antigen CD62P)	SELP GMRP GRMP	10721;	9606.ENSP00000263686;
Q9NX58	LYAR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cell growth-regulating nucleolar protein	LYAR PNAS-5	26021;	9606.ENSP00000345917;
Q7KZI7	MARK2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Serine/threonine-protein kinase MARK2 (EC 2.7.11.1) (EC 2.7.11.26) (ELKL motif kinase 1) (EMK-1) (MAP/microtubule affinity-regulating kinase 2) (PAR1 homolog) (PAR1 homolog b) (Par-1b) (Par1b)	MARK2 EMK1	3332;	9606.ENSP00000385751;
P07948	LYN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tyrosine-protein kinase Lyn (EC 2.7.10.2) (Lck/Yes-related novel protein tyrosine kinase) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn)	LYN JTK8	6735;	9606.ENSP00000428924;
O00187	MASP2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mannan-binding lectin serine protease 2 (EC 3.4.21.104) (MBL-associated serine protease 2) (Mannose-binding protein-associated serine protease 2) (MASP-2) [Cleaved into: Mannan-binding lectin serine protease 2 A chain; Mannan-binding lectin serine protease 2 B chain]	MASP2	6902;	9606.ENSP00000383690;
O43462	MBTP2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Membrane-bound transcription factor site-2 protease (EC 3.4.24.85) (Endopeptidase S2P) (Sterol regulatory element-binding proteins intramembrane protease) (SREBPs intramembrane protease)	MBTPS2 S2P	15455;	9606.ENSP00000368798;
P41968	MC3R_HUMAN	reviewed	Evidence at protein level	5 out of 5	Melanocortin receptor 3 (MC3-R)	MC3R	6931;	9606.ENSP00000243911;
P32245	MC4R_HUMAN	reviewed	Evidence at protein level	5 out of 5	Melanocortin receptor 4 (MC4-R)	MC4R	6932;	9606.ENSP00000299766;
P33032	MC5R_HUMAN	reviewed	Evidence at protein level	5 out of 5	Melanocortin receptor 5 (MC5-R) (MC-2)	MC5R	6933;	9606.ENSP00000318077;
Q8IVG9	HUNIN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Humanin (Humanin mitochondrial) (HNM)	MT-RNR2 HN	7471;	
P13612	ITA4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Integrin alpha-4 (CD49 antigen-like family member D) (Integrin alpha-IV) (VLA-4 subunit alpha) (CD antigen CD49d)	ITGA4 CD49D	6140;	9606.ENSP00000380227;
P02763	A1AG1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Alpha-1-acid glycoprotein 1 (AGP 1) (Orosomucoid-1) (OMD 1)	ORM1 AGP1	8498;	9606.ENSP00000259396;
Q8IXH8	CAD26_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cadherin-like protein 26 (Cadherin-like protein VR20)	CDH26	15902;	9606.ENSP00000339390;
P04839	CY24B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cytochrome b-245 heavy chain (EC 1.-.-.-) (CGD91-phox) (Cytochrome b(558) subunit beta) (Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)	CYBB NOX2	2578;	9606.ENSP00000367851;
Q8NEP3	DAAF1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Dynein axonemal assembly factor 1 (Leucine-rich repeat-containing protein 50)	DNAAF1 LRRC50	30539;	9606.ENSP00000367815;
Q8WXU2	DAAF4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Dynein axonemal assembly factor 4 (Dyslexia susceptibility 1 candidate gene 1 protein)	DNAAF4 DYX1C1 EKN1	21493;	9606.ENSP00000323275;
P59910	DJB13_HUMAN	reviewed	Evidence at protein level	5 out of 5	DnaJ homolog subfamily B member 13 (Testis and spermatogenesis cell-related protein 6) (Testis spermatocyte apoptosis-related gene 6 protein) (Testis spermatogenesis apoptosis-related gene 3 protein) (Testis spermatogenesis apoptosis-related gene 6 protein)	DNAJB13 TSARG3 TSARG6	30718;	9606.ENSP00000344431;
Q8N6P7	I22R1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-22 receptor subunit alpha-1 (IL-22 receptor subunit alpha-1) (IL-22R-alpha-1) (IL-22RA1) (Cytokine receptor class-II member 9) (Cytokine receptor family 2 member 9) (CRF2-9) (ZcytoR11)	IL22RA1 IL22R	13700;	9606.ENSP00000270800;
P05106	ITB3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Integrin beta-3 (Platelet membrane glycoprotein IIIa) (GPIIIa) (CD antigen CD61)	ITGB3 GP3A	6156;	9606.ENSP00000452786;
A6NK06	IRG1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cis-aconitate decarboxylase (CAD) (EC 4.1.1.6) (Aconitate decarboxylase) (Aconitate decarboxylase 1) (Cis-aconitic acid decarboxylase) (Immune-responsive gene 1 protein)	ACOD1 IRG1	33904;	9606.ENSP00000366682;
Q9H4A9	DPEP2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Dipeptidase 2 (EC 3.4.13.19)	DPEP2 UNQ284/PRO323	23028;	9606.ENSP00000458977;
P61952	GBG11_HUMAN	reviewed	Evidence at protein level	5 out of 5	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11	GNG11 GNGT11	4403;	9606.ENSP00000248564;
Q14145	KEAP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Kelch-like ECH-associated protein 1 (Cytosolic inhibitor of Nrf2) (INrf2) (Kelch-like protein 19)	KEAP1 INRF2 KIAA0132 KLHL19	23177;	9606.ENSP00000171111;
P03952	KLKB1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Plasma kallikrein (EC 3.4.21.34) (Fletcher factor) (Kininogenin) (Plasma prekallikrein) (PKK) [Cleaved into: Plasma kallikrein heavy chain; Plasma kallikrein light chain]	KLKB1 KLK3	6371;	9606.ENSP00000264690;
P10644	KAP0_HUMAN	reviewed	Evidence at protein level	5 out of 5	cAMP-dependent protein kinase type I-alpha regulatory subunit (Tissue-specific extinguisher 1) (TSE1)	PRKAR1A PKR1 PRKAR1 TSE1	9388;	9606.ENSP00000376475;
Q9UEF7	KLOT_HUMAN	reviewed	Evidence at protein level	5 out of 5	Klotho (EC 3.2.1.31) [Cleaved into: Klotho peptide]	KL	6344;	9606.ENSP00000369442;
P31321	KAP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	cAMP-dependent protein kinase type I-beta regulatory subunit	PRKAR1B	9390;	9606.ENSP00000385749;
P13861	KAP2_HUMAN	reviewed	Evidence at protein level	5 out of 5	cAMP-dependent protein kinase type II-alpha regulatory subunit	PRKAR2A PKR2 PRKAR2	9391;	9606.ENSP00000265563;
P31323	KAP3_HUMAN	reviewed	Evidence at protein level	5 out of 5	cAMP-dependent protein kinase type II-beta regulatory subunit	PRKAR2B	9392;	9606.ENSP00000265717;
Q9UIH9	KLF15_HUMAN	reviewed	Evidence at protein level	5 out of 5	Krueppel-like factor 15 (Kidney-enriched krueppel-like factor)	KLF15 KKLF	14536;	9606.ENSP00000296233;
P09601	HMOX1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Heme oxygenase 1 (HO-1) (EC 1.14.14.18) [Cleaved into: Heme oxygenase 1 soluble form]	HMOX1 HO HO1	5013;	9606.ENSP00000216117;
Q5TA76	LCE3A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Late cornified envelope protein 3A (Late envelope protein 13)	LCE3A LEP13	29461;	9606.ENSP00000335006;
Q5TA77	LCE3B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Late cornified envelope protein 3B (Late envelope protein 14)	LCE3B LEP14	29462;	9606.ENSP00000335358;
Q5T5A8	LCE3C_HUMAN	reviewed	Evidence at protein level	5 out of 5	Late cornified envelope protein 3C (Late envelope protein 15) (Small proline-rich-like epidermal differentiation complex protein 3A)	LCE3C LEP15 SPRL3A	16612;	9606.ENSP00000334644;
P01042	KNG1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Kininogen-1 (Alpha-2-thiol proteinase inhibitor) (Fitzgerald factor) (High molecular weight kininogen) (HMWK) (Williams-Fitzgerald-Flaujeac factor) [Cleaved into: Kininogen-1 heavy chain; T-kinin (Ile-Ser-Bradykinin); Bradykinin (Kallidin I); Lysyl-bradykinin (Kallidin II); Kininogen-1 light chain; Low molecular weight growth-promoting factor]	KNG1 BDK KNG	6383;	9606.ENSP00000265023;
Q07325	CXCL9_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-X-C motif chemokine 9 (Gamma-interferon-induced monokine) (Monokine induced by interferon-gamma) (HuMIG) (MIG) (Small-inducible cytokine B9)	CXCL9 CMK MIG SCYB9	7098;	9606.ENSP00000354901;
P08311	CATG_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cathepsin G (CG) (EC 3.4.21.20) [Cleaved into: Cathepsin G, C-terminal truncated form]	CTSG	2532;	9606.ENSP00000216336;
Q8WUQ7	CATIN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cactin (Renal carcinoma antigen NY-REN-24)	CACTIN C19orf29	29938;	9606.ENSP00000415078;
P16410	CTLA4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cytotoxic T-lymphocyte protein 4 (Cytotoxic T-lymphocyte-associated antigen 4) (CTLA-4) (CD antigen CD152)	CTLA4 CD152	2505;	9606.ENSP00000303939;
P35638	DDIT3_HUMAN	reviewed	Evidence at protein level	5 out of 5	DNA damage-inducible transcript 3 protein (DDIT-3) (C/EBP zeta) (C/EBP-homologous protein) (CHOP) (C/EBP-homologous protein 10) (CHOP-10) (CCAAT/enhancer-binding protein homologous protein) (Growth arrest and DNA damage-inducible protein GADD153)	DDIT3 CHOP CHOP10 GADD153	2726;	9606.ENSP00000448665;
Q9H078	CLPB_HUMAN	reviewed	Evidence at protein level	5 out of 5	Caseinolytic peptidase B protein homolog (EC 3.6.1.-) (Suppressor of potassium transport defect 3)	CLPB HSP78 SKD3	30664;	9606.ENSP00000294053;
P08246	ELNE_HUMAN	reviewed	Evidence at protein level	5 out of 5	Neutrophil elastase (EC 3.4.21.37) (Bone marrow serine protease) (Elastase-2) (Human leukocyte elastase) (HLE) (Medullasin) (PMN elastase)	ELANE ELA2	3309;	9606.ENSP00000466090;
P18510	IL1RA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-1 receptor antagonist protein (IL-1RN) (IL-1ra) (IRAP) (ICIL-1RA) (IL1 inhibitor) (Anakinra)	IL1RN IL1F3 IL1RA	6000;	9606.ENSP00000259206;
Q9NYY1	IL20_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-20 (IL-20) (Cytokine Zcyto10)	IL20 ZCYTO10 UNQ852/PRO1801	6002;	9606.ENSP00000356065;
P30740	ILEU_HUMAN	reviewed	Evidence at protein level	5 out of 5	Leukocyte elastase inhibitor (LEI) (Monocyte/neutrophil elastase inhibitor) (EI) (M/NEI) (Peptidase inhibitor 2) (PI-2) (Serpin B1)	SERPINB1 ELANH2 MNEI PI2	3311;	9606.ENSP00000370115;
Q12794	HYAL1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Hyaluronidase-1 (Hyal-1) (EC 3.2.1.35) (Hyaluronoglucosaminidase-1) (Lung carcinoma protein 1) (LuCa-1)	HYAL1 LUCA1	5320;	9606.ENSP00000266031;
P01579	IFNG_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interferon gamma (IFN-gamma) (Immune interferon)	IFNG	5438;	9606.ENSP00000229135;
Q9H293	IL25_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-25 (IL-25) (Interleukin-17E) (IL-17E)	IL25 IL17E UNQ3120/PRO10272	13765;	9606.ENSP00000328111;
Q08477	CP4F3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cytochrome P450 4F3 (EC 1.14.14.1) (20-hydroxyeicosatetraenoic acid synthase) (20-HETE synthase) (CYPIVF3) (Cytochrome P450-LTB-omega) (Docosahexaenoic acid omega-hydroxylase CYP4F3) (EC 1.14.14.79) (Leukotriene-B(4) 20-monooxygenase 2) (Leukotriene-B(4) omega-hydroxylase 2) (EC 1.14.14.94)	CYP4F3 LTB4H	2646;	9606.ENSP00000221307;
Q16610	ECM1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Extracellular matrix protein 1 (Secretory component p85)	ECM1	3153;	9606.ENSP00000358045;
P15090	FABP4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Fatty acid-binding protein, adipocyte (Adipocyte lipid-binding protein) (ALBP) (Adipocyte-type fatty acid-binding protein) (A-FABP) (AFABP) (Fatty acid-binding protein 4)	FABP4	3559;	9606.ENSP00000256104;
Q9BYW3	DB126_HUMAN	reviewed	Evidence at protein level	5 out of 5	Beta-defensin 126 (Beta-defensin 26) (DEFB-26) (Defensin, beta 126) (Epididymal secretory protein 13.2) (ESP13.2) (HBD26)	DEFB126 C20orf8 DEFB26	15900;	9606.ENSP00000371835;
Q9NYC9	DYH9_HUMAN	reviewed	Evidence at protein level	5 out of 5	Dynein axonemal heavy chain 9 (Axonemal beta dynein heavy chain 9) (Ciliary dynein heavy chain 9)	DNAH9 DNAH17L DNEL1 KIAA0357	2953;	9606.ENSP00000262442;
Q6IAN0	DRS7B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Dehydrogenase/reductase SDR family member 7B (EC 1.1.-.-) (Short-chain dehydrogenase/reductase family 32C member 1) (Protein SDR32C1)	DHRS7B SDR32C1 CGI-93 UNQ212/PRO238	24547;	9606.ENSP00000378887;
O14944	EREG_HUMAN	reviewed	Evidence at protein level	5 out of 5	Proepiregulin [Cleaved into: Epiregulin (EPR)]	EREG	3443;	9606.ENSP00000244869;
P68871	HBB_HUMAN	reviewed	Evidence at protein level	5 out of 5	Hemoglobin subunit beta (Beta-globin) (Hemoglobin beta chain) [Cleaved into: LVV-hemorphin-7; Spinorphin]	HBB	4827;	9606.ENSP00000333994;
P35367	HRH1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Histamine H1 receptor (H1R) (HH1R)	HRH1	5182;	9606.ENSP00000380247;
P07900	HS90A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Heat shock protein HSP 90-alpha (EC 3.6.4.10) (Heat shock 86 kDa) (HSP 86) (HSP86) (Lipopolysaccharide-associated protein 2) (LAP-2) (LPS-associated protein 2) (Renal carcinoma antigen NY-REN-38)	HSP90AA1 HSP90A HSPC1 HSPCA	5253;	9606.ENSP00000335153;
P0DMV8	HS71A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Heat shock 70 kDa protein 1A (Heat shock 70 kDa protein 1) (HSP70-1) (HSP70.1)	HSPA1A HSP72 HSPA1 HSX70	5232;	9606.ENSP00000364801;
Q08722	CD47_HUMAN	reviewed	Evidence at protein level	5 out of 5	Leukocyte surface antigen CD47 (Antigenic surface determinant protein OA3) (Integrin-associated protein) (IAP) (Protein MER6) (CD antigen CD47)	CD47 MER6	1682;	9606.ENSP00000355361;
P80098	CCL7_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C motif chemokine 7 (Monocyte chemoattractant protein 3) (Monocyte chemotactic protein 3) (MCP-3) (NC28) (Small-inducible cytokine A7)	CCL7 MCP3 SCYA6 SCYA7	10634;	9606.ENSP00000367832;
Q6UXB2	CXL17_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-X-C motif chemokine 17 (6-Cys CXCL17) (Dendritic cell and monocyte chemokine-like protein) (DMC) (VEGF coregulated chemokine 1) [Cleaved into: 4-Cys CXCL17]	CXCL17 VCC1 UNQ473/PRO842	19232;	9606.ENSP00000472467;
Q9NQM4	DAAF6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Dynein axonemal assembly factor 6 (PIH1 domain-containing protein 3) (Sarcoma antigen NY-SAR-97)	DNAAF6 CXorf41 PIH1D3	28570;	9606.ENSP00000441930;
Q86Y56	DAAF5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Dynein axonemal assembly factor 5 (HEAT repeat-containing protein 2)	DNAAF5 HEATR2	26013;	9606.ENSP00000297440;
Q4LDG9	DNAL1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Dynein axonemal light chain 1 (LC1)	DNAL1 C14orf168	23247;	9606.ENSP00000452037;
Q9UQL6	HDAC5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Histone deacetylase 5 (HD5) (EC 3.5.1.98) (Antigen NY-CO-9)	HDAC5 KIAA0600	14068;	9606.ENSP00000225983;
Q8WUI4	HDAC7_HUMAN	reviewed	Evidence at protein level	5 out of 5	Histone deacetylase 7 (HD7) (EC 3.5.1.98) (Histone deacetylase 7A) (HD7a)	HDAC7 HDAC7A	14067;	9606.ENSP00000080059;
Q9UKV0	HDAC9_HUMAN	reviewed	Evidence at protein level	5 out of 5	Histone deacetylase 9 (HD9) (EC 3.5.1.98) (Histone deacetylase 7B) (HD7) (HD7b) (Histone deacetylase-related protein) (MEF2-interacting transcription repressor MITR)	HDAC9 HDAC7 HDAC7B HDRP KIAA0744 MITR	14065;	9606.ENSP00000408617;
Q14289	FAK2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein-tyrosine kinase 2-beta (EC 2.7.10.2) (Calcium-dependent tyrosine kinase) (CADTK) (Calcium-regulated non-receptor proline-rich tyrosine kinase) (Cell adhesion kinase beta) (CAK-beta) (CAKB) (Focal adhesion kinase 2) (FADK 2) (Proline-rich tyrosine kinase 2) (Related adhesion focal tyrosine kinase) (RAFTK)	PTK2B FAK2 PYK2 RAFTK	9612;	9606.ENSP00000380638;
P23945	FSHR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Follicle-stimulating hormone receptor (FSH-R) (Follitropin receptor)	FSHR LGR1	3969;	9606.ENSP00000384708;
P26927	HGFL_HUMAN	reviewed	Evidence at protein level	5 out of 5	Hepatocyte growth factor-like protein (Macrophage stimulatory protein) (Macrophage-stimulating protein) (MSP) [Cleaved into: Hepatocyte growth factor-like protein alpha chain; Hepatocyte growth factor-like protein beta chain]	MST1 D3F15S2 DNF15S2 HGFL	7380;	9606.ENSP00000414287;
P24941	CDK2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) (p33 protein kinase)	CDK2 CDKN2	1771;	9606.ENSP00000266970;
Q9NQC7	CYLD_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD)	CYLD CYLD1 KIAA0849 HSPC057	2584;	9606.ENSP00000392025;
P50461	CSRP3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cysteine and glycine-rich protein 3 (Cardiac LIM protein) (Cysteine-rich protein 3) (CRP3) (LIM domain protein, cardiac) (Muscle LIM protein)	CSRP3 CLP MLP	2472;	9606.ENSP00000431813;
Q9NR30	DDX21_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nucleolar RNA helicase 2 (EC 3.6.4.13) (DEAD box protein 21) (Gu-alpha) (Nucleolar RNA helicase Gu) (Nucleolar RNA helicase II) (RH II/Gu)	DDX21	2744;	9606.ENSP00000346120;
Q02742	GCNT1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase (EC 2.4.1.102) (Core 2 beta-1,6-N-acetylglucosaminyltransferase) (C2GlcNAcT) (Core 2-branching enzyme) (Core2-GlcNAc-transferase) (C2GNT) (Core 2 GNT) (Leukocyte type core 2 beta-1,6-N-acetylglucosaminyltransferase) (C2GnT-L)	GCNT1 NACGT2	4203;	9606.ENSP00000415454;
P36969	GPX4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Phospholipid hydroperoxide glutathione peroxidase (PHGPx) (EC 1.11.1.12) (Glutathione peroxidase 4) (GPx-4) (GSHPx-4)	GPX4	4556;	9606.ENSP00000346103;
Q9Y3R0	GRIP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Glutamate receptor-interacting protein 1 (GRIP-1)	GRIP1	18708;	9606.ENSP00000381098;
P08637	FCG3A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Low affinity immunoglobulin gamma Fc region receptor III-A (IgG Fc receptor III-A) (CD16-II) (CD16a antigen) (Fc-gamma RIII-alpha) (Fc-gamma RIII) (Fc-gamma RIIIa) (FcRIII) (FcRIIIa) (FcgammaRIIIA) (FcR-10) (IgG Fc receptor III-2) (CD antigen CD16a)	FCGR3A CD16A FCG3 FCGR3 IGFR3	3619;	9606.ENSP00000356946;
P49327	FAS_HUMAN	reviewed	Evidence at protein level	5 out of 5	Fatty acid synthase (EC 2.3.1.85) (Type I fatty acid synthase) [Includes: [Acyl-carrier-protein] S-acetyltransferase (EC 2.3.1.38); [Acyl-carrier-protein] S-malonyltransferase (EC 2.3.1.39); 3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41); 3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100); 3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59); Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.39); Acyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14)]	FASN FAS	3594;	9606.ENSP00000304592;
O75844	FACE1_HUMAN	reviewed	Evidence at protein level	5 out of 5	CAAX prenyl protease 1 homolog (EC 3.4.24.84) (Farnesylated proteins-converting enzyme 1) (FACE-1) (Prenyl protein-specific endoprotease 1) (Zinc metalloproteinase Ste24 homolog)	ZMPSTE24 FACE1 STE24	12877;	9606.ENSP00000361845;
Q14116	IL18_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-18 (IL-18) (Iboctadekin) (Interferon gamma-inducing factor) (IFN-gamma-inducing factor) (Interleukin-1 gamma) (IL-1 gamma)	IL18 IGIF IL1F4	5986;	9606.ENSP00000280357;
Q86VB7	C163A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Scavenger receptor cysteine-rich type 1 protein M130 (Hemoglobin scavenger receptor) (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)]	CD163 M130	1631;	9606.ENSP00000352071;
P20160	CAP7_HUMAN	reviewed	Evidence at protein level	5 out of 5	Azurocidin (Cationic antimicrobial protein CAP37) (Heparin-binding protein) (HBP) (hHBP)	AZU1	913;	9606.ENSP00000233997;
P50750	CDK9_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (C-2K) (Cell division cycle 2-like protein kinase 4) (Cell division protein kinase 9) (Serine/threonine-protein kinase PITALRE) (Tat-associated kinase complex catalytic subunit)	CDK9 CDC2L4 TAK	1780;	9606.ENSP00000362361;
O43889	CREB3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cyclic AMP-responsive element-binding protein 3 (CREB-3) (cAMP-responsive element-binding protein 3) (Leucine zipper protein) (Luman) (Transcription factor LZIP-alpha) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3 (N-terminal Luman) (Transcriptionally active form)]	CREB3 LZIP	2347;	9606.ENSP00000342136;
Q9UGM3	DMBT1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Deleted in malignant brain tumors 1 protein (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein)	DMBT1 GP340	2926;	9606.ENSP00000357905;
Q1HG43	DOXA1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Dual oxidase maturation factor 1 (Dual oxidase activator 1) (Numb-interacting protein)	DUOXA1 NIP NUMBIP	26507;	9606.ENSP00000267803;
Q8ND90	PNMA1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Paraneoplastic antigen Ma1 (37 kDa neuronal protein) (Neuron- and testis-specific protein 1)	PNMA1 MA1	9158;	9606.ENSP00000318914;
Q92622	RUBIC_HUMAN	reviewed	Evidence at protein level	5 out of 5	Run domain Beclin-1-interacting and cysteine-rich domain-containing protein (Rubicon) (Beclin-1 associated RUN domain containing protein) (Baron)	RUBCN KIAA0226	28991;	9606.ENSP00000296343;
Q9H4P4	RNF41_HUMAN	reviewed	Evidence at protein level	5 out of 5	E3 ubiquitin-protein ligase NRDP1 (EC 2.3.2.27) (RING finger protein 41) (RING-type E3 ubiquitin transferase NRDP1)	RNF41 FLRF NRDP1 SBBI03	18401;	9606.ENSP00000342755;
Q8IWY4	SCUB1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Signal peptide, CUB and EGF-like domain-containing protein 1	SCUBE1	13441;	9606.ENSP00000354080;
Q8N697	S15A4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Solute carrier family 15 member 4 (Peptide transporter 4) (Peptide/histidine transporter 1) (hPHT1)	SLC15A4 PHT1 PTR4 FP12591	23090;	9606.ENSP00000266771;
Q86SG5	S1A7A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein S100-A7A (S100 calcium-binding protein A15) (S100 calcium-binding protein A7-like 1) (S100 calcium-binding protein A7A)	S100A7A S100A15 S100A7L1	21657;	9606.ENSP00000357718;
Q99500	S1PR3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Sphingosine 1-phosphate receptor 3 (S1P receptor 3) (S1P3) (Endothelial differentiation G-protein coupled receptor 3) (Sphingosine 1-phosphate receptor Edg-3) (S1P receptor Edg-3)	S1PR3 C9orf108 C9orf47 EDG3	3167;	9606.ENSP00000365006;
P51168	SCNNB_HUMAN	reviewed	Evidence at protein level	5 out of 5	Amiloride-sensitive sodium channel subunit beta (Beta-NaCH) (Epithelial Na(+) channel subunit beta) (Beta-ENaC) (ENaCB) (Nonvoltage-gated sodium channel 1 subunit beta) (SCNEB)	SCNN1B	10600;	9606.ENSP00000345751;
Q9H015	S22A4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Solute carrier family 22 member 4 (Ergothioneine transporter) (ET transporter) (Organic cation/carnitine transporter 1)	SLC22A4 ETT OCTN1 UT2H	10968;	9606.ENSP00000200652;
P09683	SECR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Secretin	SCT	10607;	9606.ENSP00000176195;
Q15043	S39AE_HUMAN	reviewed	Evidence at protein level	5 out of 5	Metal cation symporter ZIP14 (LIV-1 subfamily of ZIP zinc transporter 4) (LZT-Hs4) (Solute carrier family 39 member 14) (Zrt- and Irt-like protein 14) (ZIP-14)	SLC39A14 KIAA0062 ZIP14	20858;	9606.ENSP00000352779;
P19793	RXRA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Retinoic acid receptor RXR-alpha (Nuclear receptor subfamily 2 group B member 1) (Retinoid X receptor alpha)	RXRA NR2B1	10477;	9606.ENSP00000419692;
Q9BZW8	CD244_HUMAN	reviewed	Evidence at protein level	5 out of 5	Natural killer cell receptor 2B4 (NK cell activation-inducing ligand) (NAIL) (NK cell type I receptor protein 2B4) (NKR2B4) (h2B4) (SLAM family member 4) (SLAMF4) (Signaling lymphocytic activation molecule 4) (CD antigen CD244)	CD244 2B4	18171;	9606.ENSP00000357012;
P06746	DPOLB_HUMAN	reviewed	Evidence at protein level	5 out of 5	DNA polymerase beta (EC 2.7.7.7) (EC 4.2.99.-)	POLB	9174;	9606.ENSP00000265421;
P14778	IL1R1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-1 receptor type 1 (IL-1R-1) (IL-1RT-1) (IL-1RT1) (EC 3.2.2.6) (CD121 antigen-like family member A) (Interleukin-1 receptor alpha) (IL-1R-alpha) (Interleukin-1 receptor type I) (p80) (CD antigen CD121a) [Cleaved into: Interleukin-1 receptor type 1, membrane form (mIL-1R1) (mIL-1RI); Interleukin-1 receptor type 1, soluble form (sIL-1R1) (sIL-1RI)]	IL1R1 IL1R IL1RA IL1RT1	5993;	9606.ENSP00000386380;
Q3KP66	INAVA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Innate immunity activator protein	INAVA C1orf106	25599;	9606.ENSP00000392105;
Q16820	MEP1B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Meprin A subunit beta (EC 3.4.24.63) (Endopeptidase-2) (Meprin B) (N-benzoyl-L-tyrosyl-P-amino-benzoic acid hydrolase subunit beta) (PABA peptide hydrolase) (PPH beta)	MEP1B	7020;	9606.ENSP00000269202;
Q16617	NKG7_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein NKG7 (G-CSF-induced gene 1 protein) (GIG-1 protein) (Granule membrane protein of 17 kDa) (GMP-17) (Natural killer cell protein 7) (p15-TIA-1)	NKG7 GIG1	7830;	9606.ENSP00000221978;
Q16602	CALRL_HUMAN	reviewed	Evidence at protein level	5 out of 5	Calcitonin gene-related peptide type 1 receptor (CGRP type 1 receptor) (Calcitonin receptor-like receptor)	CALCRL CGRPR	16709;	9606.ENSP00000386972;
Q8IW40	CC103_HUMAN	reviewed	Evidence at protein level	5 out of 5	Coiled-coil domain-containing protein 103	CCDC103	32700;	9606.ENSP00000391692;
Q5EG05	CAR16_HUMAN	reviewed	Evidence at protein level	5 out of 5	Caspase recruitment domain-containing protein 16 (Caspase recruitment domain-only protein 1) (CARD-only protein 1) (Caspase-1 inhibitor COP) (Pseudo interleukin-1 beta converting enzyme) (Pseudo-ICE) (Pseudo-IL1B-converting enzyme)	CARD16 COP COP1	33701;	9606.ENSP00000364858;
Q9BWS9	CHID1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Chitinase domain-containing protein 1 (Stabilin-1-interacting chitinase-like protein) (SI-CLP)	CHID1 GL008 PSEC0104 SB139	28474;	9606.ENSP00000398722;
O14625	CXL11_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-X-C motif chemokine 11 (Beta-R1) (H174) (Interferon gamma-inducible protein 9) (IP-9) (Interferon-inducible T-cell alpha chemoattractant) (I-TAC) (Small-inducible cytokine B11)	CXCL11 ITAC SCYB11 SCYB9B	10638;	9606.ENSP00000306884;
O60716	CTND1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Catenin delta-1 (Cadherin-associated Src substrate) (CAS) (p120 catenin) (p120(ctn)) (p120(cas))	CTNND1 KIAA0384	2515;	9606.ENSP00000382004;
P02775	CXCL7_HUMAN	reviewed	Evidence at protein level	5 out of 5	Platelet basic protein (PBP) (C-X-C motif chemokine 7) (Leukocyte-derived growth factor) (LDGF) (Macrophage-derived growth factor) (MDGF) (Small-inducible cytokine B7) [Cleaved into: Connective tissue-activating peptide III (CTAP-III) (LA-PF4) (Low-affinity platelet factor IV); TC-2; Connective tissue-activating peptide III(1-81) (CTAP-III(1-81)); Beta-thromboglobulin (Beta-TG); Neutrophil-activating peptide 2(74) (NAP-2(74)); Neutrophil-activating peptide 2(73) (NAP-2(73)); Neutrophil-activating peptide 2 (NAP-2); TC-1; Neutrophil-activating peptide 2(1-66) (NAP-2(1-66)); Neutrophil-activating peptide 2(1-63) (NAP-2(1-63))]	PPBP CTAP3 CXCL7 SCYB7 TGB1 THBGB1	9240;	9606.ENSP00000296028;
P42830	CXCL5_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-X-C motif chemokine 5 (ENA-78(1-78)) (Epithelial-derived neutrophil-activating protein 78) (Neutrophil-activating peptide ENA-78) (Small-inducible cytokine B5) [Cleaved into: ENA-78(8-78); ENA-78(9-78)]	CXCL5 ENA78 SCYB5	10642;	9606.ENSP00000296027;
Q8IZK6	MCLN2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mucolipin-2 (Transient receptor potential channel mucolipin 2) (TRPML2)	MCOLN2	13357;	9606.ENSP00000359640;
P59044	NLRP6_HUMAN	reviewed	Evidence at protein level	5 out of 5	NACHT, LRR and PYD domains-containing protein 6 (Angiotensin II/vasopressin receptor) (PYRIN-containing APAF1-like protein 5)	NLRP6 NALP6 PYPAF5	22944;	9606.ENSP00000309767;
Q9UK39	NOCT_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nocturnin (EC 3.1.3.108) (Carbon catabolite repression 4-like protein)	NOCT CCR4 CCRN4L NOC	14254;	9606.ENSP00000280614;
Q96LT7	CI072_HUMAN	reviewed	Evidence at protein level	5 out of 5	Guanine nucleotide exchange factor C9orf72	C9orf72 DENND9 DENNL72	28337;	9606.ENSP00000482753;
P0C0L4	CO4A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Complement C4-A (Acidic complement C4) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 2) [Cleaved into: Complement C4 beta chain; Complement C4-A alpha chain; C4a anaphylatoxin; C4b-A; C4d-A; Complement C4 gamma chain]	C4A CO4 CPAMD2	1323;	9606.ENSP00000396688;
Q99829	CPNE1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Copine-1 (Chromobindin 17) (Copine I)	CPNE1 CPN1	2314;	9606.ENSP00000317257;
Q08211	DHX9_HUMAN	reviewed	Evidence at protein level	5 out of 5	ATP-dependent RNA helicase A (EC 3.6.4.13) (DEAH box protein 9) (DExH-box helicase 9) (Leukophysin) (LKP) (Nuclear DNA helicase II) (NDH II) (RNA helicase A)	DHX9 DDX9 LKP NDH2	2750;	9606.ENSP00000356520;
Q8TE73	DYH5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5)	DNAH5 DNAHC5 HL1 KIAA1603	2950;	9606.ENSP00000265104;
Q8NAC3	I17RC_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-17 receptor C (IL-17 receptor C) (IL-17RC) (Interleukin-17 receptor homolog) (IL17Rhom) (Interleukin-17 receptor-like protein) (IL-17RL) (ZcytoR14)	IL17RC UNQ6118/PRO20040/PRO38901	18358;	9606.ENSP00000295981;
P05231	IL6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-6 (IL-6) (B-cell stimulatory factor 2) (BSF-2) (CTL differentiation factor) (CDF) (Hybridoma growth factor) (Interferon beta-2) (IFN-beta-2)	IL6 IFNB2	6018;	9606.ENSP00000385675;
P15260	INGR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interferon gamma receptor 1 (IFN-gamma receptor 1) (IFN-gamma-R1) (CDw119) (Interferon gamma receptor alpha-chain) (IFN-gamma-R-alpha) (CD antigen CD119)	IFNGR1	5439;	9606.ENSP00000356713;
Q9BXW9	FACD2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Fanconi anemia group D2 protein (Protein FACD2)	FANCD2 FACD	3585;	9606.ENSP00000287647;
P36268	GGT2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Inactive glutathione hydrolase 2 (Gamma-glutamyltransferase 2 pseudogene) (Inactive gamma-glutamyltranspeptidase 2) (GGT 2)	GGT2P GGT2	4251;	9606.ENSP00000385721;
Q86YC3	LRC33_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transforming growth factor beta activator LRRC33 (Leucine-rich repeat-containing protein 33) (Negative regulator of reactive oxygen species)	NRROS LRRC33 UNQ3030/PRO9833	24613;	9606.ENSP00000328625;
P26022	PTX3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Pentraxin-related protein PTX3 (Pentaxin-related protein PTX3) (Tumor necrosis factor alpha-induced protein 5) (TNF alpha-induced protein 5) (Tumor necrosis factor-inducible gene 14 protein) (TSG-14)	PTX3 TNFAIP5 TSG14	9692;	9606.ENSP00000295927;
Q14914	PTGR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Prostaglandin reductase 1 (PRG-1) (15-oxoprostaglandin 13-reductase) (EC 1.3.1.48) (Dithiolethione-inducible gene 1 protein) (D3T-inducible gene 1 protein) (DIG-1) (Leukotriene B4 12-hydroxydehydrogenase) (NAD(P)H-dependent alkenal/one oxidoreductase) (EC 1.3.1.74)	PTGR1 LTB4DH	18429;	9606.ENSP00000385763;
Q6UW15	REG3G_HUMAN	reviewed	Evidence at protein level	5 out of 5	Regenerating islet-derived protein 3-gamma (REG-3-gamma) (Pancreatitis-associated protein 1B) (PAP-1B) (Pancreatitis-associated protein IB) (PAP IB) (Regenerating islet-derived protein III-gamma) (REG III) (Reg III-gamma) [Cleaved into: Regenerating islet-derived protein 3-gamma 16.5 kDa form; Regenerating islet-derived protein 3-gamma 15 kDa form]	REG3G PAP1B UNQ429/PRO162	29595;	9606.ENSP00000272324;
Q9BYZ8	REG4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Regenerating islet-derived protein 4 (REG-4) (Gastrointestinal secretory protein) (REG-like protein) (Regenerating islet-derived protein IV) (Reg IV)	REG4 GISP RELP	22977;	9606.ENSP00000346158;
Q95460	HMR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Major histocompatibility complex class I-related gene protein (MHC class I-related gene protein) (Class I histocompatibility antigen-like protein)	MR1	4975;	9606.ENSP00000477563;
P11142	HSP7C_HUMAN	reviewed	Evidence at protein level	5 out of 5	Heat shock cognate 71 kDa protein (EC 3.6.4.10) (Heat shock 70 kDa protein 8) (Lipopolysaccharide-associated protein 1) (LAP-1) (LPS-associated protein 1)	HSPA8 HSC70 HSP73 HSPA10	5241;	9606.ENSP00000432083;
P51460	INSL3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Insulin-like 3 (Leydig insulin-like peptide) (Ley-I-L) (Relaxin-like factor) [Cleaved into: Insulin-like 3 B chain; Insulin-like 3 A chain]	INSL3 RLF RLNL	6086;	9606.ENSP00000369017;
O00453	LST1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Leukocyte-specific transcript 1 protein (Protein B144)	LST1 B144	14189;	9606.ENSP00000365261;
Q07869	PPARA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Peroxisome proliferator-activated receptor alpha (PPAR-alpha) (Nuclear receptor subfamily 1 group C member 1)	PPARA NR1C1 PPAR	9232;	9606.ENSP00000385523;
Q96RQ9	OXLA_HUMAN	reviewed	Evidence at protein level	5 out of 5	L-amino-acid oxidase (LAAO) (LAO) (EC 1.4.3.2) (EC 1.4.3.25) (Interleukin-4-induced protein 1) (IL4-induced protein 1) (hIL4I1) (Protein Fig-1) (hFIG1)	IL4I1 FIG1 UNQ636/PRO1265	19094;	9606.ENSP00000472474;
P05121	PAI1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Plasminogen activator inhibitor 1 (PAI) (PAI-1) (Endothelial plasminogen activator inhibitor) (Serpin E1)	SERPINE1 PAI1 PLANH1	8583;	9606.ENSP00000223095;
P47712	PA24A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cytosolic phospholipase A2 (cPLA2) (Phospholipase A2 group IVA) [Includes: Phospholipase A2 (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase); Lysophospholipase (EC 3.1.1.5)]	PLA2G4A CPLA2 PLA2G4	9035;	9606.ENSP00000356436;
Q9Y624	JAM1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Junctional adhesion molecule A (JAM-A) (Junctional adhesion molecule 1) (JAM-1) (Platelet F11 receptor) (Platelet adhesion molecule 1) (PAM-1) (CD antigen CD321)	F11R JAM1 JCAM UNQ264/PRO301	14685;	9606.ENSP00000357005;
Q14653	IRF3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interferon regulatory factor 3 (IRF-3)	IRF3	6118;	9606.ENSP00000471896;
Q96PC5	MIA2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Melanoma inhibitory activity protein 2 (MIA protein 2) (CTAGE family member 5 ER export factor) (Cutaneous T-cell lymphoma-associated antigen 5) (Meningioma-expressed antigen 6/11)	MIA2 CTAGE5 MEA11 MEA6 MGEA11 MGEA6	18432;	9606.ENSP00000452252;
P46734	MP2K3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Dual specificity mitogen-activated protein kinase kinase 3 (MAP kinase kinase 3) (MAPKK 3) (EC 2.7.12.2) (MAPK/ERK kinase 3) (MEK 3) (Stress-activated protein kinase kinase 2) (SAPK kinase 2) (SAPKK-2) (SAPKK2)	MAP2K3 MEK3 MKK3 PRKMK3 SKK2	6843;	9606.ENSP00000345083;
P52564	MP2K6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (MAPK/ERK kinase 6) (MEK 6) (Stress-activated protein kinase kinase 3) (SAPK kinase 3) (SAPKK-3) (SAPKK3)	MAP2K6 MEK6 MKK6 PRKMK6 SKK3	6846;	9606.ENSP00000468348;
Q15743	OGR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ovarian cancer G-protein coupled receptor 1 (OGR-1) (G-protein coupled receptor 68) (GPR12A) (Sphingosylphosphorylcholine receptor)	GPR68 OGR1	4519;	9606.ENSP00000434045;
P42345	MTOR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1)	MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1	3942;	9606.ENSP00000354558;
Q96GX9	MTNB_HUMAN	reviewed	Evidence at protein level	5 out of 5	Methylthioribulose-1-phosphate dehydratase (MTRu-1-P dehydratase) (EC 4.2.1.109) (APAF1-interacting protein) (hAPIP)	APIP CGI-29	17581;	9606.ENSP00000379133;
P33527	MRP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter)	ABCC1 MRP MRP1	51;	9606.ENSP00000382342;
Q14995	NR1D2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nuclear receptor subfamily 1 group D member 2 (Orphan nuclear hormone receptor BD73) (Rev-erb alpha-related receptor) (RVR) (Rev-erb-beta) (V-erbA-related protein 1-related) (EAR-1R)	NR1D2	7963;	9606.ENSP00000310006;
P15428	PGDH_HUMAN	reviewed	Evidence at protein level	5 out of 5	15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Eicosanoid/docosanoid dehydrogenase [NAD(+)]) (EC 1.1.1.-) (EC 1.1.1.232) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1)	HPGD PGDH1 SDR36C1	5154;	9606.ENSP00000296522;
Q99683	M3K5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mitogen-activated protein kinase kinase kinase 5 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 1) (ASK-1) (MAPK/ERK kinase kinase 5) (MEK kinase 5) (MEKK 5)	MAP3K5 ASK1 MAPKKK5 MEKK5	6857;	9606.ENSP00000351908;
O15296	LX15B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Polyunsaturated fatty acid lipoxygenase ALOX15B (15-lipoxygenase 2) (15-LOX-2) (Arachidonate 15-lipoxygenase B) (15-LOX-B) (EC 1.13.11.33) (Arachidonate 15-lipoxygenase type II) (Linoleate 13-lipoxygenase 15-LOb) (EC 1.13.11.-)	ALOX15B	434;	9606.ENSP00000369530;
Q9BS40	LXN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Latexin (Endogenous carboxypeptidase inhibitor) (ECI) (Protein MUM) (Tissue carboxypeptidase inhibitor) (TCI)	LXN	13347;	9606.ENSP00000264265;
Q96P20	NLRP3_HUMAN	reviewed	Evidence at protein level	5 out of 5	NACHT, LRR and PYD domains-containing protein 3 (Angiotensin/vasopressin receptor AII/AVP-like) (Caterpiller protein 1.1) (CLR1.1) (Cold-induced autoinflammatory syndrome 1 protein) (Cryopyrin) (PYRIN-containing APAF1-like protein 1)	NLRP3 C1orf7 CIAS1 NALP3 PYPAF1	16400;	9606.ENSP00000337383;
Q99735	MGST2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Microsomal glutathione S-transferase 2 (Microsomal GST-2) (EC 2.5.1.18) (Glutathione peroxidase MGST2) (EC 1.11.1.-) (Leukotriene C4 synthase MGST2) (EC 4.4.1.20) (Microsomal glutathione S-transferase II) (Microsomal GST-II)	MGST2 GST2	7063;	9606.ENSP00000482639;
Q92570	NR4A3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nuclear receptor subfamily 4 group A member 3 (Mitogen-induced nuclear orphan receptor) (Neuron-derived orphan receptor 1) (Nuclear hormone receptor NOR-1)	NR4A3 CHN CSMF MINOR NOR1 TEC	7982;	9606.ENSP00000482027;
O00482	NR5A2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nuclear receptor subfamily 5 group A member 2 (Alpha-1-fetoprotein transcription factor) (B1-binding factor) (hB1F) (CYP7A promoter-binding factor) (Hepatocytic transcription factor) (Liver receptor homolog 1) (LRH-1)	NR5A2 B1F CPF FTF	7984;	9606.ENSP00000356331;
Q9Y3C5	RNF11_HUMAN	reviewed	Evidence at protein level	5 out of 5	RING finger protein 11	RNF11 CGI-123	10056;	9606.ENSP00000242719;
P00748	FA12_HUMAN	reviewed	Evidence at protein level	5 out of 5	Coagulation factor XII (EC 3.4.21.38) (Hageman factor) (HAF) [Cleaved into: Coagulation factor XIIa heavy chain; Beta-factor XIIa part 1; Coagulation factor XIIa light chain (Beta-factor XIIa part 2)]	F12	3530;	9606.ENSP00000253496;
Q12946	FOXF1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Forkhead box protein F1 (Forkhead-related activator 1) (FREAC-1) (Forkhead-related protein FKHL5) (Forkhead-related transcription factor 1)	FOXF1 FKHL5 FREAC1	3809;	9606.ENSP00000262426;
Q9H3N8	HRH4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Histamine H4 receptor (H4R) (HH4R) (AXOR35) (G-protein coupled receptor 105) (GPRv53) (Pfi-013) (SP9144)	HRH4 GPCR105	17383;	9606.ENSP00000256906;
O95197	RTN3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Reticulon-3 (Homolog of ASY protein) (HAP) (Neuroendocrine-specific protein-like 2) (NSP-like protein 2) (Neuroendocrine-specific protein-like II) (NSP-like protein II) (NSPLII)	RTN3 ASYIP NSPL2	10469;	9606.ENSP00000367050;
Q9NQC3	RTN4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Reticulon-4 (Foocen) (Neurite outgrowth inhibitor) (Nogo protein) (Neuroendocrine-specific protein) (NSP) (Neuroendocrine-specific protein C homolog) (RTN-x) (Reticulon-5)	RTN4 KIAA0886 NOGO My043 SP1507	14085;	9606.ENSP00000337838;
Q5TD94	RSH4A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Radial spoke head protein 4 homolog A (Radial spoke head-like protein 3)	RSPH4A RSHL3	21558;	9606.ENSP00000229554;
P37840	SYUA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Alpha-synuclein (Non-A beta component of AD amyloid) (Non-A4 component of amyloid precursor) (NACP)	SNCA NACP PARK1	11138;	9606.ENSP00000338345;
P54136	SYRC_HUMAN	reviewed	Evidence at protein level	5 out of 5	Arginine--tRNA ligase, cytoplasmic (EC 6.1.1.19) (Arginyl-tRNA synthetase) (ArgRS)	RARS1 RARS	9870;	9606.ENSP00000231572;
Q96A25	T106A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transmembrane protein 106A	TMEM106A	28288;	9606.ENSP00000483246;
Q14242	SELPL_HUMAN	reviewed	Evidence at protein level	5 out of 5	P-selectin glycoprotein ligand 1 (PSGL-1) (Selectin P ligand) (CD antigen CD162)	SELPLG	10722;	9606.ENSP00000228463;
Q16831	UPP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Uridine phosphorylase 1 (UPase 1) (UrdPase 1) (EC 2.4.2.3)	UPP1 UP	12576;	9606.ENSP00000330032;
Q06141	REG3A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Regenerating islet-derived protein 3-alpha (REG-3-alpha) (Hepatointestinal pancreatic protein) (HIP/PAP) (Human proislet peptide) (Pancreatitis-associated protein 1) (Regenerating islet-derived protein III-alpha) (Reg III-alpha) [Cleaved into: Regenerating islet-derived protein 3-alpha 16.5 kDa form; Regenerating islet-derived protein 3-alpha 15 kDa form]	REG3A HIP PAP PAP1	8601;	9606.ENSP00000377456;
Q9NRR4	RNC_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ribonuclease 3 (EC 3.1.26.3) (Protein Drosha) (Ribonuclease III) (RNase III) (p241)	DROSHA RN3 RNASE3L RNASEN	17904;	9606.ENSP00000425979;
Q86WV6	STING_HUMAN	reviewed	Evidence at protein level	5 out of 5	Stimulator of interferon genes protein (hSTING) (Endoplasmic reticulum interferon stimulator) (ERIS) (Mediator of IRF3 activation) (hMITA) (Transmembrane protein 173)	STING1 ERIS MITA STING TMEM173	27962;	9606.ENSP00000331288;
Q9H6I2	SOX17_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transcription factor SOX-17	SOX17	18122;	9606.ENSP00000297316;
P12931	SRC_HUMAN	reviewed	Evidence at protein level	5 out of 5	Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)	SRC SRC1	11283;	9606.ENSP00000362680;
Q9UGK3	STAP2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Signal-transducing adaptor protein 2 (STAP-2) (Breast tumor kinase substrate) (BRK substrate)	STAP2 BKS	30430;	
Q14134	TRI29_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tripartite motif-containing protein 29 (Ataxia telangiectasia group D-associated protein)	TRIM29 ATDC	17274;	9606.ENSP00000343129;
Q6P9F5	TRI40_HUMAN	reviewed	Evidence at protein level	5 out of 5	E3 ubiquitin ligase TRIM40 (EC 2.3.2.27) (Probable E3 NEDD8-protein ligase) (RING finger protein 35)	TRIM40 RNF35	18736;	9606.ENSP00000379826;
P07814	SYEP_HUMAN	reviewed	Evidence at protein level	5 out of 5	Bifunctional glutamate/proline--tRNA ligase (Bifunctional aminoacyl-tRNA synthetase) (Cell proliferation-inducing gene 32 protein) (Glutamatyl-prolyl-tRNA synthetase) [Includes: Glutamate--tRNA ligase (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS); Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase)]	EPRS1 EPRS GLNS PARS QARS QPRS PIG32	3418;	9606.ENSP00000355890;
P19320	VCAM1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Vascular cell adhesion protein 1 (V-CAM 1) (VCAM-1) (INCAM-100) (CD antigen CD106)	VCAM1	12663;	9606.ENSP00000294728;
Q86VP1	TAXB1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tax1-binding protein 1 (TRAF6-binding protein)	TAX1BP1 T6BP PRO0105	11575;	9606.ENSP00000379612;
P39019	RS19_HUMAN	reviewed	Evidence at protein level	5 out of 5	40S ribosomal protein S19 (Small ribosomal subunit protein eS19)	RPS19	10402;	9606.ENSP00000470972;
Q9H1X1	RSPH9_HUMAN	reviewed	Evidence at protein level	5 out of 5	Radial spoke head protein 9 homolog	RSPH9 C6orf206 MRPS18AL1	21057;	9606.ENSP00000361238;
P05109	S10A8_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein S100-A8 (Calgranulin-A) (Calprotectin L1L subunit) (Cystic fibrosis antigen) (CFAG) (Leukocyte L1 complex light chain) (Migration inhibitory factor-related protein 8) (MRP-8) (p8) (S100 calcium-binding protein A8) (Urinary stone protein band A)	S100A8 CAGA CFAG MRP8	10498;	9606.ENSP00000357722;
P06702	S10A9_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein S100-A9 (Calgranulin-B) (Calprotectin L1H subunit) (Leukocyte L1 complex heavy chain) (Migration inhibitory factor-related protein 14) (MRP-14) (p14) (S100 calcium-binding protein A9)	S100A9 CAGB CFAG MRP14	10499;	9606.ENSP00000357727;
P49589	SYCC_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cysteine--tRNA ligase, cytoplasmic (EC 6.1.1.16) (Cysteinyl-tRNA synthetase) (CysRS)	CARS1 CARS	1493;	9606.ENSP00000369897;
O75151	PHF2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Lysine-specific demethylase PHF2 (EC 1.14.11.-) (GRC5) (PHD finger protein 2)	PHF2 CENP-35 KIAA0662	8920;	9606.ENSP00000352185;
Q6UWF3	SCIMP_HUMAN	reviewed	Evidence at protein level	5 out of 5	SLP adapter and CSK-interacting membrane protein (SLP65/SLP76, Csk-interacting membrane protein)	SCIMP C17orf87 UNQ5783/PRO16090	33504;	9606.ENSP00000461269;
P62937	PPIA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Peptidyl-prolyl cis-trans isomerase A (PPIase A) (EC 5.2.1.8) (Cyclophilin A) (Cyclosporin A-binding protein) (Rotamase A) [Cleaved into: Peptidyl-prolyl cis-trans isomerase A, N-terminally processed]	PPIA CYPA	9253;	9606.ENSP00000419425;
Q03181	PPARD_HUMAN	reviewed	Evidence at protein level	5 out of 5	Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta)	PPARD NR1C2 PPARB	9235;	9606.ENSP00000310928;
Q9UKY4	POMT2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein O-mannosyl-transferase 2 (EC 2.4.1.109) (Dolichyl-phosphate-mannose--protein mannosyltransferase 2)	POMT2	19743;	9606.ENSP00000261534;
P49768	PSN1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Presenilin-1 (PS-1) (EC 3.4.23.-) (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12 (PS1-CTF12)]	PSEN1 AD3 PS1 PSNL1	9508;	9606.ENSP00000326366;
P03973	SLPI_HUMAN	reviewed	Evidence at protein level	5 out of 5	Antileukoproteinase (ALP) (BLPI) (HUSI-1) (Mucus proteinase inhibitor) (MPI) (Protease inhibitor WAP4) (Secretory leukocyte protease inhibitor) (Seminal proteinase inhibitor) (WAP four-disulfide core domain protein 4)	SLPI WAP4 WFDC4	11092;	9606.ENSP00000342082;
P02788	TRFL_HUMAN	reviewed	Evidence at protein level	5 out of 5	Lactotransferrin (Lactoferrin) (EC 3.4.21.-) (Growth-inhibiting protein 12) (Talalactoferrin) [Cleaved into: Lactoferricin-H (Lfcin-H); Kaliocin-1; Lactoferroxin-A; Lactoferroxin-B; Lactoferroxin-C]	LTF GIG12 LF	6720;	9606.ENSP00000231751;
Q15628	TRADD_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tumor necrosis factor receptor type 1-associated DEATH domain protein (TNFR1-associated DEATH domain protein) (TNFRSF1A-associated via death domain)	TRADD	12030;	9606.ENSP00000341268;
Q9BXR5	TLR10_HUMAN	reviewed	Evidence at protein level	5 out of 5	Toll-like receptor 10 (CD antigen CD290)	TLR10 UNQ315/PRO358	15634;	9606.ENSP00000308925;
O43541	SMAD6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mothers against decapentaplegic homolog 6 (MAD homolog 6) (Mothers against DPP homolog 6) (SMAD family member 6) (SMAD 6) (Smad6) (hSMAD6)	SMAD6 MADH6	6772;	9606.ENSP00000288840;
O75159	SOCS5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Suppressor of cytokine signaling 5 (SOCS-5) (Cytokine-inducible SH2 protein 6) (CIS-6) (Cytokine-inducible SH2-containing protein 5)	SOCS5 CIS6 CISH5 CISH6 KIAA0671	16852;	9606.ENSP00000305133;
Q96CG3	TIFA_HUMAN	reviewed	Evidence at protein level	5 out of 5	TRAF-interacting protein with FHA domain-containing protein A (Putative MAPK-activating protein PM14) (Putative NF-kappa-B-activating protein 20) (TRAF2-binding protein)	TIFA T2BP	19075;	9606.ENSP00000354911;
Q8WXG1	RSAD2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Radical S-adenosyl methionine domain-containing protein 2 (EC 4.2.-.-) (Cytomegalovirus-induced gene 5 protein) (Viperin) (Virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible)	RSAD2 CIG5	30908;	9606.ENSP00000371471;
Q99576	T22D3_HUMAN	reviewed	Evidence at protein level	5 out of 5	TSC22 domain family protein 3 (DSIP-immunoreactive peptide) (Protein DIP) (hDIP) (Delta sleep-inducing peptide immunoreactor) (Glucocorticoid-induced leucine zipper protein) (GILZ) (TSC-22-like protein) (TSC-22-related protein) (TSC-22R)	TSC22D3 DSIPI GILZ	3051;	9606.ENSP00000361458;
Q15046	SYK_HUMAN	reviewed	Evidence at protein level	5 out of 5	Lysine--tRNA ligase (EC 2.7.7.-) (EC 6.1.1.6) (Lysyl-tRNA synthetase) (LysRS)	KARS1 KARS KIAA0070	6215;	9606.ENSP00000325448;
Q9Y3Z3	SAMH1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-) (Dendritic cell-derived IFNG-induced protein) (DCIP) (Monocyte protein 5) (MOP-5) (SAM domain and HD domain-containing protein 1) (hSAMHD1)	SAMHD1 MOP5	15925;	9606.ENSP00000262878;
Q96KG9	SCYL1_HUMAN	reviewed	Evidence at protein level	5 out of 5	N-terminal kinase-like protein (Coated vesicle-associated kinase of 90 kDa) (SCY1-like protein 1) (Telomerase regulation-associated protein) (Telomerase transcriptional element-interacting factor) (Teratoma-associated tyrosine kinase)	SCYL1 CVAK90 GKLP NTKL TAPK TEIF TRAP HT019	14372;	9606.ENSP00000270176;
P80511	S10AC_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein S100-A12 (CGRP) (Calcium-binding protein in amniotic fluid 1) (CAAF1) (Calgranulin-C) (CAGC) (Extracellular newly identified RAGE-binding protein) (EN-RAGE) (Migration inhibitory factor-related protein 6) (MRP-6) (p6) (Neutrophil S100 protein) (S100 calcium-binding protein A12) [Cleaved into: Calcitermin]	S100A12	10489;	9606.ENSP00000357726;
Q9UIK5	TEFF2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tomoregulin-2 (TR-2) (Hyperplastic polyposis protein 1) (Transmembrane protein with EGF-like and two follistatin-like domains)	TMEFF2 HPP1 TENB2 TPEF UNQ178/PRO204	11867;	9606.ENSP00000272771;
P17252	KPCA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein kinase C alpha type (PKC-A) (PKC-alpha) (EC 2.7.11.13)	PRKCA PKCA PRKACA	9393;	9606.ENSP00000408695;
P09917	LOX5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34)	ALOX5 LOG5	435;	9606.ENSP00000363512;
Q8IYG6	LRC56_HUMAN	reviewed	Evidence at protein level	5 out of 5	Leucine-rich repeat-containing protein 56	LRRC56	25430;	9606.ENSP00000270115;
Q14934	NFAC4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nuclear factor of activated T-cells, cytoplasmic 4 (NF-ATc4) (NFATc4) (T-cell transcription factor NFAT3) (NF-AT3)	NFATC4 NFAT3	7778;	9606.ENSP00000388910;
Q9ULZ9	MMP17_HUMAN	reviewed	Evidence at protein level	5 out of 5	Matrix metalloproteinase-17 (MMP-17) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 4) (MT-MMP 4) (MTMMP4) (Membrane-type-4 matrix metalloproteinase) (MT4-MMP) (MT4MMP)	MMP17 MT4MMP	7163;	9606.ENSP00000353767;
O60356	NUPR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nuclear protein 1 (Candidate of metastasis 1) (Protein p8)	NUPR1 COM1	29990;	
Q7Z494	NPHP3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nephrocystin-3	NPHP3 KIAA2000	7907;	9606.ENSP00000338766;
O14495	PLPP3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Phospholipid phosphatase 3 (EC 3.1.3.-) (EC 3.1.3.4) (Lipid phosphate phosphohydrolase 3) (PAP2-beta) (Phosphatidate phosphohydrolase type 2b) (Phosphatidic acid phosphatase 2b) (PAP-2b) (PAP2b) (Vascular endothelial growth factor and type I collagen-inducible protein) (VCIP)	PLPP3 LPP3 PPAP2B	9229;	9606.ENSP00000360296;
Q16647	PTGIS_HUMAN	reviewed	Evidence at protein level	5 out of 5	Prostacyclin synthase (EC 5.3.99.4) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152) (Prostaglandin I2 synthase)	PTGIS CYP8 CYP8A1	9603;	9606.ENSP00000244043;
P25105	PTAFR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Platelet-activating factor receptor (PAF-R) (PAFr)	PTAFR PAFR	9582;	9606.ENSP00000362965;
Q5K651	SAMD9_HUMAN	reviewed	Evidence at protein level	5 out of 5	Sterile alpha motif domain-containing protein 9 (SAM domain-containing protein 9)	SAMD9 C7orf5 DRIF1 KIAA2004 OEF1	1348;	9606.ENSP00000369292;
Q9BXS9	S26A6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Solute carrier family 26 member 6 (Anion exchange transporter) (Pendrin-like protein 1) (Pendrin-L1)	SLC26A6	14472;	9606.ENSP00000378920;
P49821	NDUV1_HUMAN	reviewed	Evidence at protein level	5 out of 5	NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (EC 7.1.1.2) (Complex I-51kD) (CI-51kD) (NADH dehydrogenase flavoprotein 1) (NADH-ubiquinone oxidoreductase 51 kDa subunit)	NDUFV1 UQOR1	7716;	9606.ENSP00000322450;
Q96NG3	ODAD4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Outer dynein arm-docking complex subunit 4 (Tetratricopeptide repeat protein 25) (TPR repeat protein 25)	ODAD4 TTC25	25280;	9606.ENSP00000478589;
A5D8V7	ODAD3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Outer dynein arm-docking complex subunit 3 (Coiled-coil domain-containing protein 151)	ODAD3 CCDC151	28303;	9606.ENSP00000348757;
Q5T2S8	ODAD2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Outer dynein arm-docking complex subunit 2 (Armadillo repeat-containing protein 4)	ODAD2 ARMC4	25583;	9606.ENSP00000306410;
Q15669	RHOH_HUMAN	reviewed	Evidence at protein level	5 out of 5	Rho-related GTP-binding protein RhoH (GTP-binding protein TTF) (Translocation three four protein)	RHOH ARHH TTF	686;	9606.ENSP00000371219;
Q00887	PSG9_HUMAN	reviewed	Evidence at protein level	5 out of 5	Pregnancy-specific beta-1-glycoprotein 9 (PS-beta-G-9) (PSBG-9) (Pregnancy-specific glycoprotein 9) (PS34) (Pregnancy-specific beta-1 glycoprotein B) (PS-beta-B) (Pregnancy-specific beta-1-glycoprotein 11) (PS-beta-G-11) (PSBG-11) (Pregnancy-specific glycoprotein 11) (Pregnancy-specific glycoprotein 7) (PSG7)	PSG9 PSG11	9526;	9606.ENSP00000270077;
Q05397	FAK1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein phosphatase 1 regulatory subunit 71) (PPP1R71) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK)	PTK2 FAK FAK1	9611;	9606.ENSP00000341189;
P04406	G3P_HUMAN	reviewed	Evidence at protein level	5 out of 5	Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) (Peptidyl-cysteine S-nitrosylase GAPDH) (EC 2.6.99.-)	GAPDH GAPD CDABP0047 OK/SW-cl.12	4141;	9606.ENSP00000229239;
P21462	FPR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	fMet-Leu-Phe receptor (fMLP receptor) (N-formyl peptide receptor) (FPR) (N-formylpeptide chemoattractant receptor)	FPR1	3826;	9606.ENSP00000471493;
Q5JWF2	GNAS1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas (Adenylate cyclase-stimulating G alpha protein) (Extra large alphas protein) (XLalphas)	GNAS GNAS1	4392;	9606.ENSP00000360141;
P04899	GNAI2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Guanine nucleotide-binding protein G(i) subunit alpha-2 (Adenylate cyclase-inhibiting G alpha protein)	GNAI2 GNAI2B	4385;	9606.ENSP00000312999;
Q03013	GSTM4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Glutathione S-transferase Mu 4 (EC 2.5.1.18) (GST class-mu 4) (GST-Mu2) (GSTM4-4) (Leukotriene C4 synthase GSTM4) (EC 4.4.1.20)	GSTM4	4636;	9606.ENSP00000358851;
Q8TDQ0	HAVR2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Hepatitis A virus cellular receptor 2 (HAVcr-2) (T-cell immunoglobulin and mucin domain-containing protein 3) (TIMD-3) (T-cell immunoglobulin mucin receptor 3) (TIM-3) (T-cell membrane protein 3) (CD antigen CD366)	HAVCR2 TIM3 TIMD3	18437;	9606.ENSP00000312002;
P25103	NK1R_HUMAN	reviewed	Evidence at protein level	5 out of 5	Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)	TACR1 NK1R TAC1R	11526;	9606.ENSP00000303522;
Q8NET5	NFAM1_HUMAN	reviewed	Evidence at protein level	5 out of 5	NFAT activation molecule 1 (Calcineurin/NFAT-activating ITAM-containing protein) (NFAT-activating protein with ITAM motif 1)	NFAM1 CNAIP	29872;	9606.ENSP00000333680;
Q99527	GPER1_HUMAN	reviewed	Evidence at protein level	5 out of 5	G-protein coupled estrogen receptor 1 (Chemoattractant receptor-like 2) (Flow-induced endothelial G-protein coupled receptor 1) (FEG-1) (G protein-coupled estrogen receptor 1) (G-protein coupled receptor 30) (GPCR-Br) (IL8-related receptor DRY12) (Lymphocyte-derived G-protein coupled receptor) (LYGPR) (Membrane estrogen receptor) (mER)	GPER1 CEPR CMKRL2 DRY12 GPER GPR30	4485;	9606.ENSP00000380281;
Q96D42	HAVR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Hepatitis A virus cellular receptor 1 (HAVcr-1) (Kidney injury molecule 1) (KIM-1) (T-cell immunoglobulin and mucin domain-containing protein 1) (TIMD-1) (T-cell immunoglobulin mucin receptor 1) (TIM) (TIM-1) (T-cell membrane protein 1) (CD antigen CD365)	HAVCR1 KIM1 TIM1 TIMD1	17866;	9606.ENSP00000344844;
P55055	NR1H2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Oxysterols receptor LXR-beta (Liver X receptor beta) (Nuclear receptor NER) (Nuclear receptor subfamily 1 group H member 2) (Ubiquitously-expressed nuclear receptor)	NR1H2 LXRB NER UNR	7965;	9606.ENSP00000253727;
O14494	PLPP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Phospholipid phosphatase 1 (EC 3.1.3.-) (EC 3.1.3.106) (EC 3.1.3.4) (EC 3.1.3.81) (Lipid phosphate phosphohydrolase 1) (PAP2-alpha) (Phosphatidate phosphohydrolase type 2a) (Phosphatidic acid phosphatase 2a) (PAP-2a) (PAP2a)	PLPP1 LPP1 PPAP2A	9228;	
P37231	PPARG_HUMAN	reviewed	Evidence at protein level	5 out of 5	Peroxisome proliferator-activated receptor gamma (PPAR-gamma) (Nuclear receptor subfamily 1 group C member 3)	PPARG NR1C3	9236;	9606.ENSP00000287820;
P28715	ERCC5_HUMAN	reviewed	Evidence at protein level	5 out of 5	DNA excision repair protein ERCC-5 (EC 3.1.-.-) (DNA repair protein complementing XP-G cells) (Xeroderma pigmentosum group G-complementing protein)	ERCC5 ERCM2 XPG XPGC	3437;	9606.ENSP00000347978;
Q8WXC3	PYDC1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Pyrin domain-containing protein 1 (PAAD-only protein 1) (Pyrin-only protein 1) (cellular POP1) (cPOP1)	PYDC1 ASC2 ASCI POP1 PYC1	30261;	9606.ENSP00000304336;
Q96CC6	RHDF1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Inactive rhomboid protein 1 (iRhom1) (Epidermal growth factor receptor-related protein) (Rhomboid 5 homolog 1) (Rhomboid family member 1) (p100hRho)	RHBDF1 C16orf8 DIST1 IRHOM1	20561;	9606.ENSP00000262316;
P13521	SCG2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Secretogranin-2 (Chromogranin-C) (Secretogranin II) (SgII) [Cleaved into: Secretoneurin (SN); Manserin]	SCG2 CHGC	10575;	9606.ENSP00000304133;
Q15858	SCN9A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Sodium channel protein type 9 subunit alpha (Neuroendocrine sodium channel) (hNE-Na) (Peripheral sodium channel 1) (PN1) (Sodium channel protein type IX subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.7)	SCN9A NENA	10597;	9606.ENSP00000386306;
Q13291	SLAF1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Signaling lymphocytic activation molecule (CDw150) (IPO-3) (SLAM family member 1) (CD antigen CD150)	SLAMF1 SLAM	10903;	9606.ENSP00000306190;
O14508	SOCS2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Suppressor of cytokine signaling 2 (SOCS-2) (Cytokine-inducible SH2 protein 2) (CIS-2) (STAT-induced STAT inhibitor 2) (SSI-2)	SOCS2 CIS2 SSI2 STATI2	19382;	9606.ENSP00000481249;
Q9NVD3	SETD4_HUMAN	reviewed	Evidence at protein level	5 out of 5	SET domain-containing protein 4 (EC 2.1.1.-) (EC 2.1.1.364)	SETD4 C21orf18 C21orf27	1258;	9606.ENSP00000382163;
Q8TBK2	SETD6_HUMAN	reviewed	Evidence at protein level	5 out of 5	N-lysine methyltransferase SETD6 (EC 2.1.1.-) (SET domain-containing protein 6)	SETD6	26116;	9606.ENSP00000219315;
Q6IA17	SIGIR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Single Ig IL-1-related receptor (Single Ig IL-1R-related molecule) (Single immunoglobulin domain-containing IL1R-related protein) (Toll/interleukin-1 receptor 8) (TIR8)	SIGIRR UNQ301/PRO342	30575;	9606.ENSP00000403104;
Q9UHJ6	SHPK_HUMAN	reviewed	Evidence at protein level	5 out of 5	Sedoheptulokinase (SHK) (EC 2.7.1.14) (Carbohydrate kinase-like protein)	SHPK CARKL	1492;	9606.ENSP00000225519;
P78324	SHPS1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tyrosine-protein phosphatase non-receptor type substrate 1 (SHP substrate 1) (SHPS-1) (Brain Ig-like molecule with tyrosine-based activation motifs) (Bit) (CD172 antigen-like family member A) (Inhibitory receptor SHPS-1) (Macrophage fusion receptor) (MyD-1 antigen) (Signal-regulatory protein alpha-1) (Sirp-alpha-1) (Signal-regulatory protein alpha-2) (Sirp-alpha-2) (Signal-regulatory protein alpha-3) (Sirp-alpha-3) (p84) (CD antigen CD172a)	SIRPA BIT MFR MYD1 PTPNS1 SHPS1 SIRP	9662;	9606.ENSP00000382941;
Q96EB6	SIR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	NAD-dependent protein deacetylase sirtuin-1 (hSIRT1) (EC 2.3.1.286) (NAD-dependent protein deacylase sirtuin-1) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 1) (SIR2-like protein 1) (hSIR2) [Cleaved into: SirtT1 75 kDa fragment (75SirT1)]	SIRT1 SIR2L1	14929;	9606.ENSP00000212015;
Q9H0F6	SHRPN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Sharpin (Shank-associated RH domain-interacting protein) (Shank-interacting protein-like 1) (hSIPL1)	SHARPIN SIPL1 PSEC0216	25321;	9606.ENSP00000381698;
Q8WXD0	RXFP2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Relaxin receptor 2 (G-protein coupled receptor 106) (G-protein coupled receptor affecting testicular descent) (Leucine-rich repeat-containing G-protein coupled receptor 8) (Relaxin family peptide receptor 2)	RXFP2 GPR106 GREAT LGR8	17318;	9606.ENSP00000298386;
Q8N695	SC5A8_HUMAN	reviewed	Evidence at protein level	5 out of 5	Sodium-coupled monocarboxylate transporter 1 (Apical iodide transporter) (Electrogenic sodium monocarboxylate cotransporter) (Sodium iodide-related cotransporter) (Solute carrier family 5 member 8)	SLC5A8 AIT SMCT SMCT1	19119;	9606.ENSP00000445340;
P18827	SDC1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Syndecan-1 (SYND1) (CD antigen CD138)	SDC1 SDC	10658;	9606.ENSP00000370542;
P51692	STA5B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Signal transducer and activator of transcription 5B	STAT5B	11367;	9606.ENSP00000293328;
Q8WX94	NALP7_HUMAN	reviewed	Evidence at protein level	5 out of 5	NACHT, LRR and PYD domains-containing protein 7 (Nucleotide-binding oligomerization domain protein 12) (PYRIN-containing APAF1-like protein 3)	NLRP7 NALP7 NOD12 PYPAF3	22947;	9606.ENSP00000467123;
P43490	NAMPT_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nicotinamide phosphoribosyltransferase (NAmPRTase) (Nampt) (EC 2.4.2.12) (Pre-B-cell colony-enhancing factor 1) (Pre-B cell-enhancing factor) (Visfatin)	NAMPT PBEF PBEF1	30092;	9606.ENSP00000222553;
P04054	PA21B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Phospholipase A2 (EC 3.1.1.4) (Group IB phospholipase A2) (Phosphatidylcholine 2-acylhydrolase 1B)	PLA2G1B PLA2 PLA2A PPLA2	9030;	9606.ENSP00000312286;
Q86XR7	TCAM2_HUMAN	reviewed	Evidence at protein level	5 out of 5	TIR domain-containing adapter molecule 2 (TICAM-2) (Putative NF-kappa-B-activating protein 502) (TRIF-related adapter molecule) (Toll-like receptor adaptor protein 3) (Toll/interleukin-1 receptor domain-containing protein) (MyD88-4)	TICAM2 TIRAP3 TIRP TRAM	21354;	9606.ENSP00000415139;
O60733	PLPL9_HUMAN	reviewed	Evidence at protein level	5 out of 5	85/88 kDa calcium-independent phospholipase A2 (CaI-PLA2) (EC 3.1.1.4) (2-lysophosphatidylcholine acylhydrolase) (EC 3.1.1.5) (Group VI phospholipase A2) (GVI PLA2) (Intracellular membrane-associated calcium-independent phospholipase A2 beta) (iPLA2-beta) (Palmitoyl-CoA hydrolase) (EC 3.1.2.2) (Patatin-like phospholipase domain-containing protein 9) (PNPLA9)	PLA2G6 PLPLA9	9039;	9606.ENSP00000333142;
Q8WYR4	RSPH1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Radial spoke head 1 homolog (Cancer/testis antigen 79) (CT79) (Male meiotic metaphase chromosome-associated acidic protein) (Meichroacidin) (Testis-specific gene A2 protein)	RSPH1 TSA2 TSGA2	12371;	9606.ENSP00000291536;
P22692	IBP4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Insulin-like growth factor-binding protein 4 (IBP-4) (IGF-binding protein 4) (IGFBP-4)	IGFBP4 IBP4	5473;	9606.ENSP00000269593;
Q9GZX6	IL22_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-22 (IL-22) (Cytokine Zcyto18) (IL-10-related T-cell-derived-inducible factor) (IL-TIF)	IL22 ILTIF ZCYTO18 UNQ3099/PRO10096	14900;	9606.ENSP00000442424;
P61371	ISL1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Insulin gene enhancer protein ISL-1 (Islet-1)	ISL1	6132;	9606.ENSP00000230658;
P11215	ITAM_HUMAN	reviewed	Evidence at protein level	5 out of 5	Integrin alpha-M (CD11 antigen-like family member B) (CR-3 alpha chain) (Cell surface glycoprotein MAC-1 subunit alpha) (Leukocyte adhesion receptor MO1) (Neutrophil adherence receptor) (CD antigen CD11b)	ITGAM CD11B CR3A	6149;	9606.ENSP00000441691;
P20701	ITAL_HUMAN	reviewed	Evidence at protein level	5 out of 5	Integrin alpha-L (CD11 antigen-like family member A) (Leukocyte adhesion glycoprotein LFA-1 alpha chain) (LFA-1A) (Leukocyte function-associated molecule 1 alpha chain) (CD antigen CD11a)	ITGAL CD11A	6148;	9606.ENSP00000349252;
O75925	PIAS1_HUMAN	reviewed	Evidence at protein level	5 out of 5	E3 SUMO-protein ligase PIAS1 (EC 2.3.2.-) (DEAD/H box-binding protein 1) (E3 SUMO-protein transferase PIAS1) (Gu-binding protein) (GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein)	PIAS1 DDXBP1	2752;	9606.ENSP00000249636;
O14684	PTGES_HUMAN	reviewed	Evidence at protein level	5 out of 5	Prostaglandin E synthase (EC 5.3.99.3) (Glutathione peroxidase PTGES) (EC 1.11.1.-) (Glutathione transferase PTGES) (EC 2.5.1.18) (Microsomal glutathione S-transferase 1-like 1) (MGST1-L1) (Microsomal prostaglandin E synthase 1) (MPGES-1) (p53-induced gene 12 protein)	PTGES MGST1L1 MPGES1 PGES PIG12	9599;	9606.ENSP00000342385;
Q96LB1	MRGX2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mas-related G-protein coupled receptor member X2	MRGPRX2 MRGX2	17983;	9606.ENSP00000333800;
P00747	PLMN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Angiostatin; Plasmin heavy chain A, short form; Plasmin light chain B]	PLG	9071;	9606.ENSP00000308938;
Q13546	RIPK1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Receptor-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (Cell death protein RIP) (Receptor-interacting protein 1) (RIP-1)	RIPK1 RIP RIP1	10019;	9606.ENSP00000259808;
P10155	RO60_HUMAN	reviewed	Evidence at protein level	5 out of 5	RNA-binding protein RO60 (60 kDa SS-A/Ro ribonucleoprotein) (60 kDa Ro protein) (60 kDa ribonucleoprotein Ro) (RoRNP) (Ro 60 kDa autoantigen) (Ro60 autoantigen) (Sjoegren syndrome antigen A2) (Sjoegren syndrome type A antigen) (SS-A) (TROVE domain family member 2)	RO60 SSA2 TROVE2	11313;	9606.ENSP00000356416;
Q8N6T7	SIR6_HUMAN	reviewed	Evidence at protein level	5 out of 5	NAD-dependent protein deacylase sirtuin-6 (EC 2.3.1.-) (NAD-dependent protein deacetylase sirtuin-6) (EC 2.3.1.286) (Protein mono-ADP-ribosyltransferase sirtuin-6) (EC 2.4.2.-) (Regulatory protein SIR2 homolog 6) (hSIRT6) (SIR2-like protein 6)	SIRT6 SIR2L6	14934;	9606.ENSP00000337332;
Q9UNK4	PA2GD_HUMAN	reviewed	Evidence at protein level	5 out of 5	Group IID secretory phospholipase A2 (GIID sPLA2) (sPLA2-IID) (EC 3.1.1.4) (PLA2IID) (Phosphatidylcholine 2-acylhydrolase 2D) (Secretory-type PLA, stroma-associated homolog)	PLA2G2D SPLASH	9033;	9606.ENSP00000364246;
Q9NZ20	PA2G3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Group 3 secretory phospholipase A2 (EC 3.1.1.4) (Group III secretory phospholipase A2) (GIII sPLA2) (sPLA2-III) (Phosphatidylcholine 2-acylhydrolase 3)	PLA2G3	17934;	9606.ENSP00000215885;
P01286	SLIB_HUMAN	reviewed	Evidence at protein level	5 out of 5	Somatoliberin (Growth hormone-releasing factor) (GRF) (Growth hormone-releasing hormone) (GHRH) (Somatocrinin) (Somatorelin) (Sermorelin)	GHRH GHRF	4265;	9606.ENSP00000362716;
P00441	SODC_HUMAN	reviewed	Evidence at protein level	5 out of 5	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1) (Superoxide dismutase 1) (hSod1)	SOD1	11179;	9606.ENSP00000270142;
O15524	SOCS1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Suppressor of cytokine signaling 1 (SOCS-1) (JAK-binding protein) (JAB) (STAT-induced STAT inhibitor 1) (SSI-1) (Tec-interacting protein 3) (TIP-3)	SOCS1 SSI1 TIP3	19383;	9606.ENSP00000329418;
P27930	IL1R2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-1 receptor type 2 (IL-1R-2) (IL-1RT-2) (IL-1RT2) (CD121 antigen-like family member B) (CDw121b) (IL-1 type II receptor) (Interleukin-1 receptor beta) (IL-1R-beta) (Interleukin-1 receptor type II) (CD antigen CD121b) [Cleaved into: Interleukin-1 receptor type 2, membrane form (mIL-1R2) (mIL-1RII); Interleukin-1 receptor type 2, soluble form (sIL-1R2) (sIL-1RII)]	IL1R2 IL1RB	5994;	9606.ENSP00000330959;
Q8IU85	KCC1D_HUMAN	reviewed	Evidence at protein level	5 out of 5	Calcium/calmodulin-dependent protein kinase type 1D (EC 2.7.11.17) (CaM kinase I delta) (CaM kinase ID) (CaM-KI delta) (CaMKI delta) (CaMKID) (CaMKI-like protein kinase) (CKLiK)	CAMK1D CAMKID	19341;	9606.ENSP00000478874;
P13725	ONCM_HUMAN	reviewed	Evidence at protein level	5 out of 5	Oncostatin-M (OSM)	OSM	8506;	9606.ENSP00000215781;
Q92954	PRG4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Proteoglycan 4 (Lubricin) (Megakaryocyte-stimulating factor) (Superficial zone proteoglycan) [Cleaved into: Proteoglycan 4 C-terminal part]	PRG4 MSF SZP	9364;	9606.ENSP00000399679;
Q13018	PLA2R_HUMAN	reviewed	Evidence at protein level	5 out of 5	Secretory phospholipase A2 receptor (PLA2-R) (PLA2R) (180 kDa secretory phospholipase A2 receptor) (C-type lectin domain family 13 member C) (M-type receptor) [Cleaved into: Soluble secretory phospholipase A2 receptor (Soluble PLA2-R) (Soluble PLA2R)]	PLA2R1 CLEC13C	9042;	9606.ENSP00000283243;
Q9BRX8	PXL2A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Peroxiredoxin-like 2A (Peroxiredoxin-like 2 activated in M-CSF stimulated monocytes) (Protein PAMM) (Redox-regulatory protein FAM213A)	PRXL2A C10orf58 FAM213A PAMM PRO2290 PSEC0139 UNQ611/PRO1198	28651;	9606.ENSP00000482445;
Q9NRP7	STK36_HUMAN	reviewed	Evidence at protein level	5 out of 5	Serine/threonine-protein kinase 36 (EC 2.7.11.1) (Fused homolog)	STK36 KIAA1278	17209;	9606.ENSP00000295709;
P50452	SPB8_HUMAN	reviewed	Evidence at protein level	5 out of 5	Serpin B8 (Cytoplasmic antiproteinase 2) (CAP-2) (CAP2) (Peptidase inhibitor 8) (PI-8)	SERPINB8 PI8	8952;	9606.ENSP00000381072;
P0DJI8	SAA1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Serum amyloid A-1 protein (SAA) [Cleaved into: Amyloid protein A (Amyloid fibril protein AA); Serum amyloid protein A(2-104); Serum amyloid protein A(3-104); Serum amyloid protein A(2-103); Serum amyloid protein A(2-102); Serum amyloid protein A(4-101)]	SAA1	10513;	9606.ENSP00000384906;
P35498	SCN1A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Sodium channel protein type 1 subunit alpha (Sodium channel protein brain I subunit alpha) (Sodium channel protein type I subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.1)	SCN1A NAC1 SCN1	10585;	9606.ENSP00000303540;
O95470	SGPL1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Sphingosine-1-phosphate lyase 1 (S1PL) (SP-lyase 1) (SPL 1) (hSPL) (EC 4.1.2.27) (Sphingosine-1-phosphate aldolase)	SGPL1 KIAA1252	10817;	9606.ENSP00000362298;
Q8IWX5	SGPP2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Sphingosine-1-phosphate phosphatase 2 (SPPase2) (Spp2) (hSPP2) (EC 3.1.3.-) (Sphingosine-1-phosphatase 2)	SGPP2	19953;	9606.ENSP00000315137;
Q15399	TLR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Toll-like receptor 1 (Toll/interleukin-1 receptor-like protein) (TIL) (CD antigen CD281)	TLR1 KIAA0012	11847;	9606.ENSP00000354932;
Q15797	SMAD1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mothers against decapentaplegic homolog 1 (MAD homolog 1) (Mothers against DPP homolog 1) (JV4-1) (Mad-related protein 1) (SMAD family member 1) (SMAD 1) (Smad1) (hSMAD1) (Transforming growth factor-beta-signaling protein 1) (BSP-1)	SMAD1 BSP1 MADH1 MADR1	6767;	9606.ENSP00000426568;
Q8NFU7	TET1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Methylcytosine dioxygenase TET1 (EC 1.14.11.n2) (CXXC-type zinc finger protein 6) (Leukemia-associated protein with a CXXC domain) (Ten-eleven translocation 1 gene protein)	TET1 CXXC6 KIAA1676 LCX	29484;	9606.ENSP00000362748;
P21589	5NTD_HUMAN	reviewed	Evidence at protein level	5 out of 5	5'-nucleotidase (5'-NT) (EC 3.1.3.5) (Ecto-5'-nucleotidase) (CD antigen CD73)	NT5E NT5 NTE	8021;	9606.ENSP00000257770;
Q13490	BIRC2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Baculoviral IAP repeat-containing protein 2 (EC 2.3.2.27) (Cellular inhibitor of apoptosis 1) (C-IAP1) (IAP homolog B) (Inhibitor of apoptosis protein 2) (hIAP-2) (hIAP2) (RING finger protein 48) (RING-type E3 ubiquitin transferase BIRC2) (TNFR2-TRAF-signaling complex protein 2)	BIRC2 API1 MIHB RNF48	590;	9606.ENSP00000477613;
Q6P4H8	ACKMT_HUMAN	reviewed	Evidence at protein level	5 out of 5	ATP synthase subunit C lysine N-methyltransferase (EC 2.1.1.-) (Protein N-lysine methyltransferase FAM173B) (hFAM173B)	ATPSCKMT FAM173B	27029;	9606.ENSP00000422338;
P34969	5HT7R_HUMAN	reviewed	Evidence at protein level	5 out of 5	5-hydroxytryptamine receptor 7 (5-HT-7) (5-HT7) (5-HT-X) (Serotonin receptor 7)	HTR7	5302;	9606.ENSP00000337949;
Q9UM73	ALK_HUMAN	reviewed	Evidence at protein level	5 out of 5	ALK tyrosine kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase) (CD antigen CD246)	ALK	427;	9606.ENSP00000373700;
P08913	ADA2A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Alpha-2A adrenergic receptor (Alpha-2 adrenergic receptor subtype C10) (Alpha-2A adrenoreceptor) (Alpha-2A adrenoceptor) (Alpha-2AAR)	ADRA2A ADRA2R ADRAR	281;	9606.ENSP00000280155;
O00327	BMAL1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Aryl hydrocarbon receptor nuclear translocator-like protein 1 (Basic-helix-loop-helix-PAS protein MOP3) (Brain and muscle ARNT-like 1) (Class E basic helix-loop-helix protein 5) (bHLHe5) (Member of PAS protein 3) (PAS domain-containing protein 3) (bHLH-PAS protein JAP3)	ARNTL BHLHE5 BMAL1 MOP3 PASD3	701;	9606.ENSP00000384517;
P10415	BCL2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Apoptosis regulator Bcl-2	BCL2	990;	9606.ENSP00000381185;
P55008	AIF1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Allograft inflammatory factor 1 (AIF-1) (Ionized calcium-binding adapter molecule 1) (Protein G1)	AIF1 G1 IBA1	352;	9606.ENSP00000365227;
Q01718	ACTHR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Adrenocorticotropic hormone receptor (ACTH receptor) (ACTH-R) (Adrenocorticotropin receptor) (Melanocortin receptor 2) (MC2-R)	MC2R ACTHR	6930;	9606.ENSP00000333821;
P07711	CATL1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Procathepsin L (EC 3.4.22.15) (Cathepsin L1) (Major excreted protein) (MEP) [Cleaved into: Cathepsin L; Cathepsin L heavy chain; Cathepsin L light chain]	CTSL CTSL1	2537;	9606.ENSP00000345344;
P01258	CALC_HUMAN	reviewed	Evidence at protein level	5 out of 5	Calcitonin [Cleaved into: Calcitonin; Katacalcin (Calcitonin carboxyl-terminal peptide) (CCP) (PDN-21)]	CALCA CALC1	1437;	9606.ENSP00000331746;
P78536	ADA17_HUMAN	reviewed	Evidence at protein level	5 out of 5	Disintegrin and metalloproteinase domain-containing protein 17 (ADAM 17) (EC 3.4.24.86) (Snake venom-like protease) (TNF-alpha convertase) (TNF-alpha-converting enzyme) (CD antigen CD156b)	ADAM17 CSVP TACE	195;	9606.ENSP00000309968;
P51671	CCL11_HUMAN	reviewed	Evidence at protein level	5 out of 5	Eotaxin (C-C motif chemokine 11) (Eosinophil chemotactic protein) (Small-inducible cytokine A11)	CCL11 SCYA11	10610;	9606.ENSP00000302234;
P78556	CCL20_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C motif chemokine 20 (Beta-chemokine exodus-1) (CC chemokine LARC) (Liver and activation-regulated chemokine) (Macrophage inflammatory protein 3 alpha) (MIP-3-alpha) (Small-inducible cytokine A20) [Cleaved into: CCL20(1-67); CCL20(1-64); CCL20(2-70)]	CCL20 LARC MIP3A SCYA20	10619;	9606.ENSP00000351671;
Q9Y258	CCL26_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C motif chemokine 26 (CC chemokine IMAC) (Eotaxin-3) (Macrophage inflammatory protein 4-alpha) (MIP-4-alpha) (Small-inducible cytokine A26) (Thymic stroma chemokine-1) (TSC-1)	CCL26 SCYA26 UNQ216/PRO242	10625;	9606.ENSP00000378365;
P78348	ASIC1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Acid-sensing ion channel 1 (ASIC1) (Amiloride-sensitive cation channel 2, neuronal) (Brain sodium channel 2) (BNaC2)	ASIC1 ACCN2 BNAC2	100;	9606.ENSP00000228468;
P18846	ATF1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cyclic AMP-dependent transcription factor ATF-1 (cAMP-dependent transcription factor ATF-1) (Activating transcription factor 1) (Protein TREB36)	ATF1	783;	9606.ENSP00000262053;
P23946	CMA1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Chymase (EC 3.4.21.39) (Alpha-chymase) (Mast cell protease I)	CMA1 CYH CYM	2097;	9606.ENSP00000250378;
O15516	CLOCK_HUMAN	reviewed	Evidence at protein level	5 out of 5	Circadian locomoter output cycles protein kaput (hCLOCK) (EC 2.3.1.48) (Class E basic helix-loop-helix protein 8) (bHLHe8)	CLOCK BHLHE8 KIAA0334	2082;	9606.ENSP00000308741;
Q99788	CML1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Chemerin-like receptor 1 (Chemokine-like receptor 1) (G-protein coupled receptor ChemR23) (G-protein coupled receptor DEZ)	CMKLR1 CHEMR23 DEZ	2121;	9606.ENSP00000311733;
O43734	CIKS_HUMAN	reviewed	Evidence at protein level	5 out of 5	E3 ubiquitin ligase TRAF3IP2 (EC 2.3.2.27) (Adapter protein CIKS) (Connection to IKK and SAPK/JNK) (E3 ubiquitin-protein ligase CIKS) (Nuclear factor NF-kappa-B activator 1) (ACT1) (TRAF3-interacting protein 2)	TRAF3IP2 C6orf2 C6orf4 C6orf5 C6orf6	1343;	9606.ENSP00000357750;
P46091	CML2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Chemerin-like receptor 2 (Chemerin chemokine-like receptor 2) (Chemokine-like receptor 2) (G-protein coupled receptor 1)	CMKLR2 GPR1	4463;	9606.ENSP00000480405;
Q00610	CLH1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Clathrin heavy chain 1 (Clathrin heavy chain on chromosome 17) (CLH-17)	CLTC CLH17 CLTCL2 KIAA0034	2092;	9606.ENSP00000479606;
O43916	CHST1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Carbohydrate sulfotransferase 1 (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 1) (GST-1) (Keratan sulfate Gal-6 sulfotransferase) (KS6ST) (KSGal6ST) (KSST) (EC 2.8.2.21)	CHST1	1969;	9606.ENSP00000309270;
Q9Y4C5	CHST2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Carbohydrate sulfotransferase 2 (EC 2.8.2.-) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 2) (GST-2) (N-acetylglucosamine 6-O-sulfotransferase 1) (GlcNAc6ST-1) (Gn6ST-1)	CHST2 GN6ST	1970;	9606.ENSP00000307911;
Q8NCG5	CHST4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Carbohydrate sulfotransferase 4 (EC 2.8.2.-) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 3) (GST-3) (High endothelial cells N-acetylglucosamine 6-O-sulfotransferase) (HEC-GlcNAc6ST) (L-selectin ligand sulfotransferase) (LSST) (N-acetylglucosamine 6-O-sulfotransferase 2) (GlcNAc6ST-2) (Gn6st-2)	CHST4	1972;	9606.ENSP00000341206;
Q9H2A9	CHST8_HUMAN	reviewed	Evidence at protein level	5 out of 5	Carbohydrate sulfotransferase 8 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 1) (GalNAc-4-ST1) (GalNAc4ST-1) (N-acetylgalactosamine-4-O-sulfotransferase 1)	CHST8	15993;	9606.ENSP00000262622;
Q9NSA3	CNBP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Beta-catenin-interacting protein 1 (Inhibitor of beta-catenin and Tcf-4)	CTNNBIP1 ICAT	16913;	9606.ENSP00000366474;
Q9UMR7	CLC4A_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-type lectin domain family 4 member A (C-type lectin DDB27) (C-type lectin superfamily member 6) (Dendritic cell immunoreceptor) (Lectin-like immunoreceptor) (CD antigen CD367)	CLEC4A CLECSF6 DCIR LLIR HDCGC13P	13257;	9606.ENSP00000229332;
Q8WXI8	CLC4D_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-type lectin domain family 4 member D (C-type lectin superfamily member 8) (C-type lectin-like receptor 6) (CLEC-6) (Dendritic cell-associated C-type lectin 3) (DC-associated C-type lectin 3) (Dectin-3) (CD antigen CD368)	CLEC4D CLECSF8 MCL	14554;	9606.ENSP00000299665;
Q9ULY5	CLC4E_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-type lectin domain family 4 member E (C-type lectin superfamily member 9) (Macrophage-inducible C-type lectin) (MINCLE)	CLEC4E CLECSF9 MINCLE UNQ218/PRO244	14555;	9606.ENSP00000299663;
Q9NY25	CLC5A_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-type lectin domain family 5 member A (C-type lectin superfamily member 5) (Myeloid DAP12-associating lectin 1) (MDL-1)	CLEC5A CLECSF5 MDL1	2054;	9606.ENSP00000449999;
Q9UBR5	CKLF_HUMAN	reviewed	Evidence at protein level	5 out of 5	Chemokine-like factor (C32)	CKLF CKLF1 HSPC224 UNQ410/PRO772	13253;	9606.ENSP00000264001;
Q9BXN2	CLC7A_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-type lectin domain family 7 member A (Beta-glucan receptor) (C-type lectin superfamily member 12) (Dendritic cell-associated C-type lectin 1) (DC-associated C-type lectin 1) (Dectin-1) (CD antigen CD369)	CLEC7A BGR CLECSF12 DECTIN1 UNQ539/PRO1082	14558;	9606.ENSP00000302569;
A8K7I4	CLCA1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel family member 1) (hCLCA1) (Calcium-activated chloride channel protein 1) (CaCC-1) (hCaCC-1)	CLCA1 CACC1	2015;	9606.ENSP00000234701;
Q5QGZ9	CL12A_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-type lectin domain family 12 member A (C-type lectin-like molecule 1) (CLL-1) (Dendritic cell-associated lectin 2) (DCAL-2) (Myeloid inhibitory C-type lectin-like receptor) (MICL) (CD antigen CD371)	CLEC12A CLL1 DCAL2 MICL	31713;	9606.ENSP00000347916;
Q2HXU8	CL12B_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-type lectin domain family 12 member B (Macrophage antigen H)	CLEC12B UNQ5782/PRO16089	31966;	9606.ENSP00000344563;
P16619	CL3L1_HUMAN	reviewed	Evidence at protein level	5 out of 5	C-C motif chemokine 3-like 1 (G0/G1 switch regulatory protein 19-2) (LD78-beta(1-70)) (PAT 464.2) (Small-inducible cytokine A3-like 1) (Tonsillar lymphocyte LD78 beta protein) [Cleaved into: LD78-beta(3-70); LD78-beta(5-70)]	CCL3L1 D17S1718 G0S19-2 SCYA3L1; CCL3L3	10628;30554;	9606.ENSP00000480558;
Q9Y271	CLTR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cysteinyl leukotriene receptor 1 (CysLTR1) (Cysteinyl leukotriene D4 receptor) (LTD4 receptor) (G-protein coupled receptor HG55) (HMTMF81)	CYSLTR1 CYSLT1	17451;	9606.ENSP00000478492;
Q9NS75	CLTR2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cysteinyl leukotriene receptor 2 (CysLTR2) (G-protein coupled receptor GPCR21) (hGPCR21) (G-protein coupled receptor HG57) (HPN321)	CYSLTR2 CYSLT2 CYSLT2R PSEC0146	18274;	9606.ENSP00000282018;
Q7RTR0	NLRP9_HUMAN	reviewed	Evidence at protein level	5 out of 5	NACHT, LRR and PYD domains-containing protein 9 (Nucleotide-binding oligomerization domain protein 6) (PYRIN and NACHT-containing protein 12)	NLRP9 NALP9 NOD6 PAN12	22941;	9606.ENSP00000331857;
P10599	THIO_HUMAN	reviewed	Evidence at protein level	5 out of 5	Thioredoxin (Trx) (ATL-derived factor) (ADF) (Surface-associated sulphydryl protein) (SASP) (allergen Hom s Trx)	TXN TRDX TRX TRX1	12435;	9606.ENSP00000363641;
P48736	PK3CG_HUMAN	reviewed	Evidence at protein level	5 out of 5	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform (PI3-kinase subunit gamma) (PI3K-gamma) (PI3Kgamma) (PtdIns-3-kinase subunit gamma) (EC 2.7.1.137) (EC 2.7.1.153) (EC 2.7.1.154) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit gamma) (PtdIns-3-kinase subunit p110-gamma) (p110gamma) (Phosphoinositide-3-kinase catalytic gamma polypeptide) (Serine/threonine protein kinase PIK3CG) (EC 2.7.11.1) (p120-PI3K)	PIK3CG	8978;	9606.ENSP00000352121;
Q96EP0	RNF31_HUMAN	reviewed	Evidence at protein level	5 out of 5	E3 ubiquitin-protein ligase RNF31 (EC 2.3.2.31) (HOIL-1-interacting protein) (HOIP) (RING finger protein 31) (RING-type E3 ubiquitin transferase RNF31) (Zinc in-between-RING-finger ubiquitin-associated domain protein)	RNF31 ZIBRA	16031;	9606.ENSP00000315112;
P01033	TIMP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Metalloproteinase inhibitor 1 (Erythroid-potentiating activity) (EPA) (Fibroblast collagenase inhibitor) (Collagenase inhibitor) (Tissue inhibitor of metalloproteinases 1) (TIMP-1)	TIMP1 CLGI TIMP	11820;	9606.ENSP00000218388;
Q9BQE4	SELS_HUMAN	reviewed	Evidence at protein level	5 out of 5	Selenoprotein S (SelS) (VCP-interacting membrane protein)	SELENOS SELS VIMP AD-015 SBBI8	30396;	9606.ENSP00000381282;
Q12884	SEPR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Prolyl endopeptidase FAP (EC 3.4.21.26) (170 kDa melanoma membrane-bound gelatinase) (Dipeptidyl peptidase FAP) (EC 3.4.14.5) (Fibroblast activation protein alpha) (FAPalpha) (Gelatine degradation protease FAP) (EC 3.4.21.-) (Integral membrane serine protease) (Post-proline cleaving enzyme) (Serine integral membrane protease) (SIMP) (Surface-expressed protease) (Seprase) [Cleaved into: Antiplasmin-cleaving enzyme FAP, soluble form (APCE) (EC 3.4.14.5) (EC 3.4.21.-) (EC 3.4.21.26)]	FAP	3590;	9606.ENSP00000188790;
P21980	TGM2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein-glutamine gamma-glutamyltransferase 2 (EC 2.3.2.13) (Erythrocyte transglutaminase) (Heart G alpha(h)) (hhG alpha(h)) (Isopeptidase TGM2) (EC 3.4.-.-) (Protein G alpha(h)) (G(h)) (Protein-glutamine deamidase TGM2) (EC 3.5.1.44) (Protein-glutamine dopaminyltransferase TGM2) (EC 2.3.1.-) (Protein-glutamine histaminyltransferase TGM2) (EC 2.3.1.-) (Protein-glutamine noradrenalinyltransferase TGM2) (EC 2.3.1.-) (Protein-glutamine serotonyltransferase TGM2) (EC 2.3.1.-) (Tissue transglutaminase) (tTG) (tTgase) (Transglutaminase C) (TG(C)) (TGC) (TGase C) (Transglutaminase H) (TGase H) (Transglutaminase II) (TGase II) (Transglutaminase-2) (TG2) (TGase-2) (hTG2)	TGM2	11778;	9606.ENSP00000355330;
Q8NFZ5	TNIP2_HUMAN	reviewed	Evidence at protein level	5 out of 5	TNFAIP3-interacting protein 2 (A20-binding inhibitor of NF-kappa-B activation 2) (ABIN-2) (Fetal liver LKB1-interacting protein)	TNIP2 ABIN2 FLIP1	19118;	9606.ENSP00000321203;
Q15025	TNIP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	TNFAIP3-interacting protein 1 (A20-binding inhibitor of NF-kappa-B activation 1) (ABIN-1) (HIV-1 Nef-interacting protein) (Nef-associated factor 1) (Naf1) (Nip40-1) (Virion-associated nuclear shuttling protein) (VAN) (hVAN)	TNIP1 KIAA0113 NAF1	16903;	9606.ENSP00000317891;
Q9C035	TRIM5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tripartite motif-containing protein 5 (EC 2.3.2.27) (RING finger protein 88) (RING-type E3 ubiquitin transferase TRIM5)	TRIM5 RNF88	16276;	9606.ENSP00000369373;
Q9NZR4	VSX1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Visual system homeobox 1 (Homeodomain protein RINX) (Retinal inner nuclear layer homeobox protein) (Transcription factor VSX1)	VSX1 RINX	12723;	9606.ENSP00000365899;
P60900	PSA6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Proteasome subunit alpha type-6 (27 kDa prosomal protein) (PROS-27) (p27K) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain)	PSMA6 PROS27	9535;	9606.ENSP00000261479;
Q63HN8	RN213_HUMAN	reviewed	Evidence at protein level	5 out of 5	E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (ALK lymphoma oligomerization partner on chromosome 17) (E3 ubiquitin-lipopolysaccharide ligase RNF213) (EC 2.3.2.-) (Mysterin) (RING finger protein 213)	RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR	14539;	9606.ENSP00000464087;
P35443	TSP4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Thrombospondin-4	THBS4 TSP4	11788;	9606.ENSP00000339730;
P11684	UTER_HUMAN	reviewed	Evidence at protein level	5 out of 5	Uteroglobin (Clara cell phospholipid-binding protein) (CCPBP) (Clara cells 10 kDa secretory protein) (CC10) (Secretoglobin family 1A member 1) (Urinary protein 1) (UP-1) (UP1) (Urine protein 1)	SCGB1A1 CC10 CCSP UGB	12523;	9606.ENSP00000278282;
O95498	VNN2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Pantetheine hydrolase VNN2 (EC 3.5.1.92) (Glycosylphosphatidyl inositol-anchored protein GPI-80) (Protein FOAP-4) (Vascular non-inflammatory molecule 2) (Vanin-2)	VNN2	12706;	9606.ENSP00000322276;
Q9Y228	T3JAM_HUMAN	reviewed	Evidence at protein level	5 out of 5	TRAF3-interacting JNK-activating modulator (TRAF3-interacting protein 3)	TRAF3IP3 T3JAM	30766;	9606.ENSP00000355991;
P47992	XCL1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Lymphotactin (ATAC) (C motif chemokine 1) (Cytokine SCM-1) (Lymphotaxin) (SCM-1-alpha) (Small-inducible cytokine C1) (XC chemokine ligand 1)	XCL1 LTN SCYC1	10645;	9606.ENSP00000356792;
Q9UBD3	XCL2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Cytokine SCM-1 beta (C motif chemokine 2) (XC chemokine ligand 2)	XCL2 SCYC2	10646;	9606.ENSP00000356793;
P46094	XCR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Chemokine XC receptor 1 (G-protein coupled receptor 5) (Lymphotactin receptor) (XC chemokine receptor 1)	XCR1 CCXCR1 GPR5	1625;	9606.ENSP00000310405;
P0DPH8	TBA3D_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tubulin alpha-3D chain (Alpha-tubulin 3D) [Cleaved into: Detyrosinated tubulin alpha-3D chain]	TUBA3D	24071;	
Q9NR97	TLR8_HUMAN	reviewed	Evidence at protein level	5 out of 5	Toll-like receptor 8 (CD antigen CD288)	TLR8 UNQ249/PRO286	15632;	9606.ENSP00000312082;
O15205	UBD_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ubiquitin D (Diubiquitin) (Ubiquitin-like protein FAT10)	UBD FAT10	18795;	9606.ENSP00000366249;
Q86UC2	RSPH3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Radial spoke head protein 3 homolog (A-kinase anchor protein RSPH3) (Radial spoke head-like protein 2)	RSPH3 RSHL2 RSP3	21054;	9606.ENSP00000252655;
P01374	TNFB_HUMAN	reviewed	Evidence at protein level	5 out of 5	Lymphotoxin-alpha (LT-alpha) (TNF-beta) (Tumor necrosis factor ligand superfamily member 1)	LTA TNFB TNFSF1	6709;	9606.ENSP00000403495;
P43403	ZAP70_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tyrosine-protein kinase ZAP-70 (EC 2.7.10.2) (70 kDa zeta-chain associated protein) (Syk-related tyrosine kinase)	ZAP70 SRK	12858;	9606.ENSP00000264972;
Q9UM82	SPAT2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Spermatogenesis-associated protein 2	SPATA2 KIAA0757 PD1	14681;	9606.ENSP00000416799;
P32241	VIPR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Vasoactive intestinal polypeptide receptor 1 (VIP-R-1) (Pituitary adenylate cyclase-activating polypeptide type II receptor) (PACAP type II receptor) (PACAP-R-2) (PACAP-R2) (VPAC1)	VIPR1	12694;	9606.ENSP00000327246;
Q13114	TRAF3_HUMAN	reviewed	Evidence at protein level	5 out of 5	TNF receptor-associated factor 3 (EC 2.3.2.27) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (LMP1-associated protein 1) (LAP1) (RING-type E3 ubiquitin transferase TRAF3)	TRAF3 CAP-1 CRAF1 TRAFAMN	12033;	9606.ENSP00000454207;
P07996	TSP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Thrombospondin-1 (Glycoprotein G)	THBS1 TSP TSP1	11785;	9606.ENSP00000260356;
P98066	TSG6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tumor necrosis factor-inducible gene 6 protein (EC 3.1.1.-) (Hyaluronate-binding protein) (TNF-stimulated gene 6 protein) (TSG-6) (Tumor necrosis factor alpha-induced protein 6) (TNF alpha-induced protein 6)	TNFAIP6 TSG6	11898;	9606.ENSP00000243347;
Q9BYV6	TRI55_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tripartite motif-containing protein 55 (Muscle-specific RING finger protein 2) (MuRF-2) (MuRF2) (RING finger protein 29)	TRIM55 MURF2 RNF29	14215;	9606.ENSP00000323913;
O43914	TYOBP_HUMAN	reviewed	Evidence at protein level	5 out of 5	TYRO protein tyrosine kinase-binding protein (DNAX-activation protein 12) (Killer-activating receptor-associated protein) (KAR-associated protein)	TYROBP DAP12 KARAP	12449;	9606.ENSP00000262629;
O15455	TLR3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Toll-like receptor 3 (CD antigen CD283)	TLR3	11849;	9606.ENSP00000296795;
O75762	TRPA1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120) (p120) (Wasabi receptor)	TRPA1 ANKTM1	497;	9606.ENSP00000262209;
Q9C029	TRIM7_HUMAN	reviewed	Evidence at protein level	5 out of 5	E3 ubiquitin-protein ligase TRIM7 (EC 2.3.2.27) (Glycogenin-interacting protein) (RING finger protein 90) (Tripartite motif-containing protein 7)	TRIM7 GNIP RNF90	16278;	9606.ENSP00000274773;
Q5D1E8	ZC12A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Endoribonuclease ZC3H12A (EC 3.1.-.-) (Monocyte chemotactic protein-induced protein 1) (MCP-induced protein 1) (MCPIP-1) (Regnase-1) (Reg1) (Zinc finger CCCH domain-containing protein 12A)	ZC3H12A MCPIP MCPIP1	26259;	9606.ENSP00000362179;
P23510	TNFL4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tumor necrosis factor ligand superfamily member 4 (Glycoprotein Gp34) (OX40 ligand) (OX40L) (TAX transcriptionally-activated glycoprotein 1) (CD antigen CD252)	TNFSF4 TXGP1	11934;	9606.ENSP00000281834;
P98170	XIAP_HUMAN	reviewed	Evidence at protein level	5 out of 5	E3 ubiquitin-protein ligase XIAP (EC 2.3.2.27) (Baculoviral IAP repeat-containing protein 4) (IAP-like protein) (ILP) (hILP) (Inhibitor of apoptosis protein 3) (IAP-3) (hIAP-3) (hIAP3) (RING-type E3 ubiquitin transferase XIAP) (X-linked inhibitor of apoptosis protein) (X-linked IAP)	XIAP API3 BIRC4 IAP3	592;	9606.ENSP00000360242;
O95497	VNN1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Pantetheinase (EC 3.5.1.92) (Pantetheine hydrolase) (Tiff66) (Vascular non-inflammatory molecule 1) (Vanin-1)	VNN1	12705;	9606.ENSP00000356905;
P67936	TPM4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tropomyosin alpha-4 chain (TM30p1) (Tropomyosin-4)	TPM4	12013;	9606.ENSP00000345230;
P67809	YBOX1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Y-box-binding protein 1 (YB-1) (CCAAT-binding transcription factor I subunit A) (CBF-A) (DNA-binding protein B) (DBPB) (Enhancer factor I subunit A) (EFI-A) (Nuclease-sensitive element-binding protein 1) (Y-box transcription factor)	YBX1 NSEP1 YB1	8014;	9606.ENSP00000361626;
Q9H171	ZBP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Z-DNA-binding protein 1 (DNA-dependent activator of IFN-regulatory factors) (DAI) (Tumor stroma and activated macrophage protein DLM-1)	ZBP1 C20orf183 DLM1	16176;	9606.ENSP00000360215;
Q96EQ8	RN125_HUMAN	reviewed	Evidence at protein level	5 out of 5	E3 ubiquitin-protein ligase RNF125 (EC 2.3.2.27) (RING finger protein 125) (T-cell RING activation protein 1) (TRAC-1)	RNF125	21150;	9606.ENSP00000217740;
P40200	TACT_HUMAN	reviewed	Evidence at protein level	5 out of 5	T-cell surface protein tactile (Cell surface antigen CD96) (T cell-activated increased late expression protein) (CD antigen CD96)	CD96	16892;	9606.ENSP00000283285;
Q96KP6	TNIP3_HUMAN	reviewed	Evidence at protein level	5 out of 5	TNFAIP3-interacting protein 3 (A20-binding inhibitor of NF-kappa-B activation 3) (ABIN-3) (Listeria-induced gene protein)	TNIP3 ABIN3 LIND	19315;	9606.ENSP00000426613;
Q96AQ6	PBIP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Pre-B-cell leukemia transcription factor-interacting protein 1 (Hematopoietic PBX-interacting protein)	PBXIP1 HPIP	21199;	9606.ENSP00000357448;
P36955	PEDF_HUMAN	reviewed	Evidence at protein level	5 out of 5	Pigment epithelium-derived factor (PEDF) (Cell proliferation-inducing gene 35 protein) (EPC-1) (Serpin F1)	SERPINF1 PEDF PIG35	8824;	9606.ENSP00000254722;
Q9HC29	NOD2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nucleotide-binding oligomerization domain-containing protein 2 (Caspase recruitment domain-containing protein 15) (Inflammatory bowel disease protein 1)	NOD2 CARD15 IBD1	5331;	9606.ENSP00000300589;
P21580	TNAP3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tumor necrosis factor alpha-induced protein 3 (TNF alpha-induced protein 3) (EC 2.3.2.-) (EC 3.4.19.12) (OTU domain-containing protein 7C) (Putative DNA-binding protein A20) (Zinc finger protein A20) [Cleaved into: A20p50; A20p37]	TNFAIP3 OTUD7C	11896;	9606.ENSP00000481570;
P40429	RL13A_HUMAN	reviewed	Evidence at protein level	5 out of 5	60S ribosomal protein L13a (23 kDa highly basic protein) (Large ribosomal subunit protein uL13)	RPL13A	10304;	9606.ENSP00000375730;
Q9Y572	RIPK3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Receptor-interacting serine/threonine-protein kinase 3 (EC 2.7.11.1) (RIP-like protein kinase 3) (Receptor-interacting protein 3) (RIP-3)	RIPK3 RIP3	10021;	9606.ENSP00000216274;
P02743	SAMP_HUMAN	reviewed	Evidence at protein level	5 out of 5	Serum amyloid P-component (SAP) (9.5S alpha-1-glycoprotein) [Cleaved into: Serum amyloid P-component(1-203)]	APCS PTX2	584;	9606.ENSP00000255040;
P35247	SFTPD_HUMAN	reviewed	Evidence at protein level	5 out of 5	Pulmonary surfactant-associated protein D (PSP-D) (SP-D) (Collectin-7) (Lung surfactant protein D)	SFTPD COLEC7 PSPD SFTP4	10803;	9606.ENSP00000361366;
P55072	TERA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transitional endoplasmic reticulum ATPase (TER ATPase) (EC 3.6.4.6) (15S Mg(2+)-ATPase p97 subunit) (Valosin-containing protein) (VCP)	VCP	12666;	9606.ENSP00000351777;
Q8NER1	TRPV1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transient receptor potential cation channel subfamily V member 1 (TrpV1) (Capsaicin receptor) (Osm-9-like TRP channel 1) (OTRPC1) (Vanilloid receptor 1)	TRPV1 VR1	12716;	9606.ENSP00000459962;
Q03431	PTH1R_HUMAN	reviewed	Evidence at protein level	5 out of 5	Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH/PTHrP type I receptor) (PTH/PTHr receptor) (Parathyroid hormone 1 receptor) (PTH1 receptor)	PTH1R PTHR PTHR1	9608;	9606.ENSP00000321999;
Q9NR96	TLR9_HUMAN	reviewed	Evidence at protein level	5 out of 5	Toll-like receptor 9 (CD antigen CD289)	TLR9 UNQ5798/PRO19605	15633;	9606.ENSP00000353874;
Q13151	ROA0_HUMAN	reviewed	Evidence at protein level	5 out of 5	Heterogeneous nuclear ribonucleoprotein A0 (hnRNP A0)	HNRNPA0 HNRPA0	5030;	9606.ENSP00000316042;
P35398	RORA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nuclear receptor ROR-alpha (Nuclear receptor RZR-alpha) (Nuclear receptor subfamily 1 group F member 1) (RAR-related orphan receptor A) (Retinoid-related orphan receptor-alpha)	RORA NR1F1 RZRA	10258;	9606.ENSP00000261523;
Q9HAI6	TASL_HUMAN	reviewed	Evidence at protein level	5 out of 5	TLR adapter interacting with SLC15A4 on the lysosome	TASL CXorf21	25667;	9606.ENSP00000368245;
Q03426	KIME_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mevalonate kinase (MK) (EC 2.7.1.36)	MVK	7530;	9606.ENSP00000443551;
P43119	PI2R_HUMAN	reviewed	Evidence at protein level	5 out of 5	Prostacyclin receptor (Prostaglandin I2 receptor) (PGI receptor) (PGI2 receptor) (Prostanoid IP receptor)	PTGIR PRIPR	9602;	9606.ENSP00000291294;
P84022	SMAD3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3)	SMAD3 MADH3	6769;	9606.ENSP00000332973;
Q96QK1	VPS35_HUMAN	reviewed	Evidence at protein level	5 out of 5	Vacuolar protein sorting-associated protein 35 (hVPS35) (Maternal-embryonic 3) (Vesicle protein sorting 35)	VPS35 MEM3 TCCCTA00141	13487;	9606.ENSP00000299138;
P40763	STAT3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Signal transducer and activator of transcription 3 (Acute-phase response factor)	STAT3 APRF	11364;	9606.ENSP00000264657;
Q14765	STAT4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Signal transducer and activator of transcription 4	STAT4	11365;	9606.ENSP00000376134;
Q8IUC6	TCAM1_HUMAN	reviewed	Evidence at protein level	5 out of 5	TIR domain-containing adapter molecule 1 (TICAM-1) (Proline-rich, vinculin and TIR domain-containing protein B) (Putative NF-kappa-B-activating protein 502H) (Toll-interleukin-1 receptor domain-containing adapter protein inducing interferon beta) (MyD88-3) (TIR domain-containing adapter protein inducing IFN-beta)	TICAM1 PRVTIRB TRIF	18348;	9606.ENSP00000248244;
Q9UNG2	TNF18_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tumor necrosis factor ligand superfamily member 18 (Activation-inducible TNF-related ligand) (AITRL) (Glucocorticoid-induced TNF-related ligand) (hGITRL)	TNFSF18 AITRL GITRL TL6 UNQ149/PRO175	11932;	9606.ENSP00000385470;
O43353	RIPK2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Receptor-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (CARD-containing interleukin-1 beta-converting enzyme-associated kinase) (CARD-containing IL-1 beta ICE-kinase) (RIP-like-interacting CLARP kinase) (Receptor-interacting protein 2) (RIP-2) (Tyrosine-protein kinase RIPK2) (EC 2.7.10.2)	RIPK2 CARDIAK RICK RIP2 UNQ277/PRO314/PRO34092	10020;	9606.ENSP00000220751;
P01137	TGFB1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transforming growth factor beta-1 proprotein [Cleaved into: Latency-associated peptide (LAP); Transforming growth factor beta-1 (TGF-beta-1)]	TGFB1 TGFB	11766;	9606.ENSP00000221930;
Q5TEJ8	THMS2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein THEMIS2 (Induced by contact to basement membrane 1 protein) (Protein ICB-1) (Thymocyte-expressed molecule involved in selection protein 2)	THEMIS2 C1orf38 ICB1	16839;	9606.ENSP00000363031;
P47872	SCTR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Secretin receptor (SCT-R)	SCTR	10608;	9606.ENSP00000019103;
Q07617	SPAG1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Sperm-associated antigen 1 (HSD-3.8) (Infertility-related sperm protein Spag-1)	SPAG1	11212;	9606.ENSP00000373450;
O94804	STK10_HUMAN	reviewed	Evidence at protein level	5 out of 5	Serine/threonine-protein kinase 10 (EC 2.7.11.1) (Lymphocyte-oriented kinase)	STK10 LOK	11388;	9606.ENSP00000176763;
Q9NUY8	TBC23_HUMAN	reviewed	Evidence at protein level	5 out of 5	TBC1 domain family member 23 (HCV non-structural protein 4A-transactivated protein 1)	TBC1D23 NS4ATP1	25622;	9606.ENSP00000377700;
Q7L0X0	TRIL_HUMAN	reviewed	Evidence at protein level	5 out of 5	TLR4 interactor with leucine rich repeats (Leucine-rich repeat-containing protein KIAA0644)	TRIL KIAA0644	22200;	9606.ENSP00000479256;
P35916	VGFR3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Vascular endothelial growth factor receptor 3 (VEGFR-3) (EC 2.7.10.1) (Fms-like tyrosine kinase 4) (FLT-4) (Tyrosine-protein kinase receptor FLT4)	FLT4 VEGFR3	3767;	9606.ENSP00000261937;
P22105	TENX_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tenascin-X (TN-X) (Hexabrachion-like protein)	TNXB HXBL TNX TNXB1 TNXB2 XB	11976;	9606.ENSP00000407685;
Q9H0E2	TOLIP_HUMAN	reviewed	Evidence at protein level	5 out of 5	Toll-interacting protein	TOLLIP	16476;	9606.ENSP00000314733;
O75896	TUSC2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tumor suppressor candidate 2 (Fusion 1 protein) (Fus-1 protein) (PDGFA-associated protein 2)	TUSC2 C3orf11 FUS1 LGCC PDAP2	17034;	9606.ENSP00000232496;
P01185	NEU2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Vasopressin-neurophysin 2-copeptin (AVP-NPII) [Cleaved into: Arg-vasopressin (Arginine-vasopressin); Neurophysin 2 (Neurophysin-II); Copeptin]	AVP ARVP VP	894;	9606.ENSP00000369647;
P01303	NPY_HUMAN	reviewed	Evidence at protein level	5 out of 5	Pro-neuropeptide Y [Cleaved into: Neuropeptide Y (Neuropeptide tyrosine) (NPY); C-flanking peptide of NPY (CPON)]	NPY	7955;	9606.ENSP00000384364;
Q9Y263	PLAP_HUMAN	reviewed	Evidence at protein level	5 out of 5	Phospholipase A-2-activating protein (PLA2P) (PLAP)	PLAA PLAP	9043;	9606.ENSP00000380460;
P24821	TENA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C)	TNC HXB	5318;	9606.ENSP00000265131;
Q9BSE2	TMM79_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transmembrane protein 79 (Mattrin)	TMEM79 MATT	28196;	9606.ENSP00000384748;
P26651	TTP_HUMAN	reviewed	Evidence at protein level	5 out of 5	mRNA decay activator protein ZFP36 (G0/G1 switch regulatory protein 24) (Growth factor-inducible nuclear protein NUP475) (Tristetraprolin) (Zinc finger protein 36) (Zfp-36)	ZFP36 G0S24 NUP475 RNF162A TIS11A TTP	12862;	9606.ENSP00000469647;
Q5T1R4	ZEP3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transcription factor HIVEP3 (Human immunodeficiency virus type I enhancer-binding protein 3) (Kappa-B and V(D)J recombination signal sequences-binding protein) (Kappa-binding protein 1) (KBP-1) (Zinc finger protein ZAS3)	HIVEP3 KBP1 KIAA1555 KRC ZAS3	13561;	9606.ENSP00000361664;
P29144	TPP2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tripeptidyl-peptidase 2 (TPP-2) (EC 3.4.14.10) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase II) (TPP-II)	TPP2	12016;	9606.ENSP00000365233;
Q13404	UB2V1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ubiquitin-conjugating enzyme E2 variant 1 (UEV-1) (CROC-1) (TRAF6-regulated IKK activator 1 beta Uev1A)	UBE2V1 CROC1 UBE2V UEV1 P/OKcl.19	12494;	
P30530	UFO_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tyrosine-protein kinase receptor UFO (EC 2.7.10.1) (AXL oncogene)	AXL UFO	905;	9606.ENSP00000301178;
P02774	VTDB_HUMAN	reviewed	Evidence at protein level	5 out of 5	Vitamin D-binding protein (DBP) (VDB) (Gc protein-derived macrophage activating factor) (Gc-MAF) (GcMAF) (Gc-globulin) (Group-specific component) (Gc) (Vitamin D-binding protein-macrophage activating factor) (DBP-maf)	GC	4187;	9606.ENSP00000421725;
Q12968	NFAC3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nuclear factor of activated T-cells, cytoplasmic 3 (NF-ATc3) (NFATc3) (NFATx) (T-cell transcription factor NFAT4) (NF-AT4) (NF-AT4c)	NFATC3 NFAT4	7777;	9606.ENSP00000300659;
O00329	PK3CD_HUMAN	reviewed	Evidence at protein level	5 out of 5	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (PI3-kinase subunit delta) (PI3K-delta) (PI3Kdelta) (PtdIns-3-kinase subunit delta) (EC 2.7.1.137) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit delta) (PtdIns-3-kinase subunit p110-delta) (p110delta)	PIK3CD	8977;	9606.ENSP00000366563;
P19174	PLCG1_HUMAN	reviewed	Evidence at protein level	5 out of 5	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (EC 3.1.4.11) (PLC-148) (Phosphoinositide phospholipase C-gamma-1) (Phospholipase C-II) (PLC-II) (Phospholipase C-gamma-1) (PLC-gamma-1)	PLCG1 PLC1	9065;	9606.ENSP00000244007;
P13686	PPA5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tartrate-resistant acid phosphatase type 5 (TR-AP) (EC 3.1.3.2) (Tartrate-resistant acid ATPase) (TrATPase) (Type 5 acid phosphatase)	ACP5	124;	9606.ENSP00000468767;
Q7Z7A4	PXK_HUMAN	reviewed	Evidence at protein level	5 out of 5	PX domain-containing protein kinase-like protein (Modulator of Na,K-ATPase) (MONaKA)	PXK	23326;	9606.ENSP00000348472;
Q9HBX9	RXFP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Relaxin receptor 1 (Leucine-rich repeat-containing G-protein coupled receptor 7) (Relaxin family peptide receptor 1)	RXFP1 LGR7	19718;	9606.ENSP00000405841;
P55017	S12A3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Solute carrier family 12 member 3 (Na-Cl cotransporter) (NCC) (Na-Cl symporter) (Thiazide-sensitive sodium-chloride cotransporter)	SLC12A3 NCC TSC	10912;	9606.ENSP00000402152;
O14543	SOCS3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Suppressor of cytokine signaling 3 (SOCS-3) (Cytokine-inducible SH2 protein 3) (CIS-3) (STAT-induced STAT inhibitor 3) (SSI-3)	SOCS3 CIS3 SSI3	19391;	9606.ENSP00000330341;
O75326	SEM7A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Semaphorin-7A (CDw108) (JMH blood group antigen) (John-Milton-Hargen human blood group Ag) (Semaphorin-K1) (Sema K1) (Semaphorin-L) (Sema L) (CD antigen CD108)	SEMA7A CD108 SEMAL	10741;	9606.ENSP00000261918;
Q9NY15	STAB1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Stabilin-1 (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 1) (FEEL-1) (MS-1 antigen)	STAB1 FEEL1 KIAA0246	18628;	9606.ENSP00000312946;
Q687X5	STEA4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Metalloreductase STEAP4 (EC 1.16.1.9) (Six-transmembrane epithelial antigen of prostate 4) (SixTransMembrane protein of prostate 2) (Tumor necrosis factor, alpha-induced protein 9)	STEAP4 STAMP2 TNFAIP9	21923;	9606.ENSP00000369419;
Q969D9	TSLP_HUMAN	reviewed	Evidence at protein level	5 out of 5	Thymic stromal lymphopoietin	TSLP	30743;	9606.ENSP00000339804;
Q9HCK4	ROBO2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Roundabout homolog 2	ROBO2 KIAA1568	10250;	9606.ENSP00000417335;
P41221	WNT5A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein Wnt-5a	WNT5A	12784;	9606.ENSP00000264634;
Q04864	REL_HUMAN	reviewed	Evidence at protein level	5 out of 5	Proto-oncogene c-Rel	REL	9954;	9606.ENSP00000295025;
Q9BZZ2	SN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Sialoadhesin (Sialic acid-binding Ig-like lectin 1) (Siglec-1) (CD antigen CD169)	SIGLEC1 SN	11127;	9606.ENSP00000341141;
Q96KB5	TOPK_HUMAN	reviewed	Evidence at protein level	5 out of 5	Lymphokine-activated killer T-cell-originated protein kinase (EC 2.7.12.2) (Cancer/testis antigen 84) (CT84) (MAPKK-like protein kinase) (Nori-3) (PDZ-binding kinase) (Spermatogenesis-related protein kinase) (SPK) (T-LAK cell-originated protein kinase)	PBK TOPK	18282;	9606.ENSP00000428489;
Q9NQ25	SLAF7_HUMAN	reviewed	Evidence at protein level	5 out of 5	SLAM family member 7 (CD2 subset 1) (CD2-like receptor-activating cytotoxic cells) (CRACC) (Membrane protein FOAP-12) (Novel Ly9) (Protein 19A) (CD antigen CD319)	SLAMF7 CS1 UNQ576/PRO1138	21394;	9606.ENSP00000357022;
Q9P0V8	SLAF8_HUMAN	reviewed	Evidence at protein level	5 out of 5	SLAM family member 8 (B-lymphocyte activator macrophage expressed) (BCM-like membrane protein) (CD antigen CD353)	SLAMF8 BLAME	21391;	9606.ENSP00000289707;
Q02763	TIE2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b)	TEK TIE2 VMCM VMCM1	11724;	9606.ENSP00000369375;
O43548	TGM5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein-glutamine gamma-glutamyltransferase 5 (EC 2.3.2.13) (Transglutaminase X) (TG(X)) (TGX) (TGase X) (Transglutaminase-5) (TGase-5)	TGM5 TGMX	11781;	9606.ENSP00000220420;
P13726	TF_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tissue factor (TF) (Coagulation factor III) (Thromboplastin) (CD antigen CD142)	F3	3541;	9606.ENSP00000334145;
Q9BRX9	WDR83_HUMAN	reviewed	Evidence at protein level	5 out of 5	WD repeat domain-containing protein 83 (Mitogen-activated protein kinase organizer 1) (MAPK organizer 1)	WDR83 MORG1	32672;	9606.ENSP00000402653;
P51817	PRKX_HUMAN	reviewed	Evidence at protein level	5 out of 5	cAMP-dependent protein kinase catalytic subunit PRKX (PrKX) (Protein kinase X) (Protein kinase X-linked) (Serine/threonine-protein kinase PRKX) (EC 2.7.11.1) (Protein kinase PKX1)	PRKX PKX1	9441;	9606.ENSP00000262848;
P12272	PTHR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Parathyroid hormone-related protein (PTH-rP) (PTHrP) (Parathyroid hormone-like protein) (PLP) [Cleaved into: PTHrP[1-36]; PTHrP[38-94]; Osteostatin (PTHrP[107-139])]	PTHLH PTHRP	9607;	9606.ENSP00000441765;
P19474	RO52_HUMAN	reviewed	Evidence at protein level	5 out of 5	E3 ubiquitin-protein ligase TRIM21 (EC 2.3.2.27) (52 kDa Ro protein) (52 kDa ribonucleoprotein autoantigen Ro/SS-A) (RING finger protein 81) (RING-type E3 ubiquitin transferase TRIM21) (Ro(SS-A)) (Sjoegren syndrome type A antigen) (SS-A) (Tripartite motif-containing protein 21)	TRIM21 RNF81 RO52 SSA1	11312;	9606.ENSP00000254436;
Q9NYK1	TLR7_HUMAN	reviewed	Evidence at protein level	5 out of 5	Toll-like receptor 7	TLR7 UNQ248/PRO285	15631;	9606.ENSP00000370034;
Q9NZC2	TREM2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Triggering receptor expressed on myeloid cells 2 (TREM-2) (Triggering receptor expressed on monocytes 2)	TREM2	17761;	9606.ENSP00000362205;
P22314	UBA1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Protein A1S9) (Ubiquitin-activating enzyme E1)	UBA1 A1S9T UBE1	12469;	9606.ENSP00000338413;
Q9NQ66	PLCB1_HUMAN	reviewed	Evidence at protein level	5 out of 5	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 (EC 3.1.4.11) (PLC-154) (Phosphoinositide phospholipase C-beta-1) (Phospholipase C-I) (PLC-I) (Phospholipase C-beta-1) (PLC-beta-1)	PLCB1 KIAA0581	15917;	9606.ENSP00000338185;
P02776	PLF4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Platelet factor 4 (PF-4) (C-X-C motif chemokine 4) (Iroplact) (Oncostatin-A) [Cleaved into: Platelet factor 4, short form (Endothelial cell growth inhibitor)]	PF4 CXCL4 SCYB4	8861;	9606.ENSP00000296029;
P49190	PTH2R_HUMAN	reviewed	Evidence at protein level	5 out of 5	Parathyroid hormone 2 receptor (PTH2 receptor)	PTH2R PTHR2	9609;	9606.ENSP00000272847;
Q9BXA5	SUCR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Succinate receptor 1 (G-protein coupled receptor 91) (P2Y purinoceptor 1-like)	SUCNR1 GPR91	4542;	9606.ENSP00000355156;
Q06330	SUH_HUMAN	reviewed	Evidence at protein level	5 out of 5	Recombining binding protein suppressor of hairless (CBF-1) (J kappa-recombination signal-binding protein) (RBP-J kappa) (RBP-J) (RBP-JK) (Renal carcinoma antigen NY-REN-30)	RBPJ IGKJRB IGKJRB1 RBPJK RBPSUH	5724;	9606.ENSP00000345206;
Q9Y2C9	TLR6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Toll-like receptor 6 (CD antigen CD286)	TLR6	16711;	9606.ENSP00000389600;
P48023	TNFL6_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tumor necrosis factor ligand superfamily member 6 (Apoptosis antigen ligand) (APTL) (CD95 ligand) (CD95-L) (Fas antigen ligand) (Fas ligand) (FasL) (CD antigen CD178) [Cleaved into: Tumor necrosis factor ligand superfamily member 6, membrane form; Tumor necrosis factor ligand superfamily member 6, soluble form (Receptor-binding FasL ectodomain) (Soluble Fas ligand) (sFasL); ADAM10-processed FasL form (APL); FasL intracellular domain (FasL ICD) (SPPL2A-processed FasL form) (SPA)]	FASLG APT1LG1 CD95L FASL TNFSF6	11936;	9606.ENSP00000356694;
P01222	TSHB_HUMAN	reviewed	Evidence at protein level	5 out of 5	Thyrotropin subunit beta (Thyroid-stimulating hormone subunit beta) (TSH-B) (TSH-beta) (Thyrotropin beta chain) (Thyrotropin alfa)	TSHB	12372;	9606.ENSP00000256592;
Q56P42	PYDC2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Pyrin domain-containing protein 2 (Pyrin-only protein 2) (cellular POP2) (cPOP2)	PYDC2 POP2	33512;	9606.ENSP00000428325;
Q13464	ROCK1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Rho-associated protein kinase 1 (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-35) (Rho-associated, coiled-coil-containing protein kinase 1) (Rho-associated, coiled-coil-containing protein kinase I) (ROCK-I) (p160 ROCK-1) (p160ROCK)	ROCK1	10251;	9606.ENSP00000382697;
P43489	TNR4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tumor necrosis factor receptor superfamily member 4 (ACT35 antigen) (OX40L receptor) (TAX transcriptionally-activated glycoprotein 1 receptor) (CD antigen CD134)	TNFRSF4 TXGP1L	11918;	9606.ENSP00000368538;
Q9P2E3	ZNFX1_HUMAN	reviewed	Evidence at protein level	5 out of 5	NFX1-type zinc finger-containing protein 1	ZNFX1 KIAA1404	29271;	9606.ENSP00000379412;
P41587	VIPR2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Vasoactive intestinal polypeptide receptor 2 (VIP-R-2) (Helodermin-preferring VIP receptor) (Pituitary adenylate cyclase-activating polypeptide type III receptor) (PACAP type III receptor) (PACAP-R-3) (PACAP-R3) (VPAC2)	VIPR2 VIP2R	12695;	9606.ENSP00000262178;
P58753	TIRAP_HUMAN	reviewed	Evidence at protein level	5 out of 5	Toll/interleukin-1 receptor domain-containing adapter protein (TIR domain-containing adapter protein) (Adaptor protein Wyatt) (MyD88 adapter-like protein) (MyD88-2)	TIRAP MAL	17192;	9606.ENSP00000376445;
Q15942	ZYX_HUMAN	reviewed	Evidence at protein level	5 out of 5	Zyxin (Zyxin-2)	ZYX	13200;	9606.ENSP00000324422;
Q9ULT0	TTC7A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tetratricopeptide repeat protein 7A (TPR repeat protein 7A)	TTC7A KIAA1140 TTC7	19750;	9606.ENSP00000378320;
Q9H892	TTC12_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tetratricopeptide repeat protein 12 (TPR repeat protein 12)	TTC12	23700;	9606.ENSP00000433757;
Q92956	TNR14_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tumor necrosis factor receptor superfamily member 14 (Herpes virus entry mediator A) (Herpesvirus entry mediator A) (HveA) (Tumor necrosis factor receptor-like 2) (TR2) (CD antigen CD270)	TNFRSF14 HVEA HVEM UNQ329/PRO509	11912;	9606.ENSP00000347948;
P00734	THRB_HUMAN	reviewed	Evidence at protein level	5 out of 5	Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain]	F2	3535;	9606.ENSP00000308541;
Q9C0K1	S39A8_HUMAN	reviewed	Evidence at protein level	5 out of 5	Metal cation symporter ZIP8 (BCG-induced integral membrane protein in monocyte clone 103 protein) (LIV-1 subfamily of ZIP zinc transporter 6) (LZT-Hs6) (Solute carrier family 39 member 8) (Zrt- and Irt-like protein 8) (ZIP-8)	SLC39A8 BIGM103 ZIP8 PP3105	20862;	9606.ENSP00000378310;
Q9NYA1	SPHK1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Sphingosine kinase 1 (SK 1) (SPK 1) (EC 2.7.1.91) (Acetyltransferase SPHK1) (EC 2.3.1.-)	SPHK1 SK1 SPHK SPK	11240;	9606.ENSP00000313681;
O43508	TNF12_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tumor necrosis factor ligand superfamily member 12 (APO3 ligand) (TNF-related weak inducer of apoptosis) (TWEAK) [Cleaved into: Tumor necrosis factor ligand superfamily member 12, membrane form; Tumor necrosis factor ligand superfamily member 12, secreted form]	TNFSF12 APO3L DR3LG UNQ181/PRO207	11927;	9606.ENSP00000293825;
P20333	TNR1B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tumor necrosis factor receptor superfamily member 1B (Tumor necrosis factor receptor 2) (TNF-R2) (Tumor necrosis factor receptor type II) (TNF-RII) (TNFR-II) (p75) (p80 TNF-alpha receptor) (CD antigen CD120b) (Etanercept) [Cleaved into: Tumor necrosis factor receptor superfamily member 1b, membrane form; Tumor necrosis factor-binding protein 2 (TBP-2) (TBPII)]	TNFRSF1B TNFBR TNFR2	11917;	9606.ENSP00000365435;
Q9UMW8	UBP18_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ubl carboxyl-terminal hydrolase 18 (EC 3.4.19.-) (43 kDa ISG15-specific protease) (hUBP43) (ISG15-specific-processing protease) (Ubl thioesterase 18)	USP18 ISG43	12616;	9606.ENSP00000215794;
P35968	VGFR2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase insert domain receptor) (KDR) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309)	KDR FLK1 VEGFR2	6307;	9606.ENSP00000263923;
O75800	ZMY10_HUMAN	reviewed	Evidence at protein level	5 out of 5	Zinc finger MYND domain-containing protein 10 (Protein BLu)	ZMYND10 BLU LUCA12.4	19412;	9606.ENSP00000231749;
P21731	TA2R_HUMAN	reviewed	Evidence at protein level	5 out of 5	Thromboxane A2 receptor (TXA2-R) (Prostanoid TP receptor)	TBXA2R	11608;	9606.ENSP00000393333;
Q9NYY3	PLK2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (hPlk2) (Serine/threonine-protein kinase SNK) (hSNK) (Serum-inducible kinase)	PLK2 SNK	19699;	9606.ENSP00000274289;
P61165	TM258_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transmembrane protein 258 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TMEM258) (Oligosaccharyl transferase subunit TMEM258)	TMEM258 C11orf10 HSPC005	1164;	9606.ENSP00000443216;
Q8TF42	UBS3B_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ubiquitin-associated and SH3 domain-containing protein B (EC 3.1.3.48) (Cbl-interacting protein p70) (Suppressor of T-cell receptor signaling 1) (STS-1) (T-cell ubiquitin ligand 2) (TULA-2) (Tyrosine-protein phosphatase STS1/TULA2)	UBASH3B KIAA1959 STS1	29884;	9606.ENSP00000284273;
P07477	TRY1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Serine protease 1 (EC 3.4.21.4) (Anionic trypsin I) (Anionic trypsin-I) (Beta-trypsin) (Cationic trypsinogen) (Pretrypsinogen I) (Trypsin I) (Trypsin-1) [Cleaved into: Alpha-trypsin chain 1; Alpha-trypsin chain 2]	PRSS1 TRP1 TRY1 TRYP1	9475;	9606.ENSP00000308720;
O60636	TSN2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tetraspanin-2 (Tspan-2) (Tetraspan NET-3)	TSPAN2	20659;	9606.ENSP00000358529;
P0DMS9	TMIG3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transmembrane domain-containing protein TMIGD3	TMIGD3 UNQ1931/PRO4406	51375;	9606.ENSP00000358730;
P01270	PTHY_HUMAN	reviewed	Evidence at protein level	5 out of 5	Parathyroid hormone (PTH) (Parathormone) (Parathyrin)	PTH	9606;	9606.ENSP00000282091;
O60602	TLR5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Toll-like receptor 5 (Toll/interleukin-1 receptor-like protein 3)	TLR5 TIL3	11851;	9606.ENSP00000440643;
P48061	SDF1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Stromal cell-derived factor 1 (SDF-1) (hSDF-1) (C-X-C motif chemokine 12) (Intercrine reduced in hepatomas) (IRH) (hIRH) (Pre-B cell growth-stimulating factor) (PBSF) [Cleaved into: SDF-1-beta(3-72); SDF-1-alpha(3-67)]	CXCL12 SDF1 SDF1A SDF1B	10672;	9606.ENSP00000379140;
O94979	SC31A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein transport protein Sec31A (ABP125) (ABP130) (SEC31-like protein 1) (SEC31-related protein A) (Web1-like protein)	SEC31A KIAA0905 SEC31L1 HSPC275 HSPC334	17052;	9606.ENSP00000378721;
Q9NR00	TCIM_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transcriptional and immune response regulator (Thyroid cancer protein 1) (TC-1)	TCIM C8orf4 TC1	1357;	9606.ENSP00000319914;
P17948	VGFR1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase FRT) (Tyrosine-protein kinase receptor FLT) (FLT) (Vascular permeability factor receptor)	FLT1 FLT FRT VEGFR1	3763;	9606.ENSP00000282397;
Q6GMV2	SMYD5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Histone-lysine N-trimethyltransferase SMYD5 (EC 2.1.1.372) (Protein NN8-4AG) (Retinoic acid-induced protein 15) (SET and MYND domain-containing protein 5) ([histone H4]-lysine20 N-trimethyltransferase SMYD5)	SMYD5 RAI15	16258;	9606.ENSP00000374152;
Q96LC7	SIG10_HUMAN	reviewed	Evidence at protein level	5 out of 5	Sialic acid-binding Ig-like lectin 10 (Siglec-10) (Siglec-like protein 2)	SIGLEC10 SLG2 UNQ477/PRO940	15620;	9606.ENSP00000345243;
Q9UEW8	STK39_HUMAN	reviewed	Evidence at protein level	5 out of 5	STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)	STK39 SPAK	17717;	9606.ENSP00000348278;
Q8WUA8	TSK_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tsukushi (E2-induced gene 4 protein) (Leucine-rich repeat-containing protein 54)	TSKU E2IG4 LRRC54 TSK UNQ850/PRO1788	28850;	9606.ENSP00000434847;
Q6PJF5	RHDF2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Inactive rhomboid protein 2 (iRhom2) (Rhomboid 5 homolog 2) (Rhomboid family member 2) (Rhomboid veinlet-like protein 5) (Rhomboid veinlet-like protein 6)	RHBDF2 IRHOM2 RHBDL5 RHBDL6	20788;	9606.ENSP00000322775;
Q9HD89	RETN_HUMAN	reviewed	Evidence at protein level	5 out of 5	Resistin (Adipose tissue-specific secretory factor) (ADSF) (C/EBP-epsilon-regulated myeloid-specific secreted cysteine-rich protein) (Cysteine-rich secreted protein A12-alpha-like 2) (Cysteine-rich secreted protein FIZZ3)	RETN FIZZ3 HXCP1 RSTN UNQ407/PRO1199	20389;	9606.ENSP00000221515;
Q04206	TF65_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transcription factor p65 (Nuclear factor NF-kappa-B p65 subunit) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3)	RELA NFKB3	9955;	9606.ENSP00000384273;
Q9UK33	ZN580_HUMAN	reviewed	Evidence at protein level	5 out of 5	Zinc finger protein 580 (LDL-induced EC protein)	ZNF580	29473;	9606.ENSP00000443957;
Q9NSU2	TREX1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Three-prime repair exonuclease 1 (EC 3.1.11.2) (3'-5' exonuclease TREX1) (Deoxyribonuclease III) (DNase III)	TREX1	12269;	9606.ENSP00000296443;
O60603	TLR2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Toll-like receptor 2 (Toll/interleukin-1 receptor-like protein 4) (CD antigen CD282)	TLR2 TIL4	11848;	9606.ENSP00000260010;
O00206	TLR4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Toll-like receptor 4 (hToll) (CD antigen CD284)	TLR4	11850;	9606.ENSP00000363089;
Q01453	PMP22_HUMAN	reviewed	Evidence at protein level	5 out of 5	Peripheral myelin protein 22 (PMP-22) (Growth arrest-specific protein 3) (GAS-3)	PMP22 GAS3	9118;	9606.ENSP00000484631;
P08575	PTPRC_HUMAN	reviewed	Evidence at protein level	5 out of 5	Receptor-type tyrosine-protein phosphatase C (EC 3.1.3.48) (Leukocyte common antigen) (L-CA) (T200) (CD antigen CD45)	PTPRC CD45	9666;	9606.ENSP00000411355;
P20366	TKN1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protachykinin-1 (PPT) [Cleaved into: Substance P; Neurokinin A (NKA) (Neuromedin L) (Substance K); Neuropeptide K (NPK); Neuropeptide gamma; C-terminal-flanking peptide]	TAC1 NKA NKNA TAC2	11517;	9606.ENSP00000321106;
Q86UU9	TKN4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tachykinin-4 (Preprotachykinin-C) (PPT-C) [Cleaved into: Endokinin-A (EKA); Endokinin-A/B (EKA/B); Endokinin-C (EKC)]	TAC4	16641;	9606.ENSP00000334042;
Q9BVG3	TRI62_HUMAN	reviewed	Evidence at protein level	5 out of 5	E3 ubiquitin-protein ligase TRIM62 (EC 2.3.2.27) (Tripartite motif-containing protein 62)	TRIM62	25574;	9606.ENSP00000291416;
P19438	TNR1A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tumor necrosis factor receptor superfamily member 1A (Tumor necrosis factor receptor 1) (TNF-R1) (Tumor necrosis factor receptor type I) (TNF-RI) (TNFR-I) (p55) (p60) (CD antigen CD120a) [Cleaved into: Tumor necrosis factor receptor superfamily member 1A, membrane form; Tumor necrosis factor-binding protein 1 (TBPI)]	TNFRSF1A TNFAR TNFR1	11916;	9606.ENSP00000162749;
Q15672	TWST1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Twist-related protein 1 (Class A basic helix-loop-helix protein 38) (bHLHa38) (H-twist)	TWIST1 BHLHA38 TWIST	12428;	9606.ENSP00000242261;
P21754	ZP3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Zona pellucida sperm-binding protein 3 (Sperm receptor) (ZP3A/ZP3B) (Zona pellucida glycoprotein 3) (Zp-3) (Zona pellucida protein C) [Cleaved into: Processed zona pellucida sperm-binding protein 3]	ZP3 ZP3A ZP3B ZPC	13189;	9606.ENSP00000378326;
O43164	PJA2_HUMAN	reviewed	Evidence at protein level	5 out of 5	E3 ubiquitin-protein ligase Praja-2 (Praja2) (EC 2.3.2.27) (RING finger protein 131) (RING-type E3 ubiquitin transferase Praja-2)	PJA2 KIAA0438 RNF131	17481;	9606.ENSP00000354775;
Q04912	RON_HUMAN	reviewed	Evidence at protein level	5 out of 5	Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (CDw136) (Protein-tyrosine kinase 8) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain]	MST1R PTK8 RON	7381;	9606.ENSP00000296474;
P40818	UBP8_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ubiquitin carboxyl-terminal hydrolase 8 (EC 3.4.19.12) (Deubiquitinating enzyme 8) (Ubiquitin isopeptidase Y) (hUBPy) (Ubiquitin thioesterase 8) (Ubiquitin-specific-processing protease 8)	USP8 KIAA0055 UBPY	12631;	9606.ENSP00000379721;
P01282	VIP_HUMAN	reviewed	Evidence at protein level	5 out of 5	VIP peptides [Cleaved into: Intestinal peptide PHV-42 (Peptide histidine valine 42); Intestinal peptide PHM-27 (Peptide histidine methioninamide 27); Vasoactive intestinal peptide (VIP) (Vasoactive intestinal polypeptide)]	VIP	12693;	9606.ENSP00000356213;
P55089	UCN1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Urocortin	UCN	12516;	9606.ENSP00000296099;
Q9HBA0	TRPV4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Transient receptor potential cation channel subfamily V member 4 (TrpV4) (Osm-9-like TRP channel 4) (OTRPC4) (Transient receptor potential protein 12) (TRP12) (Vanilloid receptor-like channel 2) (Vanilloid receptor-like protein 2) (VRL-2) (Vanilloid receptor-related osmotically-activated channel) (VR-OAC)	TRPV4 VRL2 VROAC	18083;	9606.ENSP00000406191;
Q8IWB7	WDFY1_HUMAN	reviewed	Evidence at protein level	5 out of 5	WD repeat and FYVE domain-containing protein 1 (FYVE domain-containing protein localized to endosomes 1) (FENS-1) (Phosphoinositide-binding protein 1) (WD40- and FYVE domain-containing protein 1) (Zinc finger FYVE domain-containing protein 17)	WDFY1 FENS1 KIAA1435 WDF1 ZFYVE17	20451;	9606.ENSP00000233055;
Q9UL17	TBX21_HUMAN	reviewed	Evidence at protein level	5 out of 5	T-box transcription factor TBX21 (T-box protein 21) (T-cell-specific T-box transcription factor T-bet) (Transcription factor TBLYM)	TBX21 TBET TBLYM	11599;	9606.ENSP00000177694;
P06753	TPM3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tropomyosin alpha-3 chain (Gamma-tropomyosin) (Tropomyosin-3) (Tropomyosin-5) (hTM5)	TPM3	12012;	9606.ENSP00000357516;
Q06418	TYRO3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tyrosine-protein kinase receptor TYRO3 (EC 2.7.10.1) (Tyrosine-protein kinase BYK) (Tyrosine-protein kinase DTK) (Tyrosine-protein kinase RSE) (Tyrosine-protein kinase SKY) (Tyrosine-protein kinase TIF)	TYRO3 BYK DTK RSE SKY TIF	12446;	9606.ENSP00000263798;
P01375	TNFA_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]	TNF TNFA TNFSF2	11892;	9606.ENSP00000398698;
P25942	TNR5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tumor necrosis factor receptor superfamily member 5 (B-cell surface antigen CD40) (Bp50) (CD40L receptor) (CDw40) (CD antigen CD40)	CD40 TNFRSF5	11919;	9606.ENSP00000361359;
O94874	UFL1_HUMAN	reviewed	Evidence at protein level	5 out of 5	E3 UFM1-protein ligase 1 (EC 2.3.2.-) (E3 UFM1-protein transferase 1) (Multiple alpha-helix protein located at ER) (Novel LZAP-binding protein) (Regulator of C53/LZAP and DDRGK1)	UFL1 KIAA0776 MAXER NLBP RCAD	23039;	9606.ENSP00000358283;
P30518	V2R_HUMAN	reviewed	Evidence at protein level	5 out of 5	Vasopressin V2 receptor (V2R) (AVPR V2) (Antidiuretic hormone receptor) (Renal-type arginine vasopressin receptor)	AVPR2 ADHR DIR DIR3 V2R	897;	9606.ENSP00000351805;
Q13488	VPP3_HUMAN	reviewed	Evidence at protein level	5 out of 5	V-type proton ATPase 116 kDa subunit a 3 (V-ATPase 116 kDa subunit a 3) (Osteoclastic proton pump 116 kDa subunit) (OC-116 kDa) (OC116) (T-cell immune regulator 1) (T-cell immune response cDNA7 protein) (TIRC7) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 3)	TCIRG1 ATP6N1C ATP6V0A3	11647;	9606.ENSP00000265686;
Q9UHD2	TBK1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (NF-kappa-B-activating kinase) (T2K) (TANK-binding kinase 1)	TBK1 NAK	11584;	9606.ENSP00000329967;
P68036	UB2L3_HUMAN	reviewed	Evidence at protein level	5 out of 5	Ubiquitin-conjugating enzyme E2 L3 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme L3) (L-UBC) (UbcH7) (Ubiquitin carrier protein L3) (Ubiquitin-conjugating enzyme E2-F1) (Ubiquitin-protein ligase L3)	UBE2L3 UBCE7 UBCH7	12488;	9606.ENSP00000485133;
P78423	X3CL1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Fractalkine (C-X3-C motif chemokine 1) (CX3C membrane-anchored chemokine) (Neurotactin) (Small-inducible cytokine D1) [Cleaved into: Processed fractalkine]	CX3CL1 FKN NTT SCYD1 A-152E5.2	10647;	9606.ENSP00000006053;
B6A8C7	TARM1_HUMAN	reviewed	Evidence at protein level	5 out of 5	T-cell-interacting, activating receptor on myeloid cells protein 1 (OSCAR-like transcript-2 protein) (OLT-2)	TARM1	37250;	9606.ENSP00000439454;
P62328	TYB4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Thymosin beta-4 (T beta-4) (Fx) [Cleaved into: Hematopoietic system regulatory peptide (Seraspenide)]	TMSB4X TB4X THYB4 TMSB4	11881;	9606.ENSP00000370010;
P16473	TSHR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R)	TSHR LGR3	12373;	9606.ENSP00000441235;
P07947	YES_HUMAN	reviewed	Evidence at protein level	5 out of 5	Tyrosine-protein kinase Yes (EC 2.7.10.2) (Proto-oncogene c-Yes) (p61-Yes)	YES1 YES	12841;	9606.ENSP00000462468;
Q8WVJ9	TWST2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Twist-related protein 2 (Class A basic helix-loop-helix protein 39) (bHLHa39) (Dermis-expressed protein 1) (Dermo-1)	TWIST2 BHLHA39 DERMO1	20670;	9606.ENSP00000482581;
O95995	DRC4_HUMAN	reviewed	Evidence at protein level	5 out of 5	Dynein regulatory complex subunit 4 (Growth arrest-specific protein 11) (GAS-11) (Growth arrest-specific protein 8) (GAS-8)	GAS8 DRC4 GAS11	4166;	9606.ENSP00000268699;
P19440	GGT1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain]	GGT1 GGT	4250;	9606.ENSP00000383232;
P81172	HEPC_HUMAN	reviewed	Evidence at protein level	5 out of 5	Hepcidin (Liver-expressed antimicrobial peptide 1) (LEAP-1) (Putative liver tumor regressor) (PLTR) [Cleaved into: Hepcidin-25 (Hepc25); Hepcidin-20 (Hepc20)]	HAMP HEPC LEAP1 UNQ487/PRO1003	15598;	9606.ENSP00000471894;
P10145	IL8_HUMAN	reviewed	Evidence at protein level	5 out of 5	Interleukin-8 (IL-8) (C-X-C motif chemokine 8) (Chemokine (C-X-C motif) ligand 8) (Emoctakin) (Granulocyte chemotactic protein 1) (GCP-1) (Monocyte-derived neutrophil chemotactic factor) (MDNCF) (Monocyte-derived neutrophil-activating peptide) (MONAP) (Neutrophil-activating protein 1) (NAP-1) (Protein 3-10C) (T-cell chemotactic factor) [Cleaved into: MDNCF-a (GCP/IL-8 protein IV) (IL8/NAP1 form I); Interleukin-8 ((Ala-IL-8)77) (GCP/IL-8 protein II) (IL-8(1-77)) (IL8/NAP1 form II) (MDNCF-b); IL-8(5-77); IL-8(6-77) ((Ser-IL-8)72) (GCP/IL-8 protein I) (IL8/NAP1 form III) (Lymphocyte-derived neutrophil-activating factor) (LYNAP) (MDNCF-c) (Neutrophil-activating factor) (NAF); IL-8(7-77) (GCP/IL-8 protein V) (IL8/NAP1 form IV); IL-8(8-77) (GCP/IL-8 protein VI) (IL8/NAP1 form V); IL-8(9-77) (GCP/IL-8 protein III) (IL8/NAP1 form VI)]	CXCL8 IL8	6025;	9606.ENSP00000306512;
Q9Y5W3	KLF2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Krueppel-like factor 2 (Lung krueppel-like factor)	KLF2 LKLF	6347;	9606.ENSP00000248071;
O95678	K2C75_HUMAN	reviewed	Evidence at protein level	5 out of 5	Keratin, type II cytoskeletal 75 (Cytokeratin-75) (CK-75) (Keratin-6 hair follicle) (hK6hf) (Keratin-75) (K75) (Type II keratin-K6hf) (Type-II keratin Kb18)	KRT75 K6HF KB18	24431;	9606.ENSP00000252245;
P01130	LDLR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Low-density lipoprotein receptor (LDL receptor)	LDLR	6547;	9606.ENSP00000454071;
P53778	MK12_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mitogen-activated protein kinase 12 (MAP kinase 12) (MAPK 12) (EC 2.7.11.24) (Extracellular signal-regulated kinase 6) (ERK-6) (Mitogen-activated protein kinase p38 gamma) (MAP kinase p38 gamma) (Stress-activated protein kinase 3)	MAPK12 ERK6 SAPK3	6874;	9606.ENSP00000215659;
Q9UKN1	MUC12_HUMAN	reviewed	Evidence at protein level	5 out of 5	Mucin-12 (MUC-12) (Mucin-11) (MUC-11)	MUC12 MUC11	7510;	9606.ENSP00000441929;
Q16719	KYNU_HUMAN	reviewed	Evidence at protein level	5 out of 5	Kynureninase (EC 3.7.1.3) (L-kynurenine hydrolase)	KYNU	6469;	9606.ENSP00000264170;
Q05513	KPCZ_HUMAN	reviewed	Evidence at protein level	5 out of 5	Protein kinase C zeta type (EC 2.7.11.13) (nPKC-zeta)	PRKCZ PKC2	9412;	9606.ENSP00000367830;
P38571	LICH_HUMAN	reviewed	Evidence at protein level	5 out of 5	Lysosomal acid lipase/cholesteryl ester hydrolase (Acid cholesteryl ester hydrolase) (LAL) (EC 3.1.1.13) (Cholesteryl esterase) (Lipase A) (Sterol esterase)	LIPA	6617;	9606.ENSP00000337354;
Q92539	LPIN2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Phosphatidate phosphatase LPIN2 (EC 3.1.3.4) (Lipin-2)	LPIN2 KIAA0249	14450;	9606.ENSP00000261596;
P59046	NAL12_HUMAN	reviewed	Evidence at protein level	5 out of 5	NACHT, LRR and PYD domains-containing protein 12 (Monarch-1) (PYRIN-containing APAF1-like protein 7) (Regulated by nitric oxide)	NLRP12 NALP12 PYPAF7 RNO	22938;	9606.ENSP00000375653;
Q86W24	NAL14_HUMAN	reviewed	Evidence at protein level	5 out of 5	NACHT, LRR and PYD domains-containing protein 14 (Nucleotide-binding oligomerization domain protein 5)	NLRP14 NALP14 NOD5	22939;	9606.ENSP00000299481;
Q9NR99	MXRA5_HUMAN	reviewed	Evidence at protein level	5 out of 5	Matrix-remodeling-associated protein 5 (Adhesion protein with leucine-rich repeats and immunoglobulin domains related to perlecan) (Adlican)	MXRA5	7539;	9606.ENSP00000217939;
O75113	N4BP1_HUMAN	reviewed	Evidence at protein level	5 out of 5	NEDD4-binding protein 1 (N4BP1) (EC 3.1.-.-)	N4BP1 KIAA0615	29850;	9606.ENSP00000262384;
B2RTY4	MYO9A_HUMAN	reviewed	Evidence at protein level	5 out of 5	Unconventional myosin-IXa (Unconventional myosin-9a)	MYO9A MYR7	7608;	9606.ENSP00000348349;
Q6IQ20	NAPEP_HUMAN	reviewed	Evidence at protein level	5 out of 5	N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D (N-acyl phosphatidylethanolamine phospholipase D) (NAPE-PLD) (NAPE-hydrolyzing phospholipase D) (EC 3.1.4.54)	NAPEPLD C7orf18	21683;	9606.ENSP00000407112;
P25189	MYP0_HUMAN	reviewed	Evidence at protein level	5 out of 5	Myelin protein P0 (Myelin peripheral protein) (MPP) (Myelin protein zero)	MPZ	7225;	9606.ENSP00000432943;
P60201	MYPR_HUMAN	reviewed	Evidence at protein level	5 out of 5	Myelin proteolipid protein (PLP) (Lipophilin)	PLP1 PLP	9086;	9606.ENSP00000481006;
Q5VVJ2	MYSM1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Deubiquitinase MYSM1 (2A-DUB) (EC 3.4.19.-) (Myb-like, SWIRM and MPN domain-containing protein 1)	MYSM1 KIAA1915	29401;	9606.ENSP00000418734;
Q8WU39	MZB1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Marginal zone B- and B1-cell-specific protein (Mesenteric estrogen-dependent adipose 7) (MEDA-7) (Plasma cell-induced resident endoplasmic reticulum protein) (Plasma cell-induced resident ER protein) (pERp1) (Proapoptotic caspase adapter protein)	MZB1 MEDA7 PACAP HSPC190	30125;	9606.ENSP00000303920;
P19838	NFKB1_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit]	NFKB1	7794;	9606.ENSP00000226574;
Q00653	NFKB2_HUMAN	reviewed	Evidence at protein level	5 out of 5	Nuclear factor NF-kappa-B p100 subunit (DNA-binding factor KBF2) (H2TF1) (Lymphocyte translocation chromosome 10 protein) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2) (Oncogene Lyt-10) (Lyt10) [Cleaved into: Nuclear factor NF-kappa-B p52 subunit]	NFKB2 LYT10	7795;	9606.ENSP00000358983;
Q13287	NMI_HUMAN	reviewed	Evidence at protein level	5 out of 5	N-myc-interactor (Nmi) (N-myc and STAT interactor)	NMI	7854;	9606.ENSP00000243346;
